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The investigation was undertaken to study the 
effect of free fatty acids (FFA) on the performance 
of the ischaemic myocardium and the role of myocardial 
lipolysis in contributing to tissue FFA concentration.
An initial investigation using heart muscle extracts 
demonstrated cyclic-AMP stimulation of lipase hydrolysis 
of triglycerides but not monoglyceride. Subsequently, 
an investigation of the role of myocardial lipolysis 
in the ischaemically-perfused rat heart was begun.
The results demonstrated the deleterious effects 
on heart performance of FFA generated from myocardial 
triglyceride. Exogenous FFA had much less effect, 
arguing for a more potent effect or greater
availability of endogenously-generated FFA. With hearts 
from normally-fed rats, adrenaline induced inotropic and 
chronotropic (first phase) responses. These were followed 
by marked (second phase) deteriorations in performance - 
decline in beatrate and developed tension, increases in
resting tension and incidence of arrhythmias - which were
proportional to the rates of lactate and FFA release.
The deteriorations were greatly reduced by the abolition 
of the lipolytic component of the adrenaline challenge 
with nicotinic acid, at concentrations which did not 
inhibit the first phase responses. Reduction of FFA 
release also encouraged glucose oxidation.
With hearts from fat-fed rats (depending exclusively 
upon endogenous lipid as an energy source) performance was 
depressed whilst lipolysis was stimulated relative to the
normally-fed series. In addition, the performance of these 
hearts declined more markedly after adrenaline - the high 
incidence of ventricular fibrillation (V.F.) being 
particularly marked. Nicotinic acid again offered protection 
- in particular, abolishing V.F,
In both series, adrenaline challenge increased the
tissue FFA concentration and this was offset with 
nicotinic acid. In addition, adrenaline greatly stimulated 
the accumulation of FFA within the myocardium. The 
deteriorative effects on performance could not be ascribed 
solely to FFA since lactate was usually increased.
However, several observations suggest that FFA are of 
primary significance and these factors are discussed.
INTRODUCTION
SECTION A The Mammalian Heart
1. The organ and its Function
(a) Double Circulation The heart is a constantly-acting 
muscular pump which drives blood to the lungs and body in 
the pulmonary and systemic circulations respectively. The 
pump is divided into two halves to provide this double 
circulation. The left side receives oxygenated blood from
the lungs, delivering this to the systemic circulation; the 
right side receives deoxygenated blood from the body to 
deliver to the lungs (fig la). Each side of the heart is 
equipped with two chambers, the atria which receive blood 
are delicate compared to the muscular ventricles which drive
blood out into the circulations.
The two sides of the heart must pump at an exactly- 
matched rate in order that blood should nOt accumulate in
one circulation at the expense of the other. This balance 
is achieved despite a great difference in volume capacity 
and pressure develpment in the two circulations. The left
ventricle is much more powerful (with thicker walls) than
the right ventricle to enable it to develop the high pressure
necessary to drive blood into the aorta. Left ventricular
pressure rises to a peak of about 100mm mercury during
contraction (systole) compared to about 25 mm mercury in 
the right ventricle. Of the total heart muscle, about
two-thirds is represented by left ventricular muscle.
The pumping action of the heart is achieved not by
contractions in a single phase as with most skeletal 
muscle but instead, a convoluted fibre arrangement is 
displayed (figure lb). A wave of contraction spreads 
upwards from the apex of the ventricles forcing blood 
upwards and out through the arterial valves. Similar valves 
between auricles and ventricles oppose reverse flow of 
blood into the auricles. The sequence of contraction 
(systole) and relaxation (diastole) is described as the 
cardiac cycle, shown in figure 2.
(b) Coronary - Circulation The heart tissue, as any
other highly active tissue, requires an extensive supply 
of blood to deliver substrates and remove products. ' The 
chamber blood contributes relatively little to the needs of
the heart which are met, instead, by a discrete coronary 
circulation. The circulation begins with coronary arteries 
which branch from the aorta very near the aortic valve, thus 
delivering highly oxygenated blood to the myocardium. The 
circulation begins at the outer surface or subepicardial 
region from which the vessels branch into the mid- and 
subendocardial regions. An important aspect of the coronary 
circulation is the relationship between coronary flow and 
the phase of the cardiac cycle. The flow is restricted 
mainly to the diastolic period since during systole the 
increase in myocardial wall tension causes extensive 
occlusion of the coronary vessels. The occlusion is most 
extensive and of longest duration in the subendocardial 
region, figure 3. It can be seen that the supply of blood 
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These are (i) that the region is subject to the greatest
degree of occlusion and (ii) that it is most distal from
the point of initial (aortic) supply. The consequences of 
this situation will be discussed later.
The venous system of the myocardium conveys most of
the deoxygenated blood to the right atrium via the
coronary sinus although a small but significant drainage
of blood occurs directly into the chambers through . the
Thebesian and other small veins.
Another feature of the coronary circulation is the
relatively limited extent of cross-perfusion afforded by
anastomoses. The effect is that in the event of
occlusion of a major vessel, there is only a limited 
capacity for the deprived tissue to draw upon supply
from other vessels. Improvement of cross-perfusion can
occur with the development of collateral vessels but a
particular stimulus is required to increase
vascularisation. It can occur in response to coronary 
artery ligation (Charlier, 1972) and to physical
training (Penpargkul and Scheuer, 1970).
2. The heart as a muscle
(a) Ultrastructure The essential features of the 
ultrastructure of the myocardium are shown in figure 4.
The myofibrils show the striated nature (as skeletal muscle)
and the mechanism of contraction in the two types of
muscle is essentially the same (Sonnenblich 1962, Huxley 1975). 
The myofibrils are in intimate contact with sarcoplasmic 
reticulum - consistent with the involvement of the latter
in the release -sequestration of calcium ions required for 
contraction. (Naylor, 1967j Rasmussen and Tenenhouse, 1968;
Katz and Repke, 1973). The large number of mitochondria
and their highly cristate structure illustrates the highly 
oxidative nature of myocardial metabolism - in marked'
contrast to the glycolytically-oriented fast skeletal muscle. 
Glycogen granules and lipid droplets represent internal 
stores of energy substrates (Stein and Stein, 1963).
(b) Performance of the muscle The classical work of
Frank (1895) and Starling (1918) using the heart-lung 
preparation, first described the characteristics of the working 
heart which provided such subtle adaptability to the 
changing needs of the body. The essential- nature of the 
contractility which they described was the ability to 
increase cardiac output in response to a rise in venous 
(i.e. filling) pressure. Increased ventricular filling 
caused ah increase of diastolic fibre length which in turn 
induced increase in strength of contraction. (Up to a 
point beyond which a further increase in diastolic length
Figure 4

















Adapted from Kelman, 1971.
induces no further increase in output but instead induces
failure). This is described as the length-tension 
relationship.
In addition to the effect of atrial filling pressure 
(preload) upon performance, subsequent studies have shown the 
importance of two other major factors - aortic pressure 
(afterload) and contractile state of the muscle. The studies 
have mainly employed the isolated papillary muscles of rats 
and cats. Papillary muscles are the cone -shaped muscles
which project from the inner, endocardial surface of the 
ventricles and anchor the valves via their extensions - 
the cordae tendonae. The work has led to an elegant
description of myocardial contractility and the factors which 
influence it. These are described in the force - velocity 
relationship of Sonnenblick (1962, 1974), Parmley and 
Sonnenblick (1969). This relationship is derived by the 
study of the velocity of shortening of muscle over a range 
of imposed afterloads. Contractility is further described 
in the three - dimensional force - velocity - length 
relationship of Henderson and Brutsaert (1973) - figure 5.
These relationships are difficult to apply directly to 
the intact heart since they have been established using
isolated muscle preparations. Attempts have therefore been 
made to test the validity of these relationships in a 
more intact preparation. Sonnenblick, Parmley, Urschel and 
Brutsaert (1970) have been able to show the adherence to
10
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these relationships of the intact, non-working, dog ventricle.
Further extensions of these indices of function to the
working heart in situ are greatly complicated by the 
external factors which affect performance. Because of
these difficulties a number of parameters have been studied
to evaluate their possible use as indices of performance. 
Thus shortening velocity (Tomoda and Sasamoto, 1973) 
atrial-ventricular systolic time intervals (Scully, Bello, 
Beierholm, Fredericksen, Weisfeldt and Doggett, 1973), peak 
left ventricular ejection velocity (Sonnenblick and Skelton 
1971), maximal rate of rise of ventricular pressure 
(Mj^s, 1971) have all been used to indicate contractility.
It is important to determine when investigations really do
attempt to elucidate contractility since the rather less 
definitive term "function” often appears. This is usually 
a more general term than contractility and indicates the 
overall competence of the muscle.
An important aspect of the investigations into cardiac
performance has been the indication of the major factors 
contributing to MVO^. These factors (Sonnenblick and 
Skelton, 1971; Burns and Covell 1972) are as follows:
(i) Wall tension (dependent upon ventricular pressure, 
intraventricular volume and myocardial mass).





There are two minor contributors to MVO^; firstly, energy 
required for external work or active ejection (about 
5 - 10% of MVOg) and secondly, energy required for 
activation of contraction and relaxation (about 1% of MVO^).
Another problem which has been solved by these 
investigations concerns the mechanism of contraction of 
cardiac muscle. On the basis of lower maximum force 
development per unit cross-sectional area (compared to 
skeletal muscle) and other factors such as apparent immunity 
to tétanisation, a discrete mechanism of action peculiar 
to cardiac muscle had been a possibility. The differences 
were explained, instead, by different control of contraction 
in cardiac muscle. Thus the lower force developed was 
explained by the operation of a smaller proportion of the 
contractile elements at any given time. The time of active 
contraction (twitch time) in cardiac muscle was limited by 
an extended refractory period, thus reducing the possibility 
of tétanisation. (Sonnenblick, Parmley, Buccino and Spann, 1968),
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3. Non-contractile properties
In addition to the classical muscular function of
contraction, the heart exhibits other properties which can 
be described as automatacity (the ability to contract
independently of external stimulation), conductivity
(electrical impluses passed from one muscle cell to 
another without the necessary intervention of nervous 
tissue) and sensitivity to modulation of performance ,at the 
muscle cell site as well as sensitivity to nervious control.
(a) Electrical Properties Unlike skeletal muscle, the
myocardium acts as a syncytium allowing co-ordination of
contractility vital to the pumping action. Electrical 
impulses originate in a group of specialised cells called 
the sinus node, located on the surface of the right atrium 
near its junction with the superior vena cava. The node 
depolarises and repolarises cyclicly at a raté which 
(usually) determines the overall heart rate. The sinus 
node provides the usual dominant heart rhythmn but 
automaticity is also exhibited by ventricular muscle itself 
in the absence of sinus rhythmn. Indeed single-layers of
myocardial cells in tissue culture exhibit synchronous 
beating— Click, Burns and Reddy, (1974).
The impulse from the sinus node spreads across the 
surface of the atria, causing them to contract and then 
passes rapidly to the apex of the ventricles via the 
atrioventricular node and the Purkinje fibres. These are
14
muscle cells which, through specialisation, have lost the 
ability to contract but instead conduct electrical impulses
more rapidly than normal myocardial cells. From the apex
the impulse passes back up through the bulk of the 
muscle mass, initiating the rising wave of ventricular 
contraction. The electrical wave passes from one muscle 
cell to the next in a way analagous to nervous transmission 
along axons. The cells communicate at sites called 
inter-calated discs. The nature of the discs and thus 
the extent of communication is not clear.. The differences 
between nervous conductivity and myocardial conductivity are 
demonstrated by differences in the action potentials 
( figure 6a ).
(b) The Electrocardiogram ( EC G ) The co-ordinated
electrical activity of the muscle produces a strohg and 
rapidly changing electrical potential which can be detected 
at the body surface, by the application of electrodes at 
suitable points. It should be stressed that the ECG is 
the resultant of the summation of the action potentials 
of all the individual myocardial cells. A typical complete 
wave ( figure 6b ) contains components associated with 
depolarisation and repolarisation of both atria ( P wave) 
and ventricles. Ventricular depolarisation gives rise to
the QRS complex of the electrocardiogram. The plateau; of
the action potential, during which the muscle is 
depolarised, produces the ST segment. The T wave is
due to ventricular repolarisation. Paradoxically, the 
deflection of both depolarisation and repolarisation waves
15
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is in the same direction. This may be explained by
the dependence of the pathway of depolarisation upon 
factors Other than just cell - to - cell conduction 
(e.g. wall tension, Kelman, 1971).
Electrocardiography has proved extremely useful in both 
clinical and experimental situations since it gives 
valuable information concerning the performance of the 
heart by non-invasive means, (Julian, 1973; Schamroth, 1973).
Ch^aracteristic changes are found with the electrocardiogram 
coincident with various disturbances in performance and the 
procedure thus has valuable diagnostic uses. The 
particular uses of importance here are the characterisation 
of disturbances in atrial and ventricular rhythm and also
the indication of myocardial ischaemia which is manifested 
as changes in .ST segment and T wave ( Brooks, 1974;
Angell, Lakatta, Weisfeldt and Shoch, 1975). The 
physio-chemical basis of the electrocardiogram is described 
in detail by Schaefer and Haas (1962).
(c) Sensitivity to humoral influences Heart performance 
is influenced not only by nervous control (internal and 
external) but also by direct action of particular agents 
on the muscle cells. Thus a number of hormones 
(including catecholamines, ACTH, TSH and glucagon) influence 
contractility and rate of beating. At least two major 
modes of action have been proposed to describe the actions 
of these and other agents.
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The first major theory (Sutherland, Robinson and 
Butcher, 1968) considers that the hormones act at the 
plasma membrane and/or intracellular membranes, modifying 
the activity of adenylate cyclase and hence the
intracellular concentration of adenosine - 3* - 5* - cyclic 
monophosphate ( cyclic AMP ). The level of cyclic AMP
is thought to influence contactility by as yet undefined 
mechanism(s). One possibility is the modulation of 
intracellular calcium ion av ailability through the action
of cyclic AMP on the sarcoplasmic reticulum ( Epstein, 
Levey and Skelton, 1971).
The second major theory considers the effect of 
hormones and other agents such as cardiac glycosides, on 
the membrane systems involved in the release and 
sequestration of calcium ions and other ions involved in 
the excitation and contraction processes. (Katz and Repke,
1973; Nayler, 1967). The actions may involve no rise in 
cellular cyclic AMP concentration (Venter, Ross and 
Kaplan, 1975).
The basic information quoted in this section has been 
drawn largely from the texts of Kelman (1971) and 
Selkurt (1971).
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SECTION B The Metabolism of the Heart
1. Substrates utilised
The heart is a constantly active muscular tissue and
is therefore a centre of intense metabolic activity. The
substrates required for combustion to provide the energy
needed for mechanical and electrical activity are supplied 
largely by the blood. The heart thus normally depends
largely upon exogenous substrates. Under normal conditions 
the glycogen stored within the myocardium (endogenous
substrate) is not extensively utilised. Under certain 
conditions the balance between utilisation of exogenous and 
endogenous fuels can shift markedly. In particular, the 
utilisation of endogenous lipid may become significant.
Of the exogenous substrates, glucose was the first 
shown to be utilised by the heart ( Locke and Rosenheim, 
1907) using the isolated perfused rat heart preparation of
Langendorff (1895). Since that time the importance of
lipid as the other major fuel has been described. Lipid 
is supplied as free fatty acids (FFA) in the form of a
complex with serum albumin (Solomon, 1968; Spector, John and
Fletcher, 1969) and also as esterified fatty acids i.e.
triglyceride - fatty acids (TGFA). TGFA are present in the
blood in the form of chylomicra and very low density
liprporteins (VLDL). Both these forms are complexes
containing triglyceride (60%), phospholipid (15%), cholesterol 
(10%), cholesterol esters (5%) and protein (10%) - data of
Predrickson (1974). The chylomicra or primary particles
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derive their lipid directly from dietary lipid in the 
intestinal mucosa and are discharged mainly into the lymph.
VLDL or secondary particles, by contrast, are synthesised 
in the liver and are discharged into the blood. The 
depletion of lipid from these particles by extrahepatic 
tissue leads to the formation of low density lipoproteins 
(LDL) containing only about 10% triglyceride (Fredrickson, 
1974). The potential importance of TGFA as a fuel is
described by Delcher, Fried and Shipp (1965) who pointed 
out that, in those mammals studied, over 90% of the
fatty acid content of the blood is esterified.
The utilisation of FFA by the heart has been shown
by Shipp, Opie and Challoner (1961) and Scheuer and Olson
(1967) with the isolated rat heart and by Most, Brachfeld, 
Gorlin and Wahren (1969) and Gousious, Felts and Havel 
(1963) who studied the utilisation of radioactive FFA in 
man. Similar studies have been performed with the perfused
monkey heart (Crass, Tullis, McCaskill and Shipp, 1970) and 
with the heart of the conscious dog (Cowley, Scott and 
Spitzer, 1969). The uptake and oxidation of TGFA has also
been shown by Gousious et al (1963); Enser et al (1967);
Delcher et al (1965); Scheuer et al (1967) and Most et al
(1969). The utilisation of FFA has been further investigated
to elucidate any possible selectivity with regard to chain 
length or degree of unsaturation. Willebrands (1964) and 
Evans (1963) showed selective uptake in the order :
18:1 ^  18:2 ^  16:0 ^  18:0 in the isolated rat heart.
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Similar evidence has been provided for the human heart by
Rothlin and Bing (1961) and Harris, Chlouverakis, Gloster
and Jones (1962). These latter studies based their
findings on difference in FFA composition of the blood 
measured at the coronary sinus compared to that at the
aorta. Such use of arterio-venous ( a - v ) differences
has been criticised by Stein and Stein (1963) since the
compositions may be altered by exchange reactions catalysed
by lipoprotein lipase (LPL - see below) with no necessity 
for nett FFA uptake. This criticism appears valid for
in vivo investigations but seems less appropriate for the 
studies using the isolated perfused hearts which received 
no esterfied lipid. This factor could, however, explain
the contradiction of the above results by Stein and Stein 
(1963) and Most et al (1969) who found no selectivity with
regard to uptake in the group 16 : 0, 18 : 0, 18 : 1.
There was selectivity of utilisation, however, with palmitate 
entering triglyceride more readily than linoleate
conversely, linoleic acid entered lecithin more readily than 
did palmitic acid.
TGFA utilisation proceeds not by direct lipid uptake
(Crass et al 1966) but by hydrolysis at the cell surface 
to release FFA which then enter the cell. This hydrolysis
is catalysed by LPL (as described later). Crass et al
(1966) showed that the oxidation of TGFA by the isolated 
rat heart was accompanied by and indeed lagged behind a 
transient rise in FFA concentration of the perfusate.
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Both these effects were stimulated by heparin - a known 
activator of LPL. Further, the oxidation of TGFA could 
be depressed by preperfusioh with heparin in order to elute 
LPL from the tissue as shown by Enser et al (1967).
In addition to the two major substrates, the heart 
can also utilise lactate, pyrurate. ketones and amino acids 
but under most conditions their availability is not great 
(Olson, 1962).
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2. Quantitative significance of Substrates
(a) Exogenous substrates Since the heart is able to 
consume a number of different substrates, the relative 
importance of these will depend upon availability (plasma 
concentration) and preference. To determine substrate 
preference of the heart, a number of competition studies 
have been performed, in which the uptake and/or oxidation 
of a given substrate is studied in the presence and absence 
of potentially competitive substrates. Extensive reviews 
have been published by Opie (1968) and by Neely and 
Morgan (1974). The general conclusion from the investigations
reviewed is that in sufficiently high concentration any of 
the major substrates (glucose, FFA, lactate, ketones or 
pyruvate) can dominate the oxidative pathways of the heart.
At physiological concentration, however, the balance lies 
between glucose and FFA. In general, FFA are able to
pre-empt glucose oxidation rather than the reverse. Thus 
Shipp et al (1961) showed extensive inhibition of oxidation 
of glucose ( 5 - lOroM) by palmitate (0.3mM) in the isolated 
perfused rat heart. Conversely, high glucose concentrations 
gave only a limited inhibition of FFA oxidation. Crass 
et al (1970) showed similar inhibition of glucose oxidation
by pamitate in the perfused monkey heart; the inhibition
probably being effected at several points in the pathway 
of glucose metabolism. One can regard the circulating FFA 
concentration as a vital control element, particularly since
glucose uptake is insulin-sensitive (Morgan, Henderson, Regan,
23
and Park 1961; Morgan, Neely, Wood, Liebecq, Liebermeister, 
Park 1965), whilst FFA uptake seems to be dependent only
upon arterial concentration (Most et al 1969). The
relationship between glucose and FFA utilisation is
described by the glucose - FFA cycle (Randle, Garland,
Hales and Newsholme, 1963). Thus during starvation and 
diabetes the circulating FFA concentratixjn iis elevated and 
the uptake and oxidation of glucose is depressed. The 
roles of the two substrates can be reversed by perfusion
of hearts from starved or alloxan-diabetic rats with medium 
containing glucose and insulin. Similar evidence was provided
by Kreisberg. (1966).
In man during periods of fasting, lipid appears to be
the major oxidiseable substrate (Most et al 1969), accounting 
for 70% of the myocardial oxygen consumption (MVO^) whilst 
glucose accounted for the remaining 30%. Similarly, in 
healthy fasting men, Lassers, Wahlqvist, Kaijser and 
Carlson, (l97l); Lassers, Kaijser and Carlson, (1972) have shown 
that a significant negative correlation exists between FFA 
concentration and myocardial extraction of glucose, lactate 
and pyruvate. The depression of FFA concentration with the 
antilipolytic agent nicotinic acid stimulated myocardial 
extraction of the carbohydrates, (Lassers et al, 1972).
The studies above have indicated situations in which 
FFA are the preferred substxtate. Hasselblat (1970) described 
the converse situation of extensive glucose utilisation 
during the post-prandial period. A high glucose load
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mimics the effect of antilipolytic agents in depressing 
nett lipolysis in adipose tissue, thus reducing the 
circulating FFA concentration. In addition,, pancreatic 
insulin secretion is stimulated and glucose utilisation by 
peripheral tissues is stimulated.
Similar though less direct evidence for the balance
between glucose and FFA utilisation is provided by the
respiratory quotient (RQ) which tends towards unity during 
carbohydrate oxidation but falls during lipid oxidation. 
During the post-prandial period RQ = 1.0 (Goodale and 
Hackel, 1953), after an overnight fast it falls to 0.8
and during diabetes and starvation to 0.7 (Goodale, Olson
and Hackel, 1959).
Gold, Scott and Spitzer (1967) showed that the 
elevation or depression of plasma FFA concentration in 
hyper - or hypothyroid dogs respectively, was accompanied 
by changes in myocardial FFA oxidation, RQ and MVO^.
During hyperthyroidism, FFA oxidation and MVO^ were enhanced 
but RQ was depressed.
Olson (1962 showed that high concentrations of
pynvate or acetoacetate (both lOraM) were required to 
influence the utilisation of 0.3mM palmitate. Uptake of 
palmitate was inhibited 50% but oxidation was inhibited by 
75% thus a four-fold increase of cellular FFA concentration 
occurred despite a compensatory rise of FFA estérification 
into triglyceride. Little, Goto and Spitzer (1970) showed
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that ^-hydroxybutyrate and acetoacetate (lOmM) inhibited 
the oxidation of radioactive palmitate in the dog heart 
in situ. The ketones accounted for about 80% of the 
myocardial CO^ production.
Miller, Keuk and Durham (1971) studied metabolism in 
conscious dogs. Myocardial extraction of FFA was directly 
proportional to the arterial concentration and oxidation 
accounted for all the FFA uptake. FFA contributed 35% of 
the COg production during rest, 75% during exercise or 
infusion of noradrenaline but only 25% during infusion of
glucose. Lactate oxidation became significant during 
exercise.
(b) Endogenous Substrates As can be seen from the
proceeding evidence, exogenous substrates can usually account 
for most of the oxidation carried out in myocardium.
Despite these findings, the utilisation of the endogenous 
reserves has also been demonstrated. Mayer, Namm and 
Hickenbottom (1969) showed that the activation of glycogen 
phosphorylase occurred in heart muscle as . had previously 
been described for ll»ver and skeletal muscle (for review
see Fischer, Pocher and Saari 1970). Glycogen has also 
been suggested to be directly involved in fuelling
contractility on the basis of the presence of glycogen
granules near the contractile elements (Saidrasulov, 1963). 
The significance of this is uncertain in view of the
inhibition of glycogen. utilisation found by Ribeiliraa,
Wendt, Ramos, Gudbjarnason, Bruce and Bing (1964) and by
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Neely, Whitfield and Morgan (1970). The latter group in 
particular showed that glycogenolysis in the isolated rat 
heart became significant only when FFA were omitted from 
the perfusate. It could be stimulated in the working rat 
heart by elevating pressure development but during fasting, 
with elevated plasma FFA concentration, cardiac glycogen 
content actually rose (in contrast to liver glycogen).
The utilisation of endogenous fuel was demonstrated by 
substrate-free perfusion of the isolated rat heart. (Shipp 
et al, 1964; Olson and Hoeschen, 1967). Glycogen was 
depleted within 5min but further contraction was maintained 
by endogenous lipid for up to 45min. This was confirmed 
by the production of 14-00^ by perfused hearts in #hich 
the lipids had been pre-3abelled with 1 - C - 14 - palmitic 
acid (Shipp, Thomas and Crevasse, 1964). Phospholipid 
fatty acid oxidation was observed in addition to 
triglyceride fatty acid oxidation, but this was not 
confirmed by Crass, McCaskill and Shipp (1969) and Crass, 
McCaskill, Shipp and Murthy (1971). In the latter studies 
TGFA oxidation was stimulated by increasing pressure 
development but the total phospholipid content of the 
muscle remained constant throughout the perfusions (Some 
evidence for transestérification between phospholipid and 
triglyceride was presented). Endogenous lipolysis was also 
found to be stimulated by adrenaline in the potassium - 
arrested rat heart (Challoner and Steinberg, 1966 ^ ); and 
during diabetes and starvation (Kreisberg, 1966) with
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consequent depression of utilisation of exogenous TGFA by 
isolated rat hearts. Endogenous lipolysis was found to
contribute significantly to energy metabolism in the pig
heart (Karpiak, 1968).
The involvement of endogenous lipid turnover in the
utilisation of exogenous FFA is not clear. One would 
anticipate a pathway of the form:
COgextracellular — intracellular ^
FFA FFA
Triglyceride (TG)
This is supported by the sparing effect of exogenous FFA 
on endogenous TGFA utilisation (Crass et al, 1972). An 
alternative has been suggested by Shipp et al, (1964) whereby
intracellular > TG —  ► FFA CO
FFA
This would require the compartmentation of the two 
intracellular pools. Such a system would offer control of 
FFA utilisation at the level of lipolysis and the evidence 
of Masters and Glainano (1969 and 1972) is consistent with 
this. Their work shows that FFA uptake is related to the 
rate of lipolysis (being stimulated by catecholamines and 
inhibited by ^-blockade). This evidence, however, is open
to the alternative explanation that the agents act simply 
by increasing and decreasing the demand for both substrates, 
in parallel. To overcome this criticism, the work load
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in the presence of ^-blockade was increased by atrial
pacing and the uptake of FFA but not of glucose remained
inhibited. Despite these conflicting views, it is clear 
that the endogenous TG pool is active and contributes
significantly to the FFA level of the cell. Thus Kong 
and Friedberg (1971) showed biphasic kinetics for the
oxidation of labelled palmitic acid which had been
infused into the coronary artery of the dog. A rapid 
phase of 14 - CO^ release was consistent with direct 
oxidation of FFA whilst a slow phase of 14 - CO^ release
was consistent with oxidation proceeded by an intermediate
estérification step. The speed of entry of exogenous 
labelled FFA into TG droplets was as rapid as the entry
into mitochondria and 14 - CO^ (Stein and Stein 1968).
The location of lipid droplets near the oxidation sites 
(mitochondria) • Stein and Stein, 1968-may support the
pathway for FFA oxidation proposed by Shipp et al (1964) 
by offering a spatial explanation. The entry of FFA in
this study was followed autoradiographically. The extent
of involvement of myocardial TG reserves in the
utilisation of FFA is further demonstrated by Masters and
Glaviano (1972) using open-chest dogs, who showed that 30%
of palmitate uptake entered TG. In addition, the total 
TG content of the tissue remained constant, thus
indicating the turnover of the TG reserve.
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Table 1 summarises the results of the above 
investigations. The common interventions and the consequent 
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"FFA” represents the sum of the contributions of plasma 
FFA, TGFA and ketones. The concentration of ketones in the 
blood is related to that of FFA since they are released 
from the liver from FFA precursors.
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3. The effect of work on substrate utilisation
The work load of the heart dictates the level of 
substrate utilisation. Thus stimulation of contractility of 
the isolated rat heart^ Ouabain (Kreisberg and Williamson, 
1964; Gousious, Felts and Havel, 1967) stimulates the 
uptake and oxidation of glucose. Stimulation of the 
isolated rat heart with adrenaline (Kreisberg, 1966^) and
of the dog heart with noradrenaline (Cowley et àl, 1969) 
enhances the oxidation of both glucose and FFA. Neely, 
Liebomeister, Battersby and Morgan (1967); Neely, Bowman and 
Uforgan (1969) and Neely et al (1970) showed that increased 
pressure development of the isolated, perfused working rat
heart stimulated MVO^, glucose uptake, FFA uptake and 
glycogenolysis. Crass et al (1969, 1970) compared the
substrate utilisation of the working and non-working 
(Langendorff) isolated rat hearts. Glucose uptake was 
stimulated by imposition of work but FFA uptake was not:
instead, the oxidation of FFA was stimulated at the 
expense of estérification to TG.
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4, Met aboi i c Pat hway.s .  ̂ —
(a) Major Routes. The highly aerobic nature of myocardial 
metabolism exhibited under all but extreme conditions, 
is demonstrated by the large number of mitochondria, 
which make up about 30% of the cell volume (Sobel, 1974), 
Other indices of the aerobic metabolism are the capacity 
of the heart to utilise lactic acid (Opie, 1968) and 
the high concentration of oxidative enzymes, particularly 
cytochromes (Penpargkul and Scheuer, 1970), Although nett 
uptake of lactate is normal, there is still release 
of lactate across the heart as assessed by the reduction 
in the specific activity of lactate infused into the 
dog heart (Leunissen and Piatnek-Leunissen, 1973),
The pathways for generation of energy in the 
myocardium are those classically illustrated in standard 
texts (Mahler and Cordes, 1969) and will not be described 
in detail here (figure 8), Glucose is utilised by the 
Embden-Meyerhof-Parnas pathway^ producing pyruvate which 
enters the mitochondrion. Pyruvate dehydrogenase catalyses 
the activation of pyruvate to acetyl CoA (figure 9) 
which is oxidised by the tricarboxylic acid cycle (TCA), 
producing reducing equivalents to be oxidised by the 
terminal oxidation chain. Cytosolic reducing equivalents 
enter the mitochondrion mainly by the malate-aspartate 
shuttle, FFA are first activated to the CoA esters and 
then enter the mitochondrion for oxidation by the 
beta-oxidation spiral which produces acetyl CoA units.
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Legend for Figure 8










11. Fatty acid thiokinases.






18. Carnitine acyl transferase (2 forms).
19. Pyruvate dehydrogenase.
20. Beta keto acyl CoA thiolase.
21. 3-keto acid-CoA transferase.
22. Betahydroxybutyrate dehydrogenase.
23. Beta oxidation spiral.
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Figure 8. Major pathways for AcGoA. production in the 
Glucose mammalian heart.
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Figure 9
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Activated fatty acid units enter the mitochondria by 
the carnitine-cycle, under the influence of carnitine- 
acyltransferase which is located at the inner mitochondrial 
membrane. Lactic acid is utilised by conversion to pyruvate
with lactic dehydrogenase. A specific heart muscle
isoenzyme of lactic dehydrogenase exists which, unlike the 
skeletal muscle isoenzyme, is normally sensitive to
inhibition by high pyruvate concentrations, (Everse and 
Kaplan, 1973). This sensitivity must be lost during 
hypoxia or ischaemia to enable extensive ’lactate release 
by the myocardium, (unless a significant amount of the 
skeletal muscle isoenzyme is also present).
The final aspect of energy metabolism concerns - energy 
transport. The three major aspects of this process are -
(i) oxidative phosphorylation (Racher, 1970) and ATP 
transport through the inner mitochondrial membrane 
(Klingenberg, 1970); (ii) delivery of energy equivalent to 
the active sites of actinorayosini - largely as creatine 
phosphate, which obtains phosphate from ATP under the 
influence of creatine phosphokinase - (Saks, Chernousova, 
Voronkov, Smirnov and Chazov, 1974); (iii) consumption of 
energy in the processes of contraction, ion transport etc.
(b) Minor Routes
Glucose synthesis from lactate and pyr»lvate can be 
observed in heart muscle (Stadie, Haugaard and Perlmutter, 
1947) but the key enzymes of the Utter-Ochoa pathway
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r(malic enzyme, pyriivate decarboxylase, PEP carboxy kinase)
are of relatively low activity and the pathway is not of 
great quantitative significanc.-e (Racker, 1954). The same is 
true of the key enzymes^ of the hexose monophosphate shunt 
(glucose - 6 *- phosphate dehydrogenase and 6 - phosphogluconate 
dehydrogenase) - as shown by Clock and McLean (1954).
Lipid synthesis is active in the myocardium as 
described earlier. Fatty acyl CoA esters react with
sn - glycerol - 1 - phosphate to produce mono, - di - and, 
principally, triglycerides (Denton and Randle, 1965). 
Phospholipid metabolism is believed to Occur by classical
routes (for review, see Dawson, 1966). The origin of 
sn - glycerol - 1 - phosphate from glycerol or glucose is 
debated since the quantitative significance of glycerol 
kin ase in the heart is disputed. Scheuer and Olson (1967)
could find no glycerol uptake by the isolated rat heart 
but Robinson and Newsholme (1967) found significant activity 
of glycerokinase in rat heart, extracts.
Protein synthesis and degradation are obviously of 
great significance because of the constant need for 
structural, contractile and enzymic protein (particularly
exaggerated with hypertrophy) but will not be described here,
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5. Metabolic Control
It is possible to distinguish between control factors 
which operate essentially outside the tissue and those which 
operate within the tissue. The former group include 
factors which modify the circulating concentrations of 
essential substrates, such as the dietary status of the 
animal and the presence of lipolytic or antilipolytic 
hormones. This group will not be discussed further here.
(a) Respiratory Control The major element of metabolic 
control in the heart as in other tissue is the well- 
documented respiratory control exerted through the 
maintenance of a particular energy status in the cell 
(usually expressed as the extent of phosphorylation of the
ATP - ADP - AMP system - Chance and Williams, 1956; 
Klingenberg, 1970). As the work of the heart increases 
from a particular steady state, ATP and creatlrte 
phosphate (CP) are consumed and the energy status shifts 
to the right in the above equation. The operation of
adenine nucleotide translocase (Klingenberg, 1970) ensures 
that the energy status of the cytoplasm is reflected by 
that of the mitochondrion. The decline of ATP relative to
ADP and AMP in the mitochondria stimulates oxidative
phosphorylation. The consequent consumption of reducing 
equivalents and energy substrates provides for greater
production of these units via activity of the TCA cycle,
^-oxidation and glycolysis. This has been demonstrated in
the rat heart by Neely, Denton, Randle and England (1972).
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It is through this mechanism that agents such as
catecholamines, cardiac glycosides, ACTH, p-blockers can
affect metabolism. By stimulating contractility they
secondarily stimulate the metabolic routes to accommodate
the extra work load. Vital evidence concerning the order
of action of catecholamines on contractility and metabolic
responses was provided by 0ye (1965) and Cheung and
Williamson (1965) who showed a significant time-interval
between the onset of intropism and the activation of
glycogen phosphorylasie. In addition, the direct action of
catecholamines . upon phosphorylase appears to be ruled out
by the finding that glycogenolysis is stimulated by
rcmetabolite stimulation and depression of phosphorylase b 
rather than b —4 a conversion (Neely et al, 1967; Dhalla
and McLain, 1967).
(b) Key enzymic Control Points Given the basis of 
respiratory control, there are a range of subtle cellular 
controls which dictate the relative contributions of different 
substrates under different conditions.
(i) Uptake of Substrates Glucose uptake occurs by 
a specific carrier mechanism as judged by kinetic
characteristics (Morgan et al, 1961, 1965). Uptake is 
normally limited at this site but can be stimulated by 
insulin and hypoxia (Morgan et al, 1961; Morgan, Randle
and Regen, 1959) so that the subsequent phosphorylation
step becomes rate-limiting for glucose uptake.
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FFA uptake is proportional to plasma concentration
(Evans, 1964). In addition the albumin : FFA ratio is a
determinant of uptake (Goodman, 1958; Evans, Opie and 
Shipp, 1963)j but only differs from concentrations if 
albumin is varied from physiological concentrations of
2 - 4g%. One molecule of albumin binds two molecules of 
FFA with high affinity and up to 20 molecules with lower 
affinity (Solomon, 1968).
The uptake of lactate, pyruvate and ketones also
appears to be limited by plasma concentrations (see 
Section B.2.). The uptake of TGFA is additionally
dependent upon the activity of lipoprotein lipase.
(ii) Pyruvate Dehydrogenase The work of Randle,
England and Denton (1970), Denton, Randle and Martin (1972), 
Martin, Denton, Pask and Randle (1972), Shaw and Boder
(1972), Severson, Denton, Pask and Randle (1974) and 
Whitehouse, Cooper and Randle (1974) has shown the central 
role of pyruvate dehydrogenase (PDH) in the regulation of 
energy metabolism. The enzyme exists in dephosphorylated
(active) and phosphorylated (inactive) forms, the 
interconversion of the two forms is catalysed by kinase
and phosphatase which are part of the PDH complex. PDH
activity is stimulated by insulin, calcium ions, 
magnesium ions and oral hypoglycaemics such as dichloroacetic 
acid. The activity is inhibited by catecholamines, acetyl
CoA (Garland and Randle, 1963) and NADH (Garland, 1964).
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This control offers an explanation for the facility 
with which FFA can pre-empt the oxidation of glucose 
since the generation of acetyl CoA units from FFA would 
shut down PDH activity. By contrast, few points exist 
for glucose units to interfere with the oxidation of FFA. 
One possibility is a mass action effect of reducing CoASH 
availability and depressing the access of fatty 
acylcarnitine to CoASH at the inner mitochondrial membrane. 
(Vahouny, Katzen and Entenman, 1967; Olson, 1962; Evans, 
Opie and Shipp, 1963).
(iii) Phosphofructokinase (PFK) . PFK represents a most 
important point of control of glycolysis in heart. It is 
subject to inhibition by citrate - thus restricting the 
glycolytic rate when sufficient substrate is already
available for TCA activity (this represents another likely 
contribution to the depression of glucose utilisation by 
FFA). PFK is also inhibited by ATP - this inhibition 
being lifted by inorganic phosphate (P\), AMP, cAMP, ADP 
and fructose diphosphate. The engyme is thus sensitive to 
the energy status of the cell (Mansow, 1963). The effect
of inhibition of PFK is the accumulation of fructose - 6 -
phosphate and hence glucose - 6 - phosphate (since
phosphoglucose isomerase is balanced near to equilibrium).
Accumulation of glucose - 6 - phosphate inhibits glucose
phosphorylation and glucose uptake (England and Randle, 1967) 
and in addition causes inhibition of glycogenolysis by its 
inhibitory effect upon glycogen phosphorylase b (0ye, 1967).
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concentrations of glucose - 6 - phosphate cause
glucose - 1 - phosphate accumulation by mass action effect 
on phosphoglucomutose. Accumulation of glucose - 1 - 
phosphate promotes glycogen synthesis.
(iv) Other Control Points The stimulation of PFK to 
a sufficient degree passes control of the rate of glycolysis 
to glyceraldehyde - 3 - phosphate dehydrogenase or pyruvate
kinase - the other major control points of glycolysis in
the heart (Williamson, 1965).
The combination of increased flux through glycolysis 
and sufficient cytosolic reducing equivalents, results in 
an increase in sn - glycerol - 1 - phosphate concentration.
The increased capacity for estérification of FFA may be
reflected in an increase in cellular lipid concentration. 
During hypoxic perfusion, therefore, associated with rapid 
glycolytic flux and a high level of reducing equivalents 
in the cell, triglyceride accumulation occurs rapidly
(Scheuer and Brachfeld, 1966; Evans, 1964). The 
contribution of glycerol kinase to sn - glycerol - 1 - 
phosphate may also be significant (Robinson and Newsholme, 
1967). Under normoxic conditions, increased glycolytic 
flux and capacity for estérification may provide a 
mechanism for removal of FFA and stimulation of glucose 
utilisation.
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Section C The Heart in Ischaemia
1. . General Ischaemia is the reduction of the flow
through tissue of blood (or perfusate in the experimental 
situation). It is distinguished from hypoxia (or the 
extreme^ anoxia) which describes a reduction of the 
oxygen content of blood or perfusate. Both terms describe 
a situation of depressed oxygen delivery but ischaemia is 
additionally complicated by depression of the delivery of 
other substrates and, more crucially as will be seen, 
depression of the removal from the tissue of metabolic 
products.
The onset of myocardial ischaemia in the clinical 
sense usually represents the result of a progressive 
chronic reduction of blood flow caused by occlusion of one 
or more of the major coronary arteries. Ischaemia may
also occur as a transient episode caused by temporary 
oxygen deficit due to excessive cardiac activity.
Chronic occlusion is the result of the degeneration of 
the intimai lining of the major vessels described as 
atherosclerosis (Schettler and Boyd, 1969). The 
degeneration is provoked by undefined primary factor(s) 
and leads to the accumulation of lipid and fibrous material 
at the intimai lining (for reviews see Shimamoto, 1972;
Ross and Glomset, 1973). The accumulations have a two-fold 
effect ; firstly to depress flow per se by the narrowing of 
arteries and secondly, to reduce flow by depressing the
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elasticity of the vessels. Competent vessels expand during 
the peak of ventricular ejection (absorbing some of the 
cardiac output) and then contract again during diastole to 
sustain diastolic flow. The significance of the loss of 
this elastic capacity in coronary vessels is very great 
since the heart tissue is critically dependent upon 
diastolic flow.
The heart can respond to chronic ischaemia by 
revascularisation and the development of anast omoses 
(Charlier, 1971). No such response is possible to acute 
ischaemia caused by events such as coronary thrombosis - 
the blockage of a vessel by a fragment of solid material, 
usually sloughed off from atheromatous accumulation. The
tissue affected by acute restriction of flow is rapidly 
depressed mechanically (within minutes) and suffers 
irreversible damage if flow is not restored within 
30 - 60 minutes (Oliver, 1972). This is the process of 
acute myocardial infarction. Evidence has been presented
which shows that myocardial infarction may also occur in
the absence of thrombosis (Erhart, Lundman and Mellsteat,1973)
The effects of chronic ischaemia have received little 
experimental attention because of the time required and 
uncertainty concerning the nature of the causative factors. 
Attempts have been made > however, to mimic the clinical 
situation (Aubert, Ferrand, Lacaze, Pepin, Panak and 
Podesta, 1974). The major tools for the experimental
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investigation of myocardial ischaemia include acute 
occlusion of vessels - usually in the dog heart in situ 
(Braunwald, Maroke and Libby 1974) but also, more recently, 
using rat hearts (Kannengeiser, Lubbe and Opie, 1975). 
Another technique is the imposition of whole heart 
ischaemia by reduction of gross coronary flow. In 
addition, studies of hypoxia have provided a considerable 
amount of information although the interpretation of this 
in relation to ischaemia is not straightforward, as will 
be seen below.
2. Mechanical responses of the myocardium to ischaemia
The onset of ischaemia is accompanied by a marked 
depression of the performance of the affected tissue.
This has been observed in human anginal patients (Cohen, 
Elliot, Rolet and Gorlin, 1965) as assessed by ventricular 
pressure development and cardiac output. In the perfused 
rat heart subjected to ischaemia, systolic ventricular 
pressure (and tensior) and cardiac output decline, and end 
diastolic pressure riseS, (Opie, 1965; Neely, Rovetto,
Whitner and Morgan, 1973; Kannengiesser, et al, 1975; Fisher, 
Martino, Harris and Kavaler, 1969). Similar responses to 
hypoxia and anoxia l̂ ave been described by Fisher and 
Williamson (1961); Sonnenblick (1973); Henderson and 
Brutsaert (1973); Scheuer (1972); Su and Friedman (1973); 
Maher, Goodman, Bowers, Hartley and Angelakos (1972).
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. In the dog heart Theroux, Franklin, Ross and Kemper 
(1974) and Pirzada, Hood, Messer and Bing (1975) have 
shown depression of ventricular wall tension development 
using sutured strain guages. Bishop, Kaspar, Barnes and 
Kardon (1974) showed depression of systolic pressure 
development and cardiac output and a rise in wall 
stiffness and diastolic pressure, in the heart of the 
conscious dog. Similar studies have been reported by 
Redwood, Smith and Epstein (1972) and Regan, Markov, Burke 
and Oldewurtel (1970).
Despite the depressed mechanical performance of 
ischaemic tissue, the overall performance of the heart 
as assessed by cardiac output may be maintained by 
compensatory mechanisms. This has been shown in human 
patients (Hamosh and Cohn, 1971) and in experiemntal 
studies (Feola, Haiderer and Kennedy, 1971). This 
compensation was studied in the heart of the anaesthetised 
dbg by Lekven, Mj^s and Kjekshus (1973). Total coronary
flow could be reduced by 20% before cardiac output 
declined. The compensation involved reduction of 
contractility (measured by the rate of rise of ventricular 
pressure - dP/dt) but also ventricular dilation which 
provided increased ventricular diastolic filling and hence 
maintenance of cardiac output. Following these primary 
responses, extensive and persistant ischaemia leads to 
cardiac failure.
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3. Metabolic Responses to Myocardial Ischaemia
(a) Carbohydrate Utilisation In clinical studies, a 
shift of myocardial carbohydrate metabolism to the glycolytic 
mode has been described as one of the major responses to
ischaemia (Hirawich, Goldford and Nahum, 1934; Dennis and 
Moore, 1938). The shift is described as a rise in the 
lactate/pyruvate ratio of coronary venous blood, as the 
appearance of nett lactate release or as a change to a 
less positive arterio-venous difference of lactate 
(Krasnow, Neill and Messer, 1962; Bowansa, Arbogast,
Goulet, Campeau and David, 1973 and Neill, Kremkau, Oxendine 
and Phelps, 1974). These methods have been criticised by 
Kubler (1974) since the concentrations of metabolites in 
the blood may be a poor reflection of those in the 
tissue.
The responses of the heart to ischaemia and hypoxia 
differ markedly with respect to glycolysis, as described in 
experiemntal studies. With hypoxia and anoxia, glucose 
uptake (Scheuer, 1967, 1972) and lactate release (Morgan et 
al, 1961) rise sharply. The importance of glycolysis in
the preservation of function and the ability to recover 
from hypoxic interventions has been described by Weissler,
Altschuld, Gibb, pollack and Kruger (1973); Weissler,
Kruger, Baba, Scorpelli, Leighton and Gallimore, (1968) in 
the rat heart and by Muller Ruchholtz, (1973) and Henry,
Sobel and Braunwald, (1974) in the guinea pig heart.
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The importance of glycogen has also been implicated by 
the ability of the turtle heart to withstand hypoxic 
perfusion more effectively than the rat heart due to 
more . extensive glycogenolysis (Brachfeld, Ohtaka, Klein 
and Kawade, 1972; Bing, Brooks, Inamadar and Messer, 1972).
The effects of ischaemia upon substrate utilisation 
have been contrasted with the effects of hypoxia by 
Rovetto et al (1973). Although a transient rise in 
glucose uptake occurred, it was maintained for only a 
short period. Extensive lactate accumulation occurs
within the tissue since little capacity for release into 
perfusate is provided (unlike hypoxic challenge) and this 
could account for the inhibition of glucose utilisation 
at two metabolic sites. The decline in cellular pH 
would tend to inhibit PFK and the incapacity to
reoxidise NADH by the lactic dehydrogenase reaction would 
cause inhibition of glyceraldehyde-3-phosphate dehydrogenase 
by depressing the availability of NAD. Such inhibition 
depresses the utilisation of both glucose and glycogen.
This evidence seems to be contradicted by the evidence 
of Opie, Owen and Riemersma (1973) which shows a rise 
of glucose uptake in the ischaemic segment of the dog 
heart. In this study, however, glucose uptake was
expressed as [imole/ml blood, with no measurement of 
coronary flow. It is not possible, therefore, to calculate 
the true rate of glucose uptake in pmole/g/min.
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(b) Energy Status During hypoxia the creatine 
phosphate content of guinea pig heart (Feinstein, 1962) 
and rat heart (Scheuer, 1972; Neeley et al, 1973) 
declines rapidly but the content of ATP is maintained
at a high level. Despite the high ATP content, 
contractility is still depressed. Two possible 
explanations for this observation have been suggested. 
Firstly, ATP may be depleted near the site at which it
is required for muscular contraction (Gercken and 
Schlette, 1968; Gudbjamason, Mathes and Ravens, 1970) or, 
secondly, some restriction is exerted at the level of 
energy utilisation rather than energy production (Katz and 
Hecht, 1969). In ischaemically-perfused isolated rat hearts 
(Rovetto et al, 1973) the ATP content of myocardial cells 
declined more rapidly and more extensively than during
hypoxic perfusion. This is likely to be a consequence
of inhibition of glycolysis during ischaemia which plays 
a significant role in maintenance of ATP content of 
hypoxic tisisiue. This observation offers an explanation of
the ability of perfused rat heart papillary muscles and
the intact dog heart to withstand periods of hypoxia
more effectively than periods of ischaemia (Pirzada et al,
1975).
(c) Enzyme Release. The release of enzymes from the 
myocardium has been used as an index of ischaemic damage. 
(Whitby, 1968). The enzymes studied include lactic 
dehydrogenase, creatine phosphokinase, glutamate - oxaloacetate
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transaminase, malate dehydrogenase, aldolase and others
(Logan and Murdock, 1966). The use of enzyme release in
this way has been criticised by Kubler (1974) on the
basis of evidence which shows rapid release of enzymes 
(w ithin 2 minutes of the onset of anoxia) from the dog
heart, presumably before irreversible damage could have 
occurred. Despite this, the release of enzymes is of 
considerable diagnostic value and has also recently been 
studied in acute experimental ischaemia using the isolated 
rat heart (Leiris, Opie and Lubbe, 1975).
(d) Ionic Disturbances The loss of certain ions 
(particularly potassium and inorganic phosphate) has been 
observed from ischaemic tissue (Regan, Markov, Oldewurld 
and Burke, 1970; Opie , Thomas, Owen and Shulman, 1972). 
These ionic disturbancess are probably a reflection of 
the disturbed energy balance of the affected tissue. The
elevation of external potassium may be an important 
factor contributing to the high incidence of arrhythmias
in severely ischaemic tissue, particularly after acute 
myocardial infarction (Brachfeld, 1973).
Disturbances to the ionic balance of ischaemic tissue 
are reflected in the gross electrical activity of the
heart as shown by the ECG. Characteristic changes in 
EGG (principally of the S-T segment and T wave) are of 
considerable diagnostic value clinically (Schaefer and Haas, 
1962; Julian, 1973; Schamroth, 1973) and of particular use
experimentally in the estimation of the extent of ischaemic
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injury (Braunwald, et al, 1974; Lekven and Semb, 1974;
Mj(fs, Kjekshus and Lekven, 1974). The use of ECG in this
way is further validated by the finding that the more
rigorous estimate of ischaemia of tissue oxygen tension 
relates closely to observed changes in S-T segment 
(Angel1, et al, 1975).
(e) Lipid Accumulation The onset of ischaemia with
the accompanying increase in the concentration of reducing 
equivalents within the cell and also decrease in
availability of CoASH units provides stimulation of fatty 
acid estérification. Fatty acids accumulate because of
depressed oxidation and depressed capacity for release from
the tissue. The reducing equivalents tend to force the
production of sn - glycerol - 1 - phosphate by the reaction 
of glycerol - 1 - phosphate dehydrogenase. Both substrates 
for glyceride synthesis are thus made available and 
triglyceride soon accumulates, explaining the appearance of 
lipid droplets in ischaemic and hypoxic tissue (Bryant,
Thomas and O'Neal, 1958; Evans, 1964; Scheuer and
Brachfeld, 1966).
(f) Release of endogenous catecholamines Catecholamines 
stored in preterminal sympathetic fibres of the myocardium 
are released during ischaemia (Brown and Malliana, 1971; 
Wollenberger, Krause and Shabab, 1967). The catecholamine
stores are depleted as soon as one hour after coronary 
artery ligation in the dog heart, reaching 75% depletion 
after 24 hrs. (Russel, Crafoord and Harris, 1961).
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The release of endogenous catecholamines (together with the 
generally high systemic sympathetic activity) following acute 
myocardial infarction may be implicated in the high
mortality associated with the acute episode (Julian and 
Oliver, 1968). Further evidence is provided by the
increase in the extent of ischaemic injury caused by 
catecholamines during acute coronary artery ligation in the 
dog heart. (Mj/s et al, 1974; Braunwald et al, 1974). In 
these studies, beta-blockade offset the effects of 
catecholamines. The tendency of ischaemic tissue to
develop arrhythmias is related to the presence of 
catecholamines (Mailing and Moran, 1957) and is depressed 
by the removal of endogenous catecholamine release by
dénégation (Schaal, Wallace and Sealy, 1969). In other 
studies of acute ischaemia in dog hearts, the release of
succinic and lactic dehydrogenases was abolished in the 
absence of catecholamines (Herbacznska - Cedro, 1970).
The mechanism by which catecholamines induce such
effects is not known although there are several possible
contributing factors. Thus catecholamines could act by 
enhancing MVO^ and thereby exaggerating the already severe 
oxygen deprivation of the ischaemic tissue. MVO^ can be
increased by the stimulation of contractility, rate and 
tension development (Coleman, Sonnenblick and Braunwald,
1971). MVOg can also be elevated in the absence of
mechanical effects and this can be explained by the
increased delivery of FFA due to stimulation of cardiac
lipolysis (Challoner and Steinberg, 1965). The significance
of FFA in the ischaemic heart will be discussed below.
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4. Ultrastructural changes in the ischaemic myocardium
Within minutes of the onset of acute ischaemia, 
glycogen granules disappear and myofibrils become relaxed 
when visualised by electron microscopy (Jennings, Baum and 
Herdson, 1965). Within one-two hours, cells and 
mitocondria were found to have swollen in the ischaemic 
rat heart (Bryant et al, 1958). Rather more rapid
swelling of mitochondria was observed by Jennings and 
Ganote (1974) within 30-40 minutes of the onset of 
ischaemia in the dog heart. The swelling was accompanied 
by the accumulation of amorphous densities within the 
mitochondria. Within a similar time interval of 1-4 hours 
lysosmal disruption was observed (Ricciutti, 1972) and this
was one of the earliest structural changes following the
onset of ischaemia in the dog heart.
The functional capacity of sarcoplasmic reticulum, 
assessed by its capacity to take up calcium, was also 
depressed within 1-2 hours of the onset of ischaemia
(Lee, Ladinsky and Stuckey, 1967).
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SECTION D Effects of FFA in the Heart
Ischaemia presents conditions which encourage FFA 
accumulation within the myocardium. Both adipose (Vaughan
and Steinberg, 1963) and cardiac lipolysis (Kruger and
Leighty, 1967) are stimulated by the presence of 
catecholamines, thus delivering both exogenous and 
endogenous FFA to the myocardium. In addition, the 
capacity for removal of FFA by oxidation is depressed by
oxygen limitation (Opie et al, 1973) The extensive lipid 
accumulation described earlier also indicates the presence
of high cellular FFA levels during ischaemia.
1, Effects observed in vitro. With the above factors
contributing to an accumulation of FFA within ischaemic 
tissue, the actions of FFA to be described below could
contribute significantly to the deleterious effects of
ischaemia.
It should be mentioned that although I have talked of 
FFA and will describe the effects of FFA as investigated 
experimentally, other species could contribute to the
observed effects. In particular, the contribution of fatty 
acyl CoA is a possibility in view of the capacity of 
the cell to activate FFA in the presence of ATP which
may not be completely depleted during ischaemia (Neely et 
al, 1973).
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FFA have been shown, to depress contractility in the 
hypoxic perfused rat heart and hypoxic papillary muscles
but not in well-oxygenated preparations. (Henderson, Most
and Sonnenblick, 1969; Henderson, l\tost. Parmi ey, Gorlin, 
Sonnenblick, 1970; Henderson, Craig, Gorlin and Sonnenblick, 
1970; Gmeiner, Apstein and Brachfeld, 1975). The effects
were attributed to physio-chemical action of the free acids 
rather than some oxidation product since the non-oxidiseable 
pent - 4 - enoic acid had similar actions to palmitic 
and linoleic acids. Most, Szydlik and Sprem (1972)
similarly observed depression of developed tension and 
elevation of resting tension in isolated rat papillary
muscles subjected to periods of hypoxia. The action of
FFA was abolished by the presence of glucose in the 
perfusate. The effects of FFA on contractility and rhythmn 
of the isolated rat heart were found to be due to molar
excess of FFA over albumin in the perfusate, rather than
simply to the concentration of FFA alone (Willebrands, Ter, 
Welle and Tasseron, 1973).
FFA require greater oxygen consumption for each unit 
of metabolic energy produced - expressed by the P/0 ratio
- than do carbohydrates. The P/0 ratio describes the 
number of high-energy phosphate bonds produced per unit of
oxygen consumed (Mahler and Cordes, 1969). The ratios are 
2,8 for FFA but 3.0 for glucose. In addition, FFA
oxidation may be still less efficient due to the 
uncoupling of oxidative phosphorylation (as described by 
Borst, Christ, Slater and Loos, 1962).
55
FFA have been found to have a fairly non-specific 
"detergent" effect which causes enzyme inhibition (Pande and 
Mead; 1968; Wills, 1961). In more specific investigations 
hexokinase (Borreback and Spydevold, 1970) and glyceraldehyde - 
3 - phosphate dehydrogenase (Nagradova, Psasolova and Kriukova,
1972) were inhibited by FFA.
FFA at low absôlute concentrations (^M) but high 
FFA : albumin ratio (6 : 1) were found to labilise
lysosomes and mitochondria obtained from cultured myocardial 
cells (Acosta and Wenzel, 1974). Labilisation was assessed 
by the release of marker enzymes. These effects could be 
explained by interference with membrane integrity - this 
is consistent with the hydrophobic characteristics of FFA 
and offers a possible general explanation for the range 
of apparent toxic effects. The labilisation of lysosomes 
could be a vital factor since this could eventually 
induce cell lysis.
FFA and fatty acyl CoA esters were found to inhibit 
mitochondrial ademine nucleotide tran$:lQcase at concentrations 
below those required to induce uncoupling of oxidative 
phosphorylation (Shug and Shrago, 1973). The significance 
of this effect during ischaemia is uncertain since FFA 
seem to exert an oxygen-wasting effect (see below) which 
is inconsistent with a simple inhibition of energy transport. 
With effective coupling of oxidation and phosphorylation, 
this inhibition would be expected to depress oxygen 
consumption.
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2. Effects in intact tissue
The actions of FFA which have been described in the 
above experimental investigations offer a possible
explanation of the gross actions of FFA indicated by the
clinical and whole organ studies described below.
FFA have been argued to contribute to the incidence
of ventricular arrhythmias and death after acute myocardial
infarction (Oliver, Kurien and Greenwood, • 1968; Julian and 
Oliver, 1968; Gupta, Young, Jewitt, Hartog and Opie, 1969; 
Oliver, 1974) and to ventricular arrhythmias in the dog 
heart after acute coronary artery occlusion (Kurier, Yates 
and Oliver, 1971). The protective effect of an antijipolytic
agent (5 - fluoro - 3 - hydroxymethyl - pyridine) against 
ventricular arrhythmias after myocardial infarction was 
significant provided the control of plasma FFA was good
(Rowe, Neilson and Oliver, 1975). FFA have also been 
shown to reduce the electrical threshold required to provoke 
ventricular fibrillation in normal dogs and those suffering 
from experimental myocardial infarction (Kostis, 1973).
FFA have been found to enhance MVO^ in the heart of
the rat (Challoner and Steinberg, 1966*) and in the dog
heart in situ, where lipolytic agents enhanced MVO^
(Mjĵ s, 1971, 1973; Ilebekk and Mj^fs, 1973; Ilebekk and
Lekven, 1974). The lipolytic agents used -isoproterenol and
nicotine - also directly affect contractility but this
contribution to MVO was accounted for by the use of an2
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antilipolytic agent, p-pyridylcarbinol. The abolition of the
lipolytic component of the nicotine and isoproterenol 
challenges significantly reduced the rise in MVO^. An
extension of these studies has shown that lipolytic 
intervention extends the area of ischaemic injury during 
acute coronary artery ligation in dogs. The converse 
saving effect of antilipolytic treatment is also reported 
(Kjekslus and Mjjzfs, 1973; Kjekshus, 1974; Lekven, Kjekshus 
and Mkgfs, 1973, 1974). A recent report has shown that 
the presence of FFA accentuates the release of lactic 
dehydrogenase from the isolated perfused rat hearts during 
coronary artery ligation (Leiris et al, 1975).
A number of reports have appeared which contradict 
the findings reported above. Rutenberg, Pamintuan and
ft
Soloff , (1969) and Bucher, \1973) concluded from studies on 
human patients that FFA levels during the first 24 hours 
after infarction were not related to arrhythmias, late
death or cardiogenic shock. Russo, Friesinger, Margolis and 
Ross (1970) reported that the elevation of plasran FFA 
concentration by heparin injection (in 20 patients after 
acute myocardial infarction) failed to increase the 
incidence of ventricular arrhythmias. Similarly, FFA were 
argued not to be arrhythmo genic in dog hearts after 
coronary artery occlusion (despite the occurrance of ectopic
activity in 4 dogs, ventricular tachycardia in 2 and 
ventricular fibrillation in 2 - 8 of a total of 30).
FFA were elevated by' the infusion of adrenaline (Opie,
Norris, Thomass, Holland, Owen and Van Noorden, 1971).
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In other studies, FFA were found not to influence 
the degree of ischaemic injury produced by coronary artery 
occlusion in pigs (Most, Capone, Seydlik, Bruno and 
De Vona, 1974) or to influence MVO^ in the intact 
anaethetised dog (most, Lipsky, Szydlik and Bruno, 1973).
The discrepencies between the effects of FFA observed
by different workers may be resolved in several cases by
the presence or absence of catecholamines together with 
FFA. The summation of the effects of both catecholamines 
and exogenous FFA may account for the different experimental 
results. A possible mechanism for the catecholamine effect 
is the stimulation of myocardial lipolysis. The possibility 
of contribution of both externally-applied and internally- 
generated FFA to the deleterious consequences of ischaemia
has been indicated (Mj^s et al, 1973; Oliver, 1973) but no
direct evidence for the involvement of myocardial lipolysis 
is available. The catecholamine effect could also be 
explained in terms of some other metabolic or ionic 
effects or by more direct action on the contractile 
processes.
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SECTION E . Lipases
1. General Several discrete lipase activities have been
characterised, in work mainly studying the activities of 
tissues of the rat, particularly adipose tissue. The
main activities include lipoprotein lipase (LPL), hormone- 
sensitive lipase (HSL), monoglyceride lipase and acid 
lipase. (Pancreatic lipase and intestinal lipase will not
be described here). In addition to these discrete
activities other activities have been described which may 
or may not be unique. Thus tributyrinase may be a non­
specific esterase (Biale, Gorin and Shafrir, 1968) and Tween
hydrolase may be associated with monoglyceridase (Wallach,
1962). The position of diglyceridase activity is also not
established (Buchet and Lauwerys, 1971) although recent 
evidence (Buchet, Roels and Lauwerys, 1974) indicates that 
in rat heart and adipose tissue monoglyceridase and
diglyceridase activities are discrete.
The degree of fatty acid specificity of the lipases 
has not been investigated extensively. In the studies of 
Buchet et al (1974) both mono- and diglyceridases hydrolysed
a range of substrates equally well, whereas Katocs,
Gnewuch, Lech and Calvert (1972) report specific monoolein
and monolaurin lipases in rat adipose tissue.
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2. Discrete Lipases
(a) Lipoprotein Lipase Sometimes synonomously linked
with clearing factor lipase, LPL is only a component 
(albeit the major component) of the total clearing factor 
activity. Clearing factor is found in the blood after
heparin administration and is able to *clear* lipaemic
serum. Clearing factor contains at least one activity -
(monoglyceridase) - which can be distinguished from LPL 
(Greten, Fredrickson and Leny, 1969).
LPL was first described by Hahn (1943) and was 
extracted from bovine heart by Overbeek and Van der Vies
SL b(1955) and Korn (1955 * ) and from adipose by Korn and
Quigley (1957). The enzyme is stimulated by heparin,
inhibited by 0.5M sodium chloride and protamine sulphate 
and exhibits a pH optimum of 8.5. The activity is
critically dependent upon the presence of serum protein
factors - particularly alpha^- lipoprotein - pure glycerides
being hydrolysed very slowly. The activator has been 
further characterised by LaRosa, Levy, Herbert, Lux and
Fredrickson (1970). Borgstrom and Carlson (1957) found that
LPL hydrolysed di- and triglycerides but not monoglycerides 
and also, using radioactively - labelled substrates, found
that reversible exchange of fatty acyl residues was 
catalysed by LPL. The enzyme could be readily eluted
from heart and adipose by medium containing heparin 
suggesting a superficial cellular location, possibly in
the capillary lining or extracellular space ( Cherkes and 
Gordan, 1959; Feldman, 1960). Despite this, only 50% of
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the total tissue activity of LPL was eluted by heparin
(Mallov and Alousi, 1964) the rest remaining at
intracellular sites. Further, Payza, Fiber and Walters 
(1967) showed that intracellular LPL was the precursor 
of the eluted fraction.
LPL is considered to be responsible for the
hydrolysis of plasma lipid in order that TGFA may be
utilised by peripheral tissues (Robinson and French,
1960). The sensitivity of LPL to the dietary status
of the animal has been reported by Robinson and French 
(1960); Robinson and Jennings (1965) and Borensztajn,
Otway and Robinson (1970). During fasting, adipose tissue 
LPL declines whilst that in the heart increases - 
consistent with nett lipolysis from adipose tissue but
the consumption of TGFA by peripheral tissues. The 
oxidation of TGFA by isolated perfused hearts from fasted 
rats is greater than that of hearts from fed rats and 
further, is inhibited by pre-perfusion with medium which 
contains heparin (Borensztajn and Robinson, 1970). Further 
differences between cardiac LPL and adipose LPL with 
regard to control by glucagon (Borensztajn, Keig and
Rubenstein, 1973) and insulin (Borensztajn, Samols and
Rubenstein, 1972) have been described.
(b) Hormone-Sensitive Lipase (HSL) HSL differs from
LPL in a number of properties. It is a tissue lipase
and is not eluted by heparin. It is not stimulated by .
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heparin and has no requirement for serum factors. HSL 
exhibits a pH optimum of 6.8 and is inhibited by sodium 
fUaride but not sodium chloride or protamine sulphate 
(Rizack, 1961; Ho,Ho and Meng, 1967; Bjorntorp and Furman,
1962).
HSL as rapidly stimulated in the presence of cAMP and 
ATP or calcium and ATP (Rizack, 1964). It is also 
activated by incubation of fat pads with medium which 
contains adrenaline, noradrenaline, glucagon, TSH, ACTH 
(Vaughan and Steinberg, 1963; Vaughan, Berger and 
Steinberg, 1964).
The similarity of cardiac hormone-sensitive lipolysis 
to that of adipose tissue has been demonstrated by 
studies of heart homogenates and acetone powders (Leighty, 
1967; Kniger, Leighty, Schreibman and Weisler, 1968; Mallov 
and Alousi, 1969) and of the perfused rat heart by 
Leighty (1967) and Christian, Kilsheimer, Pettett, Paradise 
and Ashmore, (1968). The inhibition characteristics of the
adipose and heart forms of HSL have been shown to be
similar (Shimoda, 1968).
The purification of rat adipose tissue HSL has enabled
further characterisation. The enzyme appears to be lipid- 
rich (Huttanen, Ellingboe, Pittman and Steinberg, 1970,a,b) 
and may well exist in more than one molecular form 
(Pittman, Golanly and Steinberg, 1972) although the human
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adipose enzyme was not thus resolved by affinity 
chromatography (Verine, Giudicelli and Boyer, 1974).
Studies on the purified lipase of rat adipose have
shown (by analogy to glycogen phosphorylase) that the 
lipase is activated by a cyclic AMP-stimulated protein 
kinase (Corbin, Reimann, Walsh and Krebs, 1970; Huttunen, 
Steinberg and Mayer, 1970). Similar results were obtained 
with lipase from human adipose tissue (Khoo, Fong and
Steinberg, 1972). Further, the activation has been shown 
to be acompanied by phosphorylation of the purified rat
adipose enzyme (Huttunen and Steinberg, 1971).
In contrast to the above studies, a novel system of 
activation has been suggested by Okuda, Yanagi, Sele and 
Pujii (1970) and Saito, Matsuoka, Okuda and Fujii, (1975)
whereby activation is achieved by facilitation of the 
substrate-enzyme interaction rather than by activation of 
the enzyme per se. In addition, Okuda and Fujii (1973) 
present evidence which suggests that the protein content 
of HSL and LPL are immunologically indistinguishable and 
that the two activities differ instead in lipid content.
(c) Monoglyceride Lipase Adipose tissue monoglyceridase 
has been distinguished from LPL by ‘♦ inhibitor and 
stimulator studies and from HSL on the basis of non- 
activatability by hormones or cAMP (Vaughan et al, 1964; 
Charbonnier, Arnaud and Boyer, 1973; Kupieki, 1966; Tsai 
and Vaughan, (1970). The adipose tissue monoglyceridase was
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further differentiated from HSL on the basis of
different pH optima and heat-sensitivity (Heller and 
Steinberg, 1972). The heart monoglyceridase has been
studied by Okamoto, Glaviano and Pindoh, (1971) and 
Yamamoto and Drummond (1967).
(d) Acid Lipase(s) Lipase activity with pH optimum 
in the region 4.0 - 4.5 have been studied in adipose 
(Schatz, 1965)p liver and kidney (Mahadevan and Tappell,
1961; Guder, Weiss and Wieland, 1969; Teng and Kaplan, 1974) 
and heart (Weglicki, Owens, Rugh and Sonnenblick, 1974).
The enzymes are closely associated with lysosomes and have 
been termed "cellular clearing factor” .
METHODS
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SECTION A MYOCARDIAL LIPASES 
1, Preparation of Lipases
(a) Pig heart lipases The method is based on that
of Reed (1975), Hearts were placed on ice within 15 min of 
the killing of the animals at the slaughterhouse; a further 
45 min was required for transport to the laboratory.
Operations were subsequently carried out at 4°. Only the 
central region of ventricular myocardium was used. The atria
and vessels were discarded together with the epicardial and 
endocardial margins of ventricular muscle which were trimmed 
away. The remaining bulk of ventricular muscle was cut into 
small cubes with scissors, rinsed with chilled buffer - 
potassium dihydrogen orthophosphate (0.15M); disodium hydrogen 
orthophosphate (0.15), pH 6.8; containing sucrose (o.25M) - and 
hereafter called Sorensen-sucrose - lightly blotted on tissue 
and weighed. Approximately lOOg of fresh tissue was 
obtained from each heart. The fresh tissue w^s mixed with 
Sorensen-sucrose (lOOg to a final volume of 500ml) and 
homogenised in a Braun blender for a total of 2 min in 
15 sec bursts.
The crude homogenate was strained through a single 
layer of muslin and then centrifuged for 30 min at lOOOg 
and at 4°. The pellet of cell debris and nuclei was 
discarded after washing with a further 100ml Sorensen-sucrose 
and the supernatant freed of suspended material by straining 
through two layers of muslin. The pooled lOOOg supernatants
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were recentrifuged at 4^ for 30min at 105,000g. The
osupernatant when used, was stored at 4 , the pellet was
washed with Sorensen-sucrose and finally Sorensen-sucrose 
containing 4mg/ml low-fat bovine serum albumin to remove 
FFA. The pellet was finally suspended in 10ml Sorensen-
sucrose at a protein concentration of 40-60mg/ml and stored
at 4°. The lipase activity was stable for about one week,
(b) Rat Heart Lipases Male Wistar rats weighing 
180-250g were fed ad libitum on laboratory chow (Oxo diet
41B - modified) and killed by decapitation between 9 a.m. and
11 a.m. The heart was quickly removed, rinsed with cold
Sorensen-sucrose and the atria and vessels removed. The
ventricular muscle was cut finely with scissors and 
homogenised by 10 passes of a motor-driven teflon pestle
(Potter-Elvejelm at 2,000rpm). The clearance between pestle and
mortar was 0.0075". The mortar was supported in an ice bath.
The subsequent procedure was the same as that described for
the pig heart, up to the 100,000g pellet which was used 
as the enzyme preparation. Two or three rat hearts were 
required to give sufficient lipase activity.
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2. Preparation of Lipid Substrates
(a) *Ediol* A commercial coconut oil emulsion,
*Ediol* was diluted either 1 volume in 10 or 1 volume in 
20 with Sorensen-sucrose and gently homogenised with a motor- 
driven pestle and mortar (SOOrpm, clearance of 0.0075").
(b) Pure glyceride substrates The solid (or liquid) 
substrate was added to Sorensen-sucrose, heated until molten 
(about 60°) and homogenised by 10 passes of a motor-driven 
pestle and mortar at SOOOrpm with a clearance of 0.0075".
The pestle was then driven at about 500rpm until the
emulsion had cooled to about 30°. Such emulsions were 
stable for only 2-3hr, so the possibility of further
stabilising them was investigated. The final procedure 
adopted involved the addition of Tween-60 (0.5-1.Omg/ml) to 
the substrate mixture prior to homogenisation. (Gum acacia
at 2.5g% did not stabilise the emulsions). After 
homogenisation the emulsions were further treated by 
ultrasonication.
The emulsion was sonicated at 17kcs for a total of 
45 sec in 15 sec bursts. The cooling of the emulsion during 
sonication and treatment for more than 90sec were both found 
to adversely affect the stability of the emulsions.
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Monoglyceride substrates were usually prepared without
the necessity for Tween or sonication since they are
themselves good emulsifying agents, with the necessary 
balance of both hydrophilic and lipophilic moieties.
The presence of Tween required an additional control
experiment since it was itself hyorolysed by the lipase 
preparation, releasing FFA. (The Tweens are a series of
polyhydric alcohols esterified with long-chain fatty acyl 
residues).
3. Determination of Lipase Activity
(a) Conditions of Incubation Four component solutions,
each made up in Sorensen-sucrose, were mixed in equal
volumes (1ml) to give the final incubation mixture.
Figures in parentheses indicate the final concentration in 
the incubation mixture as opposed to the concentration in 
that particular component solution.
(i) low-fat bovine serum albumin (5mg/ml), ATP (0.5mM), 
theophylline (4mM), MgCl^ (ImM).
(ii) Substrate (10-12m
(iii) Lipase preparation (100,000g pellet diluted either 
1 volume in 5 or 1 volume in 10 with Sorensen- 
sucrose) .
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(iv) Sorensen-sucrose containing any additional factors 
e.g. cAMP (50^M)
The reaction was started by the addition of lipase. 
Reagents were pre-equilibrated at 37° and the incubations 
were carried out aerobically at 37° with shaking in
stoppered flasks. The final volume was usually 5ml and
0.5-1.0ml aliquots were withdrawn at various times for 
analysis of glycerol release or, more commonly, FFA release,
(b) Glycerol Determination The method is based on
that of Turner (1973), glycerol being oxidised directly by 
glycerol dehydrogenase (from , Aerobacter aero genes ) in 
the presence of NAD .
Glycerol + NAD^ ~GDH ^ dihydroxy acetone + NADH +
The reaction was followed by the rise in absorbance at
340 due to the production of NADH. The rate ofrun
production of NADH was measured over the first 3-5min
of reaction at room temperature with an automatic
recording spectrophotometer, which gave a full-scale chart
deflection with 0.100 A The curvette contained:-o40nm.
100^1 samle (or 0.1 - l.OmM stock glycerol)
lOOpl NAD (18mM)
1.8ml buffer (0.05M glycine pH 9.5)
The reaction was started by the addition of 25jul of GDH
(4mg/ml freeze-dried powder). The enzyme is absolutely
70
dependent upon the presence of and thus potassium
hydroxide and not sodium hydroxide must be used to adjust 
the pH of the glycine buffer. The GDH was a gift from
R.8. Eisenthal of this department. The method, whilst less 
convenient for large numbers of assays than that of Wieland
(1962) is convenient for small numbers and is very much less 
expensive. The method is sensitive to glycerol concentrations 
of 0.1 - 1 .Oyamoles/ml. The variability between duplicates is 
- 6%.
(c) Determination of FFA Compared to many standard
enzymic assays (e.g. those for glucose and lactate) the 
methods available for the estimation of FFA are rather less 
reproducible or considerably less convenient to perform. 
Beacuse of this, several methods of assay have been 
tested in the course of the work in order to achieve the 
most convenient and the most reproducible.
(i) The first assay system used was the Mosinger (1965) 
colourimetric modification of the titrimetric procedure of 
Dole and Meinertz (1960). The FFA was extracted as in 
the Dole method but then was reacted with sodium barbitone 
to produce diethylbarbitqric acid which converted the 
indicator phenol red into its yellow acid form. A fall in 
absorbance measured at 560nm indicated the presence of FFA, 
The great disadvantage of this method was interference from
atmospheric carbon dioxide which also converted the indicator 
to its acid form. This necessitated the purging of the 
final coloured solution with nitrogen - ideally in the
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eu vette. This was a tedious procedure and also introduced 
the errors from vaporisation of the final mixture. The
zero - FFA value (in this case the highest observed
absorbance) was difficult to determine, being rather 
variable (variability between duplicates was commonly - 15%), 
The assay procedure was as follows:- 1ml sample of lipase
incubation (or standard 0.05 - 0.5 mM palmitic acid in 
heptane) was mixed with 5ml of extraction medium and shaken 
for 2 min. The extraction medium was propan - 2 - ol :
n-heptane : sulphuric acid (Iff) in the volume ratio 
40 : 10 : 1. A further 3ml n-heptane and 2ml water were
then added to the mixture and the whole shaken for 2 min. 
The mixture was allowed to settle and 2 x 1ml aliquots of
the upper (heptane) layer were mixed with 1.5ml of the
colour reagent. After lOmin the mixture was purged with 
(scrubbed in sodium hydroxide (IN) and then heptane) and 
the absorbance measured at 560nm against n - heptane: ethanol 
(2:1, V:V). The colour reagent was made up as a stock
solution from which the working solution was diluted just 
before use. The stock solution was prepared by mixing 
lOOmg phenol red (suspended in about 1ml ethanol) with 
9ml water, containing 0.25g sodium barbitone. The working
solution was prepared by mixing 1ml stock colour reagent 
with 99ml ethanol and 200ml n-heptane.
(ii) The second method used was that of Buncombe (1963) 
modified by the phase-inversion solvent of Lauwerys (1969). 
The estimation is based on the formation of copper soaps
of the FFA which are extracted into chloroform and thus
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draw copper into this organic phase. The copper content 
of the chloroform is an estimate of FFA and is detected 
with a highly-coloured copper-sensitive reagent. The copper 
reagent employed was diethyldithiocarbamate.
(iii) A modification of the above procedure using the 
more sensitive diphenylcarbazide as copper reagent was 
described by Mikac-Devic, Stankovic and Boskovic (1973). This
method is the one used most extensively and it is 
described as follows: to 0.2ml of sample (or standard
0.05-0.5mm palmatic acid in n-heptane) is added 1ml of sodium
chloride solution (5g/l00ml water) and 1ml copper reagent, 
which is freshly prepared by mixing equal volumes of two 
stock solutions - aqueous triethanolamine (M) and cupric 
nitrate trihydrate (0.22M). The mixture is shaken with an 
automatic tube-shaker for 2min in stoppered glass tubes, 4ml
of chloroform added and the mixture shaken again for 5rain.
The mixture is centrifuged at lOOOg for 5min to effect a
clear separation of the chloroform and aqueous phases (breaking 
any emulsion which may have formed during the shaking) and
compacting the intermediate layer of precipitated protein.
The copper layer floats on the chloroform in this method 
(unlike the Lauwerys phase-inversion, so-called because the
aqueous phase contains a very high salt concentration to 
make it more dense than chloroform) and is thus removed by
suction. 2ml of the chloroform is carefully pipetted into 
a tube containing 0.2ml colour reagent (lOOmg depheylcarbazide
in 10ml acetone) and after lOmin the absorption at 550nm is 
determined. The assay is sensitive to FFA at a
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concentration of 20 - SOOnmole/ml. The variability between 
duplicates is - 5%.
It is most important to acid-wash the glassware to 
remove conta minating lipid and FFA (Chromic acid was used 
routinely). Certain commercial detergents are difficult to 
remove without extensive rinsing and thus contribute to a 
high blank. In addition, great care must be taken to avoid
contamination of the chloroform by 'wetting* with aqueous 
copper phase; both centrifugation and careful pipetting - to 
avoid touching the sides of the tubes - are important in 
this respect. Tests of recovery using 1 - C - 14 - palmitic
acid, gave values close to 100%.
(iv) For the continuation of the lipase investigations 
a continuous assay would be a great advantage. Thus both
control and stimulated (or inhibited) rates could be followed 
in one reaction without the necessity for multiple sampling.
The possible use of a pH stat assay was investigated since
the lipolytic reaction involves the production of a proton 
(or more correctly a hydronium ion H^O^), The proton would
be available to titration by added alkali to give a measure 
of the extent of reaction. For the investigation, the model 
reaction of pancreatin with *ediol* was used. The reaction 
Indeed proceeded measureably but when aliquots were assayed 
for FFA the pH stat was found to underestimate the activity. 
It was thought that the FFA may not have been made 
available for titration but instead were being held in the
lipid micelles. This was confirmed by the addition of agents
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such as calcium and serum albumin which were able to expose 
added FFA for titration. (FFA added in the absence of any
such solubilising agent produced virtually no release of 
titrant). The full theoretical titration of FFA was achieved 
with 4mM calcium chloride. Magnesium chloride up to 20mM 
was not fully effective, neither was serum albumin at 
1Omg/ml. Other emulsifying agents (e.g. deoxycholates) 
should be tested since it is desirable to eliminate calcium
in view of its potential stimulation of hormone-sensitive 
lipase. The sensitivity of the assay can be made adequate by 
the use of the appropriate strength of titrant and size of 
titrant syringe.
(d) Preparation of FFA - serum albumin complex The
solid fatty acid is dissolved by heating in one equivalent
of sodium hydroxide solution. The hot solution of the 
sodium salt of the fatty acid is then added dropwise to a 
stirred solution of defatted serum albumin. A molar ratio
of FFA to albumin of two to one should be regarded as 
maximal, since each albumin molecule has two high-affinity 
sites for long-chain fatty acids (Solomon, 1968). Solutions 
are stable at 4° for several weeks. If the advised 
maximal molar ratio is exceeded, precipitation of the free 
acid becomes noticeable.
(e) Protein Determination The protein content of lipase
preparations was determined by the modified biuret method
of Haurowitz (1963), using bovine serum albumin as 
standard. A linear calibration over the range 0.2 - 2.0mg 
protein was obtained and the variability between duplicates
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was 2 2%, 1.5ml sample is incubated with 1.5ml reagent
for lOmin at room tempterature and the absorance at 540nra 
determined. The reagent is prepared by dissolving 0.75g 
cupric sulphate pentahydrate and 3.0g sodium potassium 
tartrate tetrahydrate in 250ml water. To this is added 
150ml of 10% (^/v) potassium hydroxide and the final
volume is adjusted to 500ml with water.
4. Preparation of Protein Kinase from rat heart
The first two steps in the method of Corbin, Reimann 
Walsh and Krebs (1970) were used. Rat hearts were obtained
as for the rat heart lipase preparation and homogenised in 
buffer at 2° with 10 passes of a motor-driven - pestle and 
mortar. (3,000rpm, clearance of 0.0075".) The buffer used 
was potassium orthophosphate (lOmM pH 6.5), containing EDTA
(lOmM) sodium chloride (0.5M) and theophylline (ImM). The
homogenate was centrifuged at 2° for 30min at 27,000g and 
the supernutant used as the protein kinase preparation.
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SECTION B PERFUSION OF ISOLATED RAT HEARTS
1. Perfusate
(a) Inorganic Salts The following salts were added
in the order reported to double-distilled water, each salt 
being fully dissolved before the addition of the next.
The final component, calcium chloride dihydrate, was 
dissolved in water before adding to the final mixture; thus 
preventing the mixing of calcium ions and phosphate ions at
high concentration. The components were: sodium chloride
(118.4mM), sodium hydrogen carbonate (24.9mM), glucose (11.ImM), 
potassium chloride (4.6mM), magnesium sulphate heptahydrate 
(l.lmM), sodium dihydrogen orthophosphate dihydrate (l.OmM) and 
calcium chloride dihydrate (1.9mM ). The final ionic
concentrations are similar to those reported for rat serum 
(Krebs, 1950) except calcium (which will be discussed later)
and orthophosphate which, if increased, caused precipitation 
of calcium phosphate.
(b) Serum albumin The perfusate also contained low-fat
serum albumin at 2g/l00ml. The albumin was dissolved in
perfusate and dialysed against a large volume of the same 
for at least 60hr at 4°. Ig albumin was dialysed against
1 litre perfusate. This extensive dialysis was required to 
allow complete equilibration of calcium with binding sites on
the albumin.. Insufficient dialysis gave a calcium-depleted 
perfusate to which a calcium chloride supplement had . to be 
added in order to maximise the contractility of the perfused
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heart. A marked time-dependence was observed; thus after
24hr dialysis a 2mM supplement of calcium chloride was
required and after 72hr no supplement was required .(After
48hr the supplement required was ImM).
(c) Reduction of Lipid content of serum albumin Albumin
was washed by the charcoal method of Chen (1967). A
solution of 50g albumin in 500ml water was cooled to 2°,
25g of activated charcoal added and the pH adjusted to
3.0 with hydrochloric acid (IN). The mixture was stirred
omagnetically at 2 for Ihr and the charcoal then removed by 
centrifugation at 2° for 20min at 20,000g. The charcoal 
pellet was washed with 100ml acidified water (pH 3.0, 2°).
The pooled supernatant fractions were filtered by membrane 
filtration (pore size 0.45ji) to remove the last ti*aces of
charcoal and the pH adjusted to 7.0 with 2N sodium hydroxide.
The solution was freeze-dried for storage. The washing
procedure reduced the FFA concentration of albumin solution 
(2g%) from about 30nraole/ml to less than 5 nmol e/ml - not
detectable by the chemical method but by G.L.C.
After dialysis against perfusate, the albumin was
filtered by membrane filtration, as above, just before use.
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2. Perfusion and analysis of perfusate
(a) Method of Perfusion and design of apparatus The
perfusion apparatus is described in figures 10 and 1Î. It
is composed of standard water-jacketed glassware connected 
by translucent vinyl tubing (i.d. 0.63mra o.d. 1.4mm) and
maintained at 37° by a thermostat recirculating pump.
Male albino rats of Wistar strain, weighing 180 - 250g
and fed ad libitum (for diet see later) • were killed by 
decapitation. The heart was quickly removed into albumin-free 
perfusate (ph 7.4, 10°) to arrest heartbeat, rinsed free of
blood and the aorta attached to a vinyl cannula with a
bulldog clip. The cannula was grade 80 vinyl tubing
(i.d. 0.63mm, o.d. 1.4mm) approximately 10mm long, cut
obliquely at the end inserted into the aorta (for ease
of insertion) and notched 3-5mra from the same end. The
heart was then immediately mounted into the perfusion 
circuit to begin washout perfusion with albumin-containing
perfusate, maintained at 37° and gassed with 95% oxygen :
5% carbon dioxide. The time taken betweeen decapitation 
and the start of washout perfusion was kept as short as
possible and was usually about 90sec. During the lOmin 
washout perfusion, the aorta was secured to the cannula with 
thread (tied just above the notch to prevent it slipping) 
and the bulldog clip removed. Thread was also tied through 
the apex of the ventricular muscle and in addition, 
extraneous tissue carefully dissected away from the atria 
and aorta. Recirculating perfusion was started by inverting
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the heart into the perfusion chamber and securing the thread
from the ventric le to a Dynamometer UF2 strain guage situated
above the perfusion chamber. The resting tension of the
muscle was adjusted to about 2g when the perfusion chamber 
had filled with perfusate. Above 2g resting tension there 
is little further rise in developed tension per unit rise 
in resting tension. The heart was thus supported both by 
the fluid in the perfusion chamber and by the strain ^age 
thread. The recirculating volume of perfusate was about 
30ml. Agents to be investigated were infused at the point 
in the circuit most distal from the heart (the aerator 
column) in order to allow dilution to a known concentration 
throughout the perfusate. Samples of perfusate were withdrawn 
from a 3-way tap situated on the "venous* side of the heart
- fresh perfusate was added back to maintain the 
recirculating volume. For the investigation of tissue 
metabolites, hearts were removed, blotted on tissue and
quickly dropped into liquid nitrogen. The hearts were 
stored in screw-topped vials at -20°. Extractions and 
estimations were usually performed within two weeks so that 
extensive metabolite changes should not have occurred over 
this period ( Mayer, Stull and Wastila, 1974).
(b) Measurement of Mechanical Performance Tension 
development and EC G were recorded continuously with a two-pen 
chart recorder. (The tension recorded is essentially 
isometric or rather isovolumic and rhe resting tension is 
taken to be an index of he end-diastolic pressure function).
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From the pen deflections heart rate was calculated manually 
using a stopwatch. An instantaneous ratemeter was used 
when available. The two methods gave values which agreed 
within - 5 beats/min, up to about 300 beats/min above which 
rate the manual method was unreliable. A bi-polar ECG was 
recorded by means of silver electrodes attached to 
epoxy - resin- coated stainless steel thread. One electrode
uwas situated below the right atrim and the other above the 
ventricles. The oxygen tension of the perfusate was 
monitored immediately before and immediately after the heart 
chamber with modified Clarke oxygen electrodes (Chappell,
1961) and recorded continuously. Electrodes were calibrated 
before and after perfusions with zero oxygen solution 
(Radiometer "sulphite" solution) and water gassed with 
95% oxygen : 5% carbon dioxide.
Coronary flow was measured by rapidly removing a 1ml 
sample of perfusate from the sampling tap immediately after 
the perfusion chamber (thus reducing the level of perfusate 
in the chamber) and noting the time taken for the level 
in the chamber to return to its original position. The
method was validated by comparison with the values obtained 
with an electromagnetic flowmeter (used throughout the series 
in which hearts from fat-fed rats were perfused) - values 
agreed within - 0.2ml/min. Coronary flow measured in this 
way and perfusion pressure registered on the mercury 
manometer were noted frequently.
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Intraventricular pressure was determined In several
experiments by inserting a needle (guage 23G) through the
ventricular wall, which sealed around it. The needle was
connected by fluid-filled tubing to a pressure transducer 
and intraventricular pressure recorded continuously.
Arrhythmias (that is, ventricular arrhythmias) became 
apparent from the tension and EGG traces. The definition
of arrhythmias for these purposes was any period during 
whic& the time interval between contractions (or EGG spikes) 
was irregular. Such periods were also manifested by
fluctuation in peak developed tension so that an irregular
tension trace was obtained. Atri-âl fibrillation with 
3 to 1 or 4 to 1 atrio-ventricular block appeared to be
quite common by inspection of the hearts during the perfusion
but was difficult to record except with the EGG.
Ventricular fibrillation was quite apparent both from chaotic 
EGG traces and also very poor tension development as well
as quite overt rippling of the epicardial surface of the 
ventricles.
(c) Bacterial Gontamination The contamination of the
apparatus with bacteria was found to contribute significantly 
to glucose uptake (Burges and Blackburn^ personal
communication). To eliminate this interference the 
apparatus was filled overnight with an antibiotic mixture 
containing penicillin and streptomycin (each 300U/ml). In 
addition, the apparatus was washed with chromic acid after 
6-8 perfusions and the vinyl tubling replaced.
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(d) Determination of the uptake of glucose and the 
release of FFA, glycerol and lactate Perfusate 
samples were stored at -20° until analysis (usually within 
one week). Determinations were performed in duplicate.
(i) Glucose was determined by the glucose oxidase method 
of Huggett and Dixon (1957), using the Roche test kit. A 
20jul sample of perfusate was added to 2ml reagent, incubated 
for 45min at room temperature and the absorption at 450nm 
determined. The reagent was 0.12M phosphate pH 7.0,
containing 0-dianisidine (66mg/ml), glucose oxidase (0.25 mg/ml) 
and peroxidase (0.05mg/ml)
(ii) FFA ) determined as described under
)
(iii) Glycerol ) Section A - 38 and 3c.
(One advantage of glycerol determination by this method is 
that pretreatment with perchloric acid is unnecessary). Some
oxidation of glucose is found in the assay but this is 
constant despite variation in glucose concentration. It
seems, fortunately, that even the lowest glucose concentrations
were above the Km of glycerol dehydrogenase for glucose.
(iv) Lactate was determined by the method of HOhorst 
(1962) modified for reaction rate analysis. The rise in 
absorbance at 340nm due to NADH production was monitored 
over the first 3-5 rain of reaction at room temperature. The
full scale of deflection of the automatic recording
spectrophotometer was achieved at 0.1 A340nm.
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The eu vette contained:
lOOpl perfusate (or 5mM lactate standard)
lOOpl NAD (12mg/ml, 13mM)
1.8ml buffer (O.IM glycine, pH 10)
The reaction was started by the addition of lOpl lactic
dehydrogenase (0.1 mg/ml). The assay was sensitive to
lactate at SO/SOOnmole/saraple (0.5/5mW) and the variability
between deplicates was - 5%.
Alternative assays were utilised in the Pfizer
laboratories so these are briefly described below.-
(i) The Boehringer test kit for glucose differed in
the colour reagent used (being ABTS at Img/ml - as described
by Werner et al 1970) and the absorbance was thus
determined at 436nm.
(ii) Glycerol was determined by reaction rate analysis 
using the method of Eggstein (1966) with the reaction
sequence:
glycerol + ATP > sn - glycerol - 1 - P + ADPkinase
ADP + PEP Pyruvate + ATPkinase
Pyruvate + NADH„ ^ Lactate + NAD^" y
The decline in absorbance at 340nm was follwed for 4min 
oat 30 . The full scale deflection of the automatic sampling 
and recording spectrophotometer was 0.05 A340nm. The cu vette
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contained:
50pl perfusate (or O.lmM standard)
1ml buffer
50pl glycerokinase injected automatically to start 
the reaction (60pg/ml)
The buffer was a mixture of the following:
20ml O.IM triethanolamine, 4mM magnesium sulphate pH 7.6 
250pl NADH (6mM), ATP (33mM) and PEP (llmM) 
lOOpl pyruvate kinase (Img/ml) and lactic 
dehydro genfts? ( 2mg/ml )
Variability between duplicates was better than - 5%.
(iii) Pyruvate was determined by the method of Bucher
(1962). The decline in absorption at 340nm due to the
oxidation of NADH in the presence of lactic dehydrogenase
was followed for 4min at 30° with an automatic sampling
and recording spectrophotometer. (Full scale deflection
0.05 A340nm). The cu vette contained :
100 - 200pl sample (or 50pM standard)
1.0ml buffer (0.4M triethanolamine pH 7.6, 40mM 
disodium EDTA, NADH (70pM)
50pl LDH (20pg/ml) injected automatically to start
the reaction.
Variability between duplicates was - 5%.
(e) Diet of animals
(i) Normally-fed In most cases animals were fed
ad libitum on Oxo diet 41B (modified).
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(ii) Fat-fed Rats of Wistar strain (as for the normally- 
fed group) were fed ad libitum on a diet containing a 
high proportion of the total calories as saturated fat.
The diet was maintained for three weeks prior to use.
The diet had no obvious gross effects upon the behaviour of 
the rats although the weights varied much more within any 
one group. Special care was therefore required to select 
rats in the weight range 180 - 250g normally used. The 
composition of the diet was :
Casein 540g/2kg total
Potato starch GOg
Saturated fat (dripping) 500g
Vitamin mixture lOg
Salt mixture 58g
Avicel (cellulose) bulk mixture 832g
The powdered components (for source of components see Appendix)
owere blended with molten fat (preheated to 60 ) and mixed 
thoroughly.
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3, Analysis of the content of lipid and lactate of tissue
(a) Tissue Lipid Hearts were frozen immediately after
perfusion as described earlier. Lipids were extracted and 
quantified by the method of Denton and Randle (1965), A
weighed quantity of frozen tissue was extracted with 5ml 
of propan-2-ol : n-heptane : IN sulphuric acid (in the 
volume ratio 40:10:1) by grinding in a pestle and mortar
on an ice bath. A further 3ml n-heptane and water (0.8 
ml/g tissue) were added and the mixture ground again.
The total extract was centrifuged for 5min at 3,000g and 
the upper (heptane) layer was removed and reduced to 
dryness under a stream of nitrogen. The dried extract was
taken up in about lOOpl n-heptane and applied to a thin 
layer plate (20cm x 20cm) coated with a 0,5mm layer of 
silica gel G. The chromatogram was developed with n-hexane:
diethyl ether: methanol: glacial acetic acid (90:20:2:3, v:v:v:v). 
The plates dried quickly in air at room temperature and
were sprayed with dichlorofluorescein (200mg/100ml ethanol). 
Yellow spots on a purple background were visible under U.V. 
light (254nm). A separation is shown in figure 12. The
spots were scraped from the plate and the lipids eluted 
from the gel by shaking with 4ml chloroform in stoppered 
tubes, for 5min. FFA were assayed directly in the chloro.
form extract as described previously. Glyceride extracts were 
reduced to dryness under a stream of nitrogen and
hydrolysed prior to FFA determination. The extracts were 
hydrolysed for 4hr at 60°, in the presence of 5ml ethanol
and 1ml potassium hydroxide (40% w/v)^
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Figure 12
Thin layer chromatogram of total lipid extract of rat 
heart ventricular muscle.
Lipids were extracted by the method of Denton and 









gel G. The chromatogram was developed with n-hexane: 
methanol ; diethyl ether : glacial acetic acid (90:2:20:3 v/v)
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14The recoveries of known amounts of C - labelled FFA 
and triglyceride (as 1 - C - 14 - acid and 1 - C - 14 
tripalmitin) added to the tissue prior to extraction were
4.determined. The recovery of FFA was 60 - 4% and that for 
+triglyceride 78 - 3% (four experiments in each case).
(b) Tissue Lactate Lactate v;as extracted by the 
method of Hohorst (1962) and assayed as described earlier.
A weighed amount of frozen tissue was dropped into ice
cold perchloric acid (6%, ^/v) and agitated with a glass rod
until thoroughly dispersed. Precipitated protein was removed
by centrifugation for 5min at 3 ,000g and washed with ice 
cold perchloric acid (6% /v). The pooled supernatants were
made up to 8ml/g frozen tissue with the same acid.' The 
pH of the supernatant was adjusted to 7-8 with potassium
hydroxide (10 N), the solution allowed to stand on ice for 
lOmin and then centrifuged for lOmin at 3,000g: The clear
supernatant was assayed for lactate. The recovery of 
lactate is complete (Hohorst, 1962).
(c) Tissue water Total tissue water was determined
by comparing the weight of fresh blotted tissue to that 
of tissue which had been cut finely with scissors and 
taken to constant weight at 80°.
The total tissue water is distributed between the
intra- and extracellular spaces and these two fractions
were also estimated. Hearts were perfused with saline which
contained 1 - C - 14 - Sorbitol (this is assumed to penetrate
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only the extracellular space of the tissue and to equilibrate 
with the perfusate as a whole). Measurement of radioactivity
in the perfusate and in the total tissue thus allows the 
calculation of the extracellular volume as follows :
extracellular volume = cpm/g wet wei ght
(ml/g wet weight of tissue) cpm/ml perfusate
Intracellular volume is then calculated by the difference 
between total water and extracellular water.
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4. Characterisation of FFA and Glyceride - FA by Gas
Liquid Chromatography
(a) Preparation of Samples Fatty acids were
chromatographed as the methylesters, prepared by reacting 
and etherial solution of the acids with diazomethane. 
Perfusate samples (0.2ml) were extracted by shaking for
5min with 4ml chloroform, the organic phase taken to dryness
under nitrogen and the dried residue dissolved in diethyl 
ether.
Tissue FFA and glycerides were extracted, chromatographed 
and eluted as described earlier. FFA were eluted with
diethyl ether; glycerides were eluted, hydrolysed (as 
described earlier) extracted with chloroform, taken to 
dryness • under and finally dissolved in diethyl ether.
(b) Preparation of diazomethane Considerable caution
must be exercised when diazomethane is used because of 
its explosive nature. It is rendered harmless with acetic 
acid (forming methyl acetate) and so glassware is carefully 
rinsed with acetic acid after use.
Potassium hydroxide (0.4g in 9ml of 95% ethanol) is 
added to 2. 4g N - meth - N - nitrosotoluene - 4 - sulphonamide 
(in 30ml diethyl ether). The reaction vessel is stood on 
ice during the addition of reagents but transferred to water 
(80°) for the distillation of diazomethane which is 
collected in an ice-cool flask. The distillation is
94
allowed to proceed until the yellow colouration has 
disappeared from the reagent mixture. The diazomethane 
product is redistilled at 50° and collected in an ice-cool 
flask.
The fresh diazomethane is added dropwise to the etherial
solution of FFA until yellow cokur persists. The mixture
is incubated at room temperature for 20min and then heated 
over steam to remove excess diazomethane.
(c) Chromatography The glass column, 3m in length with 
an internal diameter of 4mm, was packed with stationary
phase of Apiezon grease L at 10%onchromosorb *W’ support.
The carrier gas was nitrogen. Detection was by flame 
ionisation. Hydrogen and ocygen were used at 30psi vs 
15psi for ignition (temperature 210 - 220°) and at 24psi 
vs 24psi for operation (at 210°). The total gas flow was
60ml/min.
The samples were injected as Ipl aliquots in n-hexane 
and compared to pure methyl eàter standards. Individual
fatty acids were quantified by peak area - assessed as the
product of peak height and peak width at half height.
This calculation gave a linear calibration for standards 
over the range 0.1 - 2.5pg fatty acid.
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Figure 13
Gas-liquid chromatogram of fatty acid methyl esters.
The esters (approximately Ijjg FFA) were applied in 1^1 
n-hexane. Stationary phase was Apiezon grease L (10%) 
on Chromosorb W. Carrier gas was nitrogen, total gas ̂ 









5. Preparation of Cell-free Haemoglobin solution
The method of Rabiner, Herbert, Lopas and Friedman (1968)
was used. Out-dated bank blood was obtained from the local
transfusion unit and kept on ice during transport. The
whole blood was centrifuged at 4° for 15min at 6,000g.
The packed cells were washed three times with sodium
chloride solution (1.6% ^/v) and then lysed by mixing one
volume of packed cells with 4 volumes of typotonic sodium
phosphate pH 7.6 (5 milliosmolar or 0.2mM). The mixture was
allowed to stand on ice for Ihr with occasional gentle
mixing and the cell debris then removed by centrifugation
(4° for 30min at 40,000g). The crude haemoglobin solution
owas dialysed against perfusate for 24hr at 4 and finally
filtered by membrane filtration (pore size . 0.45p) before 
mixing with albumin - containing perfusate to give a final 
haemoglobin concentration of 5g/l00ml (albumin at 2g/l00ml 
as usua:̂ .
6. Analysis of Results
(a) Statistical analyses were performed according to 
the usual formulae for Students t-test and regression 
analysis as described by Bailey (1968).
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(b) Individual calculations
(i) When calculating the uptake of glucose and the
release of products (all being reduced to unit wet weight
of tissue) it was necessary to account for the nett 
addition of glucose to the recirculating perfusate involved 
in the sampling technique (i.e. fresh perfusate is added 
back to maintain the recirculating volume). Similarly a
nett removal of FFA, glycerol and lactate occurs. Thus, 
for example, glucose uptake (pmole) =
( gi - gt+3 ) , V + ( gi - gt+2 ) + ( gi - gt+1 )
gi = initial glucose concentration (pmole/ml) - first sample
of perfusate.
gt+3 (gt+2, gt+1) = glucose concentration of fourth (third,
second) perfusate sample.
(ii) Myocardial oxygen consumption, MVO^, (pi oxygen/min/g
wet weight of tissue) is calculated from the equation.
MVOg "arterial” oxygen - "venous” oxygen I x coronary 
(pl/ml) (y1/ml) I flow (ml/
-* min/g wet 
wei ght)
The oxygen concentration in the perfusate is calculated from 
the Bunsen coefficient, which describes the solubility of 
oxygen in water at S.T.P. as 0.023ml oxygen/ml water, when 
water is exposed to pure oxygen. This value is corrected 
for temperature and solutes in the perfusate and finally the
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partial pressure of oxygen which were determined with oxygen 
electrodes. The "arterial" concentration of oxygen usually 
16.2yl/ml perfusate with these corrections made.
An additional point concerning the calibration of the 
oxygen electrodes is that the electrodes are not exposed 
to 95% oxygen : 5% carbon dioxide as the highest standard
but this gas mixture saturated with water vapour. This 
reduces the oxygen tension from a theoretical 725mm mercury 
(95% of 760mm mercury) to 685mm mercury according to
Umbreit, Burris and Stauffer (1964)
RESULTS
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SECTION A . Myocardial Lipases
1. Summary
The aim of this study was to try to confirm the 
presence in myocardium, of an activatable lipase system, 
as previously described by Leighty et al (1968) for a rat 
heart preparation.
The present investigation confirmed the existence of 
a lipase system in pig heart homogenate which could be 
stimulated by cyclic AMP (50pM). The stimulation was 
apparent with triglyceride but not with monoglyceride as 
substrate. With rat heart preparations no activation of 
lipolysis with cyclic AMP could be found unless an 
addition of protein kinase was made.
2. Pig Heart Lipases
(a) Location of Lipase activity A crude
fractionation of the homogenate was performed, giving 600g 
and 100,000g fractions. The activity of the various 
fractions towards *Ediol* is shown in Table 2.
Activity was present in all the fractions tested but
only the 100,000g pellet showed an increased rate of 
lipolysis in the presence of cyclic AMP (50pM). This
fraction also gave the most conveniently concentrated form
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TABLE 2
Location of cyclic AMP-sensitive lipase of pig 
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of activity as judged by activity/ml extract. This 
fraction was used as the lipase preparation in subsequent 
studies.
(b) Nature of Activation The typical reaction progress 
shown in figure 14 reveals the transient nature of 
activation found with cyclic AMP. The activation was 
marked for the first 15 min of incubation but fell away - 
often to rates slower than in the non-cAMP control.
This is precisely the effect observed by Leighty (1968) 
and evidence in that case indicated that a concurrent 
stimulation of glycogeno lysis was providing units of 
glycerol - 1 - phosphate sufficient to allow re-esterification 
of some of the released FFA.
To begin to characterise the activatable activity, it 
was considered that the first step should be to determine 
the class of substrate(s) hydrolysed. Activity towards
•ediol* was activated but this crude substrate contains 
three main components - triglyceride, monoglyceride and 
Tween. Each of these substrates were tested in the pure
form in the presence and absence of cyclic AMP (50pM). 
Glycerides and ediol were presented at lOmg/ml and
Tween - 60 at Img/ml. It can be seen (Table 3) that




Stimulation of lipolysis by cyclic AMP .
Hydrolysis of ediol was by pig heart 100,000g 













Substrate specifidAy of cyclic AMP - stimulated 
lipase of pig heart homogenate (100,000g pellet)
Substrate
Activity (pmole FFA/hr/mg protein 
- mean - S.E.
Control activity + cyclic AMP (50^M)
Tween - 60 0.032 - 0.006 0.032 - 0.006
Ediol 0.058 - 0.006 0.088 - 0.006
Monostearira 0.160 - 0.008 0.160 - 0.010
+Tripalmitin 0.064 - 0.020 0.168 - 0.018
n = 5
Tripalmitin was emulsified with Tween - 60 (Img/ml)
The Tween constribution to the overalll rate has been 
deducted.
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2. Rat Heart Lipases
When pig hearts became unavailble due to the closure 
of the abbatoir, rat hearts were used instead. On the
basis of the above results, the 100,000g pellet fraction 
was used. The range of activities was found to be 
similar to that in the pig heart preparation (Table 4)
using substrates at the same concentrations as before.
Unlike the pig heart preparation, that of the rat
heart was not sensitive to cyclic AMP, even up to
lOÔ iM. Since the rate of ediol hydrolysis was rather 
more rapid with the rat heart preparation it was thought 
that the lipase system may have been somewhat activated 
prior to incubation. This might be expected because the 
decapitation procedure would cause extensive catecholamine 
release due to sympathetic stimulation. By analogy to the
method of Huttunen and Steinberg (1968) who preincubated 
adipose tissue prior to homogenisation in order to 
deactivate lipolysis, the heart tissue was incubated in 
perfusate at 37° for up to 60min before homogenisation. 
This preinc ubation - did not, however, reduce the lipolytic
activity of the heart extract prepared subsequently.
Conversely, prior activation of the lipase system by 
preincubation of intact tissue with (-) adrenaline and 
(-) noradrenaline (IpM) was similarly ineffective.
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TABLE
Substrates hydrolysed by lipase preparation of 
rat heart homogenate
Substrate Activity (pmole/hr/mg protein) - 
mean - S.E.
Tween - 60 0.012 - 0.002
Ediol 0.164 - 0.008
Monostearin 0.218 - 0.052
Tripalmitin 0.042 - 0.006
Triolein 0.038 - 0.006
n = 5
Tripalmitin (but not triolein) was emulsified with Tween 
(Img/ml). The Tween contribution to the overall rate of 
lipolysis has been deducted.
106
To further test for the possibility of activation of 
the tissue extract, a protein kinase preparation was added 
in addition to cyclic AMP. The hydrolysis of *ediol*
was indeed stimulated. The rate with lipase and kinase
incubated together was 0.196 praole FFA/hr/mg protein, 
whilst the sum of the rates of the separately - incubated 
enzymes was 0.154 pmole FFA/hr/mg protein. The reaction
progress was similar to that for the pig heart extract, 
showing only a short-lived activation at 37°.
This work has since been confirmed in these 
laboratories (Handley, 1975).
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SECTION B The Isolated Perfused Rat Heart as a Model of 
Ischaemia
1. Summary
The possible deleterious effects of FFA in the 
ischaemic heart were described in the introduction. The
possible contribution of endogenous lipolysis to the FFA 
pool of the myocardium had been indicated. The presence of 
a hormone-sensitive lipase system in the heart had been 
reported previously and was confirmed in this study 
(Section A). It was considered that the study of the 
intact tissue would give insight into the involvement of
myocardial lipolysis in the metabolism and performance of
the heart. The investigation of myocardial lipolysis was 
particularly directed to a study of its importance in 
ischaemic tissue. For this reason it was necessary to
develop a model system in which lipolysis could be studied
and upon which an ischaemic challenge could be imposed.
The model which was developed is described in this section.
An essential feature of the system is the imposition of 
low coronary flow as opposed to the use of hypoxic 
perfusate. The differences between these challenges have
been described in the introduction and will be pointed 
out where appropriate in the discussion.
The results in this section indicate that the model 
responds in the way expected of ischaemic tissue - as 
described for the clinical and experimental situations (see 
introduction). Thus heart rate and tension development are
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depressed; metabolism shifts to a more glycolytic mode (and
lb
in addition absolute glucose uptake^ depressed); characteristic 
changes in the electrocardiogram develop, particularly 
changes in T wave and ST segment.
Previous experimental work has investigated ischaemia in
an essentially discontinuous manner, but in this model 
ischaemia of graded intensity is imposed and the
corresponding graded responses observed.
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2. General
The effects of ischaemia, imposed by reducing coronary 
flow, were studied in the isolated perfused rat heart.
The method of Langendorff (1898) was modified (as described 
in "Methods*) to give a closed recirculating system in which
the heart was immersed in perfusate. The oxygen tension of 
the perfusate was as high as the system would allow. The 
perfusate emerging from the bottom of the aerator contained
oxygen at a partial pressure of 650 - 30 mm mercury» at the 
point of entry of the perfusate to the heart, this had 
declined to 560 — 30mm mercury.
The effects of coronary flow (expressed throughout as 
ml perfusate/min/g wet weight) on developed tension, heart
rate, oxygen extraction, glucose uptake and lactate release
are described. These indices of mechanical performance and
metabolism were studied during control recirculating perfusion 
once the hearts had stabilised following the washout
perfusion. Each heart was perfused at one flow rate only; 
thus each point of the graphs represents one heart.
Hearts were perfused at coronary flow rates in the range 
2 - 8 ml/min/g. This is a convenient range since below about
2ml/min/g contractility fails entirely, whilst rates above 
lOml/min/g are commonly considered to give competent 
(non-ischaemic) preparations. (Fisher and Williamson, 1962; 
Shipp et al 1964)
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3. Mechanical Reponses to Ischaemia
(a) Heart Rate and Developed Tension Both heart rate
and developed tension were directly proportional to coronary 
flow over the range studied (see figures 15 and 16).
The correlation coefficients and probability (P) values
were +0.89 (P^O.OOl) and +0.71 (P ̂ 0.001) respectively.
The equations which describe the relationships (y = mx+c)
are as follows:
heart rate = (40.8 x coronary flow) + 10.0
(beats/min) (ml/min/g)
developed = (9.67 x coronary flow) + (-0.70)
tension (g)
(b) Resting Tension and Arrhythmias Resting tension
was stable during control perfusion over the coronary flow 
range studied. Arrhythmias were infrequent during control 
perfusion and their occurrence did not show any 
relationship to coronary flow.
Ill
Figure 15
Effect of coronary flow on heart rate in the 
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Figure 16
Effect of coronary flow on the tension development 
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4, Metabolic Responses to Ischaemia
(a) Oxygen Consumption Hearts responded to the decline 
in coronary flow by extracting a greater percentage of the 
oxygen being delivered.
Percent oxygen = "arterial” pO^ - "venous" pC^ x 100
extraction  :--
"arterial" pO^
The relationship between percent oxygen extraction and 
coronary flow is described by the equation:
Percent oxygen = (- 6.72 x coronary flow) + 106.3
extraction (ml/mn/g)
(n = 24, correlation coefficient = -0.66, P ̂ 0.02). Thus
oxygen extraction reached 100% when the coronary flow had 
been reduced to about 2ml/rain/g. See figure 17.
The rise in the percent oxygen extraction was not
sufficient to compensate for the decline in delivery of 
oxygen as the coronary flow was reduced. Thus the total 
oxygen consumption of the hearts - MVO^ (jil/min/g) 
declined in proportion to the coronary flow (figure 18). 
The regression equation is :
MVOg = (8.33 X coronary flow) + 4.5
(n = 30, correlation coefficient = 0.87, P <^0.001). The
predominant role of coronary flow over percent oxygen 
extraction is predictable since the extraction can only 
rise from 60% to 100% whilst coronary flow is reduced
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Figure 17
Effect of coronary flow on the percent oxygen







C o r o n a r y  F l o w  ( m l / m i n / g  wet  w t )
Percent




Effect of coronary flow on MVO^ in the isolated
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more extensively - in this case to about 20% of the 
peak value.
(b) Lactate Release. Ischaemic tissue is considerably 
dependent upon glycolysis for energy production ( Opie et al,
1973). Under our perfusion conditions, lactate release into
the perfusate was extensive ( mean + S.E. = 44.1 + 2.1
pmole/hr/g wet weight). The release of lactate was not
statistically related to coronary flow over the range
studied. The release at a coronary flow of 2.0 - 3.5
ml/min/g (44.8 + 7.0 ÿimole/g/hr) was not significantly 
different to that observed at a coronary flow of 5.5 - 7.0
ml/min/g (40.0 + 5.0 pmole/g/hr).
(c) Glucose Utilisation. The effect of coronary flow rate 
on glucose uptake is shown in figure 19. As coronary 
flow is reduced, glucose uptake declines according to the 
equation ;
glucose uptake = (9.7 x coronary flow) + 13.6
(pmole/hr/g) (ml/min/g)
(correlation coefficient = 0.57, P <0.05, n = 26).
The decline of glucose uptake over a range of coronary
flow which exhibits a more constant lactate release
indicates a rise in the fraction of the glucose uptake
which can be accounted for by lactate release. The
relationship is shown in figure 20, where :
percent conversion of = (-7.2 x coronary flow) + 64.2
glucose to lactate
This parameter expresses. the fraction of the energy product­
ion from glucose which is derived from glycolysis (and
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by difference the fraction from glucose oxidation) and is
calculated from the equation :
percent conversion of = lactate release (pmole/hr/g) x 100
glucose to lactate ------------------------------- - -------
glucose uptake (pmole/hr/g) x 2
The calculation does not allow for the contribution of
endogenous glycogen, which is expected to be small in
the absence of catecholamine stimulation (Gartner and
Vahouny, 1969; Shipp et al 1970). The contribution of
glycogen may be more significant following adrenaline
infusion. By discounting the contribution of glycogen to
lactate release, the fractional conversion of glucose to
lactate may be overestimated.
(d) Lipolysis Neither the release of FFA nor that 
of glycerol showed a significant linear relationship to
coronary flow over the range studied.
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Figure 19
Effect of coronary flow on the glucose uptake










Effect of coronary flow on the fractional conversion 
of glucose to lactate by isolated perfused hearts 
from normally-fed rats.
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5. Electrocardiographic Responses to Ischaemia
Preliminary data are available concerning the effects of 
coronary flow on the electrocardiogram (ECG). The effects
of coronary flow on T wave and S-T segment are shown in 
Table 5. It can be seen that both factors become more 
negative as the coronary flow is reduced.
Typical traces are shown in figure 21. These illustrate 
a reservation concerning the significance of these results 
that of signal size, which is rather small using the
electrode arrangement described. This could possibly be 
improved by the use of an epicardial probe electrode to
avoid the resistance imposed by the perfusate.
The changes in the T wave were easily measured but 
those in the S-T segments were more ambiguous considering 
the small changes involved. The procedure of Schaefer and 
Haas (1962) was employed to determine the height of the
S-T segment. It was assessed by the difference in height 
between the QR upstroke and the RS downstroke. The zero 
line was taken as the TQ interval since P and Q waves 
were not usually observed.
Despite the reservation concerning signal size, the 




Effects of coronary flow on ST segment and T wave







8 - 11 (n = 3) + 0.14 -0.06 + 0.10 t 0.01
5 - 8  (n = 9) + 0.08 - 0.03 - 0.01 - 0.01
2 - 4  (n = 9) - 0.02 - 0.03 - 0.03 - 0.01
P for difference 
2 - 4 vs 5 - 8 <  0.001 ^  0.002
2 - 4 vs 10“14 < 0.001 < 0.001
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Figure 21
Effect of coronary flow on the bi-polar ECG recorded
from the isolated perfused hearts from normally-fed
rats.
The traces were recorded in three broad coronary 
flow ranges : 2-4, 5-8 and 9-12 ml/min/g wet weight,
ImV _ _........ .............
9-12 ml/min/g
1 Sec
]  JUUUUUUUJUL 5-8 ml/min/g
1 MAJUAAJUAMAJL 2-4 ml/min/g
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SECTION C The Role of Myocardial Lipolysis in the
ischaemically-perfused rat heart
1, Summary
Having established that the isolated perfused rat heart 
preparation could be used as a suitable model of ischaemia, 
the effects on lipolysis in this model were investigated.
The results have been divided into four sub-sections.
In the first sub-section the effects of adrenaline 
stimulation are described. The hearts exhibited a biphasic 
response : in the first phase (2 - 8  min) positive inotropic
and chronotropic effects were observed; in the second 
phase ( 8 - 3 0  min) the performance of the hearts 
deteriorated, thus heart rate and developed tension 
returned to or declined below the pre-adrenaline control,
resting tension rose and the incidence of arrhythmias 
increased. The rise in resting tension was linearly 
correlated to the release of FFA and lactate. The decline 
in developed tension was linearly correlated to the release 
of FFA.
In the second sub-section the contribution of the
recirculating perfusate to the deleterious (second phase) 
consequences of the adrenaline challenge were investigated. 
The recirculating perfusate was shown to contribute 
significantly to the second-phase responses of the hearts 
to adrenaline, since these deteriorations in performance 
were greatly reduced by the imposition of non-recirculating
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perfusion. The imposition of non-recirculating perfusion was 
also accompanied by an increased release of FFA and a
lower fractional conversion of glucose to lactate.
In the third sub-section the effects of exogenous
FFA and lactate are reported. The increase in FFA and
lactate concentrations represented the major metabolic 
changes observed in the recirculating perfusion following 
adrenaline challenge but neither exogenous FFA nor exogenous 
lactate induced any marked effects upon mechanical performance 
of the hearts.
In the final sub-section the effects of antilipolytic
treatment (with nicotinic acid) upon the responses of the 
heart to adrenaline are described. The first-phase responses 
to adrenaline were unaffected by nicotinic acid but the 
second-phase deteriorations were reduced. Thus the rises in 
resting tension, the decline in developed tension and the 
incidence of arrhythmias were reduced. Glucose oxidation 
was encouraged by nicotinic acid.
The results indicate that both FFA and lactate
contribute to the decline in mechanical performance of the 
perfused hearts after adrenaline challenge. The possible 
primary role of FFA is discussed.
2. Effects of adrenaline in the recirculating perfusion
Hearts were perfused at 3-4 ml/min/g to impose a marked
degree of ischaemia as indicated in Section B. In 
preliminary experiments the chronotropic and inotropic 
responses of the heart were found to be maximal at
125
“610 M (-) adrenaline. The hearts were thus perfused for
30 min control period and then adrenaline was infused to
“6a final concentration of 10 M. The effects were observed 
during the following 30 min.
(a) Major Mechanical and Metabolic Responses to Adrenaline
A biphasic response to adrenaline was observed. The first
phase lasted 2-8 min during which time heart rate and
developed tension were elevated above the pre-adrenaline
control values. During the second phase from 8-30 min after
adrenaline infusion, the resting tension increased,
arrhythmias developed and heart rate and developed tension
returned to or declined below the pre-adrenaline control.
Typical responses to adrenaline are shown in figure 22.
During the second phase of the adrenaline response,
changes in the metabolic as well as the functional
characteristics of the heart became apparent. The glucose
uptake, lactate release, fractional conversion of glucose
to lactate and lipolysis (as assessed by FFA and glycerol
release) were all stimulated.
The effects of adrenaline are shown in table 6. The
major statistically significant changes detected during the
second phase response to adrenaline were: the rise in
+resting tension (109.7 - 20.0%), the rise in the
incidence of arrhythmias (48.7 - 8.3%), the stimulation of
the release of lactate (150 - 42%) and FFA (146 - 53%), and 
the rise in the fractional conversion of glucose to
lactate (30.1 - 3.7%).
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Figure 22
** 0Effects of adrenaline (10 M) on the performance of 
isolated perfused hearts from normally-fed rats. Hearts 
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Biphasic response to adrenaline
First Phase
Function Control Peak response change
Heart rate Cb/min) 194 -16
Developed TensionCg) 3.4 -0.5
273 -16
5.6 -0.6
48 - 12 * 
52 - 13 *
Second Phase
Function Control 30 min post­
adrenaline
% change


























% glucose to 
lactate
62.2 -6.4 74.9 -10.4 26.8 -20.9
65.0 -12.5 129.3 -18.3 150.5 -42.4 *
49.4 -7.8% 79.5 - 7.6% 30.1 - 3.7 *
FFA release 
(jjmole/g wet wt/ 
hr)
1.9 -0.4 3.6 - 0.75 146.0 -53.4 *
glycerol release 
(pmole/g wet wt/ 
hr)
1 . 6  - 0 . 6 3.5 - 1.4 104.2 -32.3
(n = 11, * = significantly different to control)
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(b) Relationship between Mechanical and Metabolic 
Responses to Adrenaline
It was considered that the metabolic and mechanical 
responses to adrenaline may be related. An analysis was 
therefore performed of the possible relationships between
the major metabolic changes (stimulation of the release of
FFA and lactate) and the deterioration in performance over 
the second phase of the adrenaline challenge. It was
considered that a direct toxic effect of adrenaline or one 
(or more) of its breakdown products was unlikely with the
low concentration used. The rates of release of FFA and 
of lactate correlated linearly to the rise in resting 
tension. The equations which describe the relationships 
are:
rise in resting = (0.24 x FFA release) + 0.96
tension (g) (pmole/g/hr)
(correlation coefficient = 0.66, P ^  0.05 n = 9).
rise in resting = (0.01 x lactate release) + (- 0 .12)
tension (g) (pmole/g/hr)
(correlation coefficient = 0.64, P ^ 0.05, n = 11). See
figure 23. In addition, the rate of release of FFA
(but not that of lactate) was significantly related to the
decline in developed tension after adrenaline. The
relationship is described by the equation:
developed tension = (- 0.17 x FFA release) + 2.25
(g) -
(correlation coefficient = - 0.78, P ^  0.02, n = 9). See
figure 24.
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Neither the rate of release of FFA nor that of lactate
was significantly related to either heart rate or the 
incidence of arrythmias after adrenaline.
Since rates of release of FFA and lactate were usually 
linear both before and after adrenaline infusion, the rates
of release of the metabolic products is also an index of
their concentration in the perfusate.
Figure 23
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Relationship between the release of lactate and FFA 
and the rise in resting tension in isolated hearts
from normally-fed rats.
~6Hearts were perfused with adrenaline (10 M) 









This represents a second phase response to adrenaline, 




Relationship between release of FFA and the decline in 
developed tension in isolated hearts from normally-fed 
rats.
Hearts were perfused with adrenaline (10 ^M) during 
ischaemic perfusion (3-4ml/min/g). This represents a second 














3. Effects of Adrenaline - Comparison between recirculating
and non-recirculating perfusion
Experiments were performed in order to investigate the 
possible role of the recirculating metabolic products in the 
adrenaline-induced deterioration in mechanical performance 
observed in sub-section A. The conditions of perfusion were
identical in the two series except that for non-recirculation 
perfusions a large rese voir of perfusate was incorporated 
prior to the aerator column. In addition, perfusate was 
collected after a single pass through the heart. (This
allowed direct measurement of coronary flow in this series).
-6(-) Adrenaline (10 M) was infused for periods of about
l6^ i n  and the results are compared to the measurements of 
adrenaline effect 10 min after infusion in the recirculating 
system.
The phase I responses of the hearts were not
significantly different in the two modes of perfusion but 
marked differences in the second phase response were apparent 
as shown in Table 7.
Significant differences in metabolism are also apparent 
when a comparison is made between recirculating and non­
recirculating perfusion systems. The rates of release of
FFA and glycerol are greater in the non-recirculating 
perfusion; in addition, glucose uptake is greater and lactate 
release is smaller. Thus the fractional conversion of
glucose to lactate is smaller in the non-recirculating 
perfusion, indicating that the metabolism is more extensively
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TA3LE
-6Second phase response of hearts to (-) adrenaline (10 Ml infusion 
in non-recirculating (NR) and recirculating (R) perfusion.
NR
Function Control lOmin post­
adrenaline
R
Control 10 min post­
adrenaline
Resting tension(g) 1.1 -0.2











































( n = 6, adrenaline induced a significantly greater change in 
R than NR.
pre-adrenaline control is significantly greater in 
NR than in R.
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aerobic. Adrenaline induced a similar rise in the rate of
release of FFA and glycerol in the two systems but the
effect on glucose and lactate was such that the fractional 
conversion of glucose to lactate rose more markedly in
the recirculating perfusion.
The results indicate that the recirculating perfusate 
contributes significantly to the adrenaline - induced
deterioration. The major metabolic changes to be detected 
were a greater release of FFA and glycerol into the 
non-recirculating perfusate and a greater contribution from
glucose oxidation to the overall energy production. One 
could postulate that these two observations are related, 
thus the greater clearance of FFA from the tissue
(possibly explained by the supply of fresh albumin
containing no bound FFA) could explain the greater oxidation
of glucose in the non-recirculating perfusion. The 
elimination or reduction of FFA fragments pre-empting the
terminal oxidation sequence beyond the level of pyruvate 
dehydrogenase would allow the more extensive oxidation of 
glucose carbon (Randle et al, 1963). Such a hypothesis
would thus attempt to explain the improved mechanical
response to adrenaline in the non-recirculating perfusion
in terms of improved clearance of metabolites from the
tissue.
In order to further test the involvement of the
recirculating perfusate, the factors presumed to be of 
significance (lactate and FFA) were applied directly as
described in the following section.
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4. Effects of exogenous FFA and Lactate in the
Ischaemically-perfused Rat Heart.
Palmitic acid (bound to low-fat serum albumin) and
lactic acid were infused into hearts for 10 min following 
a 30 min control perfusion. All hearts were perfused by
the non-recirculating method at a coronary flow of 3-4 
ml/min/g. The concentrations of lactic acid and palmitic 
acid were more than double those previously measured in 
the recirculating system. Thus the maximum FFA concentration 
previously measured was 0.2 mM whilst palmitic acid was 
presented at 0.5 mM and 1.0 mM in these experiments.
The maximum lactic acid concentration previously measured 
was 5mM so the concentrations used in these experiments
were 5mM and lOmM.
Lactic acid at 5mM had no observable effects at all 
and even the effects seen with 10 mM lactic acid were 
not statistically significant. Lactic acid (lOmM) had no 
effect on heart rate, resting tension, developed tension, 
incidence of arrhythmias, glucose uptake or FFA release. 
Similarly, little evidence for a direct action of applied 
palmitic acid could be seen. At O.SmM no significant
changes were observed, at l.OmM the heart rate was 
significantly depressed (from 170 - 16 to 106 - 12 beats/min,
P ̂ 0.002, n = 6) but the depression of developed tension
was not significant (from 2.6 - 0 . 4  to 1.3 -0.5g n = 6
P = NS). No changes were observed in resting tension,
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incidence of arrhythmias or in any of the metabolic 
parameters studied (glucose uptake, lactate release, 
fractional conversion of glucose to lactate).
The results show that the effects of lactic acid
and palmitic acid as applied externally are not 
sufficient to explain the damaging effects of adrenaline
found in the recirculating perfusion. To complete this 
investigation one would need to apply both FFA and lactic 
acid together in order to exclude the possibility of a 
synergistic action, although the possible mode of action of 
such synergism is difficult to predict.
The only indication of direct action is that of 
l.OmM palmitic acid on heart rate (and possibly developed 
tension) but the concentration required is far above that 
normally present in the recirculating perfusate. The
important effects of the recirculating perfusate shown in 
sub-section 3 cannot, therefore, be explained simply by the
concentration of lactate and FFA presented. Assuming that
other components in the perfusate do not contribute, an
alternative explanation such as that suggested earlier 
^concerning the effect of the recirculating perfusate upon
metabolite clearance from the heart tissue becomes more 
likely. It is possible that a relatively small
^concentration of FFA or lactate in the perfusate may be
sufficient to significantly disturb the outflow of metabolic 
products whilst exerting no direct effect.
To further investigate the role of endogenously- 
generated FFA and lactic acid, recirculating perfusions were
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performed in which the adrenaline challenge was modified by 
the presence of an antilipolytic agent. Nicotinic acid was 
the main antilipolytic agent used althou^ insulin was also 
applied in two experiments.
5. Effects of antilipolytic treatment on the responses of
the isolated perfused rat heart to adrenaline
(a) General Hearts were perfused for a 2 0 - 3 0  min control
period before the infusion of nicotinic acid (5 x 10 M).
-6After a further 20 min, adrenaline (10 M) was infused.
All hearts were perfused at the ischaemic coronary flow rate
of 3 - 4  ml/min/g.
—6Preliminary experiments had shown that 5 x 10 M -
—510 M nicotinic acid was a convenient antilipolytic
—6concentration. At concentrations below 10 M, nicotinic acid
-4had no antilipolytic effect. At 10 M nicotinic acid was 
apparently toxic, causing cardiac arrest - this was a time-
dependent effect, occurring after about 20 min perfusion
(and interstingly only in the recirculating perfusion, not 
in the non-recirculating system). Insulin was used at 
100 pU/ml which represents the upper range of serum 
concentration in vivo (Selkurt, 1971). Nicotinic acid alone 
did not affect any of the metabolic or mechanical parameters
which were measured during control perfusion.
(b) Effects of nicotinic acid on the first phase
responses to adrenaline. Comparison of these values
with those reported for the effects of adrenaline alone
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(Tables6^0) shows that nicotinic acid did not significantly
affect the mechanical response of the hearts to adrenaline. 
In fact the percent rise of developed tension following 
adrenaline with nicotinic acid (145 - 46%) is greater than
that seen with adrenaline alone (52 - 13%). This, however, 
is rather a reflection of the difference in control
developed tension which coincidentally was higher in the 
group treated with adrenaline alone. The results demonstrate
that nicotinic acid has not acted as a negatively inotropic 
or chronotropic agent.
(c) Effects of nicotinic acid on the second phase
responses to adrenaline The effects of nicotinic acid
on the second phase response of hearts to adrenaline are 
shown in table 9 and figure 25. In this phase, nicotinic 
acid exerted a marked saving effect upon the subsequent 
deterioration in performance following adrenaline. Thus 
developed tension was maintained better (177 - 17% of 
control) in the presence of nicotinic acid than with 
adrenaline alone ( 85 - 20% of control). Resting tension
was stable in the presence of nicotinic acid but rose
109 - 20% with adrenaline alone. The incidence of 
arrhythmias was much reduced in the presence of nicotinic 
acid (19.2 * 6.3% of time) compared to adrenaline alone
(56.5 - 9.4% of time). Heart rate returned to pre­
adrenaline control similarly with both treatments.
The metabolic responses of the heart to adrenaline were 
also modified by tl%e presence of nicotinic acid. Thus
FFA release rose only 5.8 - 3.4% with nicotinic acid but
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TABLE 8
Effect of nicotinic acid (5.10 on the first phase
responses of hearts to adrenaline.
Function Control





Heart rate Cb/min) 171 -18 210 - 18 +42.1 - 17.5
Developed tensionCg) 1.8 -0.4 3,5 - 0.7 + 145 - 46
Data are for hearts from normally-fed rats perfused
for 20min prior to nicotinic acid infusion and

















































C n = 8, = change is significantly different to that
obtained with adrenaline alone)
Measures of performance were taken 30 min after adrenaline
(in the presence of nicotinic acid). Metabolic parameters
represent the linear rates of uptake or release over the
30 min period after adrenaline.
“6Adrenaline was used at 10 M after a prior 40min




Effects of antilipolytics on the second phase responses
of isolated perfused hearts from normally-fed rats.
Hearts were perfused at the ischaemic flow 3-4ml/min/g.
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Rise in resting tension (g) determined 30min 
after adrenaline infusion.
2.0 - 0.3 (n = 12)
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rose 146 - 53% with adrenaline alone. In addition the
stimulation of lactate release induced by adrenaline alone
4.
(150 - 43%) was markedly reduced by the presence of
nicotinic acid (to 79 - 28%). The response of glucose 
uptake in the two groups was siqilar, showing no
significant increase with adrenaline, and so the fractional 
conversion of glucose to lactate rose less in the presence 
of nicotinic acid (12.0 - 6.5%) than with adrenaline alone 
(30.1 - 3.7%).
(d) Effects of Insulin on the responses of the heart to 
adrenaline. In two experiments insulin (lOOpU/ml) was 
used as an alternative antilipolytic agent. It had no 
effect on any of the mechanical or metabolic parameters 
measured during the pre-adrenaline control perfusion, 
including glucose uptake. The second phase responses to 
adrenaline (Table 10, figure 25) in the presence of insulin 
were similar to those observed in the presence of nicotinic 
acid. Thus no arrhythmias were observed and no rise in
resting tension occurred after adrenaline in the presence 
of insulin. Developed tension was maintained above the 
pre-adrenaline control level (425 - 78%) but heart rate 
declined below the control (-47.5 - 6.6%) - in contrast
to the values obtained with adrenaline alone (-15 - 20% and 
11-9%).
Insulin also modified the metabolic responses of the
heart to adrenaline. The release of FFA and glycerol 
were not stimulated at all and the uptake of glucose 
was similarly unaffected. Lactate release rose less in
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the presence of insulin (23 - 23%) than with adrenaline 
alone (150 - 42%). The fractional conversion of glucose 
to lactate also rose less in the presence of insulin 
(13 - 13%) compared to 30 - 4% with adrenaline alone.
The overall effect of nicotinic acid (and insulin) 
was to abolish the lipolytic component of the adrenaline 
challenge and at the same time to greatly offset the 
deteriorations in performance associated with the second 
phase adrenaline responses. In particular, the rise in 
resting tension and in the incidence of arrhythmias 
associated with adrenaline challenge were significantly 
reduced. In addition, the developed tension was maintained 
above the pre-adrenaline control level for longer in the 
presence of the antilipolytics (although with insulin 
there was a converse, more marked, decline in heart 
rate than with adrenaline alone). Antilipolytic treatment 
also offset the rise in the fractional conversion of 
glucose to lactate previously observed with adrenaline 
alone. This indicates a greater degree of oxidation of 
glucose after adrenaline in the presence of antilipolytics.
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TABLE 10
Effects of insulin (100pU/ml) on the response of 
Ischaemically-perfused hearts to adrenaline (10~^n)
First Phase response
Function Contol 30 min post - % change
Cp-e-adw, + adrenaline *
wsidUv) insulin
tbeaLmln! ^30 Î10 325 -*25 41.5 :4,5
Developed tensiohCg) 1.0 -0.0 3.5 -0.5 250 ^50 *
Second Phase response
Heart rate Cb/min) 230 -10 120 -20 -47,5 *6.6 *
Developed tensionCg) 1.0 -0 5.3 -0,8 425 - 78 *
lucose uptake 100.0 -10 100.0 -10 0 - 0pmole/g/hr)
Cpmole/g/hr) ^^O.O -30 175.0 -75 23.0 - 23
gluc“ a l t e  , ^4.0 78.0 :22. / : 13.0  ̂13 '
Cpmole/g/hr) "°.9 4.0 -0,6 -25,0 - 14 *
Cn = 2, * = difference is significantly different to that
observed with adrenaline alone).
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SECTION P. Perfusion of Hearts from Fat-Fed Rats
In order to obtain further information concerning the 
role of myocardial lipolysis during ischaemic perfusion, 
hearts from rats fed on a diet containing a high 
proportion of saturated fats were studied. It was
anticipated that the hearts from fat-fed rats would 
exhibit higher total lipid stores and/or a higher lipolytic 
capacity than hearts from normally-fed rats (Agostini and 
Angelotti, 1973), It would therefore be anticipated that 
more exaggerated responses to the mobilisation of endogenous 
lipids would be found in such hearts.
Hearts from fat-fed rats were perfused at coronary
flow rates over the range 2-14ml/min/g. After a control
-6perfusion of 30min, adrenaline (10 M) was infused and the
perfusion continued for a further 30min. In a separate
group of hearts (all perfused at 5-7ml/min/g) nicotinic 
-6acid (5 X 10 M) was infused after 20min control perfusion.
After 20min in the presence of nicotinic acid, adrenaline
-0(10 , M) was infused and the perfusion continued for a
further 20min. Comparisons have thus been drawn between
the hearts from fat-fed and normally-fed rats with respect 
to ; (1) control perfusion - metabolism and performance
(2) responses to adrenaline
For simplicity, the two groups are referred to as
"fat-fed hearts" and "normally-fed hearts" in the text.
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1. Control Perfusion (Fat-fed vs Normally-fed)
(a) Mechanical properties The hearts from both groups 
were perfused by the recirculating method. The fat-fed 
hearts were perfused over a wider range of coronary flow
in an attempt to maximise performance, Even up to 
14ml/min/g the improvement in perfo-nance with the rise 
in coronary flow was not as marked as had been observed
with the normally-fed hearts. For most comparisons, the 
highest flow rates of the fat-fed series have been 
eliminated so that the mean coronary flow rates of the 
two groups are more similar (normally-fed = 4.9 - 0.8
ml/min/g, fat-fed = 6.9 - 0.7 ml/min/g). Even so the
direction of error is to permit more adequate performance 
of the fat-fed hearts. Significant differences between the 
fat-fed and normally-fed hearts were observed with regard 
to both performance (Table 11, figures 26-28) and metabolism 
(Table 12).
The factors used to describe mechanical performance 
are those used in the normally-fed series with two 
additions. Firstly, dT/dt (the rate of rise of developed 
tension) was determined with the use of an electronic
differentiator in the fat-fed series but by direct 
measurement from the tension trace in the normally-fed 
series. The second additional factor is the oxygen-cost 
of "work” as described below.
The results show that heart rate (148 - 9 beats/min) 
and dT/dt (58 - 13 g/sec) are both markedly depressed in 
the fat-fed hearts compared to the normally-fed hearts
147
Table 11
Performance of isolated perfused rat hearts from 

















Normally-fed (n = 24)

















0.21 -  0.02
Values are mean - S.E.
** indicates that difference between the means is 
significant.
Data are for the stable 30min control perfusion,
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(194 - 16 beats/min and 173 - 17 g/sec). Developed tension
was not significantly different in the two groups.
The rise in resting was very marked in the fat-fed
hearts (1.7 - 0.4g) but was constant during control perfusion 
in the normally-fed hearts. Although the percent extraction
of oxygen was not significantly different in the two
groups, the total MVO^ was higher in the fat-fed hearts 
(54 - 6 pl/g/min) than in the normally-fed hearts (36 - 2
pl/g/min). From a consideration of heart rate and MVO^ 
it can be seen that the oxygen-cost of ."work" is
higher in the fat-fed hearts (0.34 - 0.03 |il/g/beat) than
in the normally-fed hearts (0.21 - 0.02 pl/g/beat).
MVOg/beat is derived from the equation;
MVOg/beat = pi oxygen/g/min ,
beats/min
The use of this term is .justified by relationship o-f keoV Ooc
with MVOg. The relationship is described by the regression
equations:
MVOg (pl/g/rain) = (0.84 x beats/min) + (-76.3)
(correlation coefficient 0.62, P ^  0.01, n = 20), in fat-fed
hearts.
MVOg (pl/g/min) = (0.09 x beats/min) + 21.4
(correlation coefficient = 0.50, P ̂  0.02, n = 20), in
normally-fed hearts.
This evidence is in agreement with the argument of
Sonnenblick and Skelton (1971) that heart rate contributes 
significantly to MVO^.
Of the parameters described in table 11, only percent 
oxygen extraction and resting tension showed a dependence
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Figure 26
Effect of coronary flow on the percent oxygen extraction
of isolated perfused hearts from normally-fed and fat-fed 
rats.
See figure 17 for derivation of % oxygen extraction
Data are for the stable 30min control perfusion





Coronary flow (ml/min/g wet weir;ht) 120
150
Figure 27
Effect of coronary flow on resting tension in isolated 
perfused hearts from normally-fed and fat-fed rats.
The points represent hearts from fat-fed rats only











Effect of coronary flow on heart rate in isolated perfused 
hearts from normally-fed and fat-fed rats. Data are for 
the first stable 30rain control perfusion. Points represent 








coronary flow (ml/min/g wet
weight)
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upon coronary flow (figures 26, 27). The lack of dependence
of heart rate upon coronary flow (figure 28) is a sharp
contrast to the relationship observed in the normally-fed
hearts.
(b) Metabolic properties. The differences between the fat- 
fed and normally-fed hearts is principally expressed as 
an almost complete dependence upon endogenous lipid for 
energy production (table 12) in the former group.
The results show a significantly increased rate of
FFA release from fat-fed hearts (4.2-0.5 pmole/g/hr) compared 
to normally-fed hearts (2.3 - 0.3 pmole/g/hr) and a shift
in the extent of FFA release relative to glycerol 
release in the fat-fed hearts ( FFA/glycerol =* 2.8 - 0.4
compared to 1.3 - 0.5 in the normally-fed hearts). Glucose 
uptake was very low in the fat-fed hearts (2.9 - 0.4
pmole/g/hr compared with a value of 55.7 - 10.0 pmole/g/hr
in normally-fed hearts) but a significant lactate release
was still observed in the fat-fed hearts (20.7 - 3.5 
pmole/g/hr). This lactate may arise from glucose uptake 
since the error of measurement of the latter is large 
enough to account for the lactate. Alternatively, the 




Metabolism of isolated perfused rat hearts from fat-fed
and normally-fed rats.
Function Fat-fed (n =20) Normally-fed (n = 24)
+ + ■ ** Glucose uptake 2.9 - 0.2 55.7 - 10.0
+ + **Lactate release 20.7- 3 . 5  54.2-5.8
+ + **FFA release 4.2 - 0.5 2.3 - 0.3
glycerol release 1.5 - 0.2 1.8 - 0.7
FFA/glycerol 2.8 - 0.4 1 . 3 - 0 . 5
Values are mean - S.E. expressed as pmole/hr/g wet weight 
** indicates that the difference between the means is 
significant.
Data are for the stable 30min control perfusion.
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2. Responses to Adrenaline (Fat-Fed vs Normally-Fed)
(a) First phase responses. The results are presented in 
table 13, In both absolute and percent terms, the 
chronotropic and inotropic responses of the two groups 
were not significantly different,
(b)Second phase responses - mechanical. One would anticipate 
a worsening of mechanical performance after adrenaline in 
the hearts from fat-fed rats compared to those from 
normally-fed rats. The results are not entirely consistent 
but significant factors support the original contention that 
fat-feeding may predispose hearts to poor performance 
following adrenaline challenge during ischaemic perfusion.
Heart rate declined more rapidly (returning to the 
pre-adrenaline rate in 8.9 - 2.4 min compared to 1 4 . 1 - 4 . 0  
min with normally-fed hearts) and more extensively ( to 
112 - 11 beats/min or 75 - 6% of control by 30 min after 
adrenaline, in contrast to the values for the normally-fed
hearts - 188 - 20 beats/min or 111 - 10% of control) in 
the fat-fed hearts. Although there was no significant 
difference between the two groups with regard to the 
incidence of arrhythmias, there were significantly more 
ventricular fibrillations in the fat-fed hearts (23.3 -
8.3% of the time after adrenaline) than in the normally- 
fed hearts (5.9 - 5.9% of time).
The two groups did not differ significantly in their 
responses to adrenaline with regard to either developed 
tension or resting tension.
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Table 13
Responses of isolated perfused rat hearts to adrenaline
(Ipr^M).
The responses are the initial (first phase) 
inotropic and chronotropic responses of hearts from 
fat-fed and normally-fed rats.
Function
Fat-fed Normally-fed
Control Adrenaline Control Adrenaline
Heart rate 148 - 9 229 - 22
(beats/min)
194 - 16 273 - 16
% change 
heart rate
53 - 12 48 - 12
Developed 
tension (g)
2.2 - 0.7 3.6 - 0.9
**




95 - 33 52 - 13
Values are means - S.E.
** indicates that the peak adrenaline-induced tensions 
are significantly different.
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The interpretation of the rise in resting tension in 
the fat-fed hearts is complicated by the high levels
obtained during the control perfusion. There may exist 
a finite limit to which the final approach is non-linear.
This would increase the significance of the relatively 
smaller changes found with the fat-fed hearts.
Considering the mixed evidence it is necessary to 
decide which parameters are most significant in order to 
clearly differentiate between the responses to adrenaline 
of the two groups of hearts. In this respect, the
incidence of ventricular fibrillation should be firmly 
emphasised since this is the most critical single event 
in the determination of the survival of the heart. Thus
catecholamine challenge during ischaemic perfusion may 
depress performance to a certain degree, beyond which
the .maintainance of contractility is jeapardised. The 
additional stress of an increased rate of endogenous 
lipolysis may be sufficient to enforce such irreversible 
responses. See table 14.
(c) Second phase - metabolic. The small glucose uptake 
observed during the control perfusion of the fat-fed hearts 
was not stimulated by adrenaline. The percent stimulation
of lactate release by adrenaline was greater in the fat-fed 
hearts (365 - 85% compared to 150 - 42% with the normally- 
fed hearts) but the absolute lactate release was much
reduced (47.3 - 4.4 pmole/g/hr compared to 129.3 - 18.3 




Second phase mechanical responses to adrenaline (10 M)
of isolated perfused rat hearts, from fat-fed and
normally-fed rats.
Function Fat-fed Normally-fed
(n = 16) (n = 11)
Heart rate (beats/min) 112.- 11 188 - 20
Heart rate (% control) 7 5 - 6  111 - 10
Heart rate (min to ^ ^
return to control) 8,9 - 2,4 14,1 - 4,0
Resting Tension (g) 4,5 - 0,4 3,7 - 0,4
Resting tension +




n . 23,3 - 8,2 5,9 - 5,9
43,5 + 9.4 56.5 + 9,4
+ +68,6 7,8 33.0 5,2
132,3 + 10,2 124,8 + 7,3









+ + **(% control) 177 - 20 143 - 10
Values are mean - S,E,
Parameters were measured 30min after adrenaline infusion. 
Arrhythmias and fibrillations are expressed as % of the 
total 30min, ** indicates that th® difference between 
the means is significant.
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conversion of glucose to lactate is not meaningful in 
the fat-fed hearts because of the low glucose uptake.
The rate of release of FFA after adrenaline was more 
rapid from fat-fed hearts (6.5 - 1.3 pmole/g/hr compared 
to 3.0 - 0.7 pmole/g/hr in the normally-fed hearts) but 
the percent stimulations were not significantly different. 
Neither the rates of release of glycerol nor the 
stimulation of the rates of glycerol release by adrenaline 




-6Second phase metabolic responses to adrenaline (10 M)
of isolated perfused hearts from fat-fed and normally-
fed rats.
Function Fat-fed Normally-fed
(n =s 16) (n = 11)














* +take 100 126,8 - 20,9
+ + **lease 47,3 - 4,4 129.3 - 18,3
+ + **lease 465 - 85 250 - 42
ersion of 100 * 7 9 , 5 - 7 , 6
6,5 - 1,3 3,0 - 0,7
lease 1,9 - 0,3 3,5 - 1,4
+Values are mean - S,E, representing the linear rates of 
release or uptake during the 30min after adrenaline 
infusion, ** indicates that the difference between the 
means is significant, * indicates approximate values due 
error in determination of small glucose changes.
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3. Effects of Nicotinic acid
(a) During control perfusion. The effects of antilipolytic
treatment on the responses to adrenaline of hearts from 
fat-fed rats were investigated.
-6As in the normally-fed hearts, nicotinic acid(5.10 M)
had no effects on the indices of mechanical performance
during the control perfusion. Unlike the normally-fed 
hearts, however, there were changes in metabolism with 
nicotinic acid (table 16).
The pre-adrenaline rate of lipolysis was depressed by
nicotinic acid. Thus FFA release was reduced from 4.3 - 1.2 
pmole/g/hr to 1.9 - 1.2 pmole/g/hr, glycerol release was
reduced from 1.8 - 0.3 pmole/g/hr to 0.6 - 0.3 pmole/g/hr. 
Glucose uptake rose in the presence of nicotinic acid 
from 6.0 - 4.0 to 45.1 - 23.1 pmole/g/hr but the large 
standard errors mean that the rise is not significant 
(P = 0.1). The lactate release was not affected by the
presence of nicotinic acid so the fractional conversion of 
glucose to lactate was reduced from about 100% to 53 - 19%.
(b) Effects on the first phase responses to adrenaline.
The first phase responses of the hearts from fat-fed 
rats to adrenaline were not restricted by the presence 
of nicotinic acid. Heart rate was not affected at all
and in fact the developed tension (7.8 - 1.7g) and dT/dt
(185 - 40g/sec) were significantly higher after adrenaline 
in the presence of nicotinic acid than with adrenaline 
alone (3.6 - 0.9g and 86 - 18g/sec). The percent stimulations
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Table 16
Effects of nicotinic acid (5210 ^M) on the metabolism
of the isolated ischaem^cally-perfused hearts from
fat-fed rats.
Function Control + Nicotinic acid
Glucose uptake 6,0 - 4,0 45,1 - 23,1
(pmole/g/hr)
Lactate release 31,5 - 5,9 32,8 - 13,2
(pmole/g/hr)
_  * + **% conversion of 100 53,0 - 18,8
glucose to lact.
FFA release 4,3 - 1,2 1,9 - 1,0
(pmole/g/hr)
+ **Glycerol release 1,8 - 0,3 0,6 0,3
(pmole/g/hr)
+Values are mean - S,E, (n = 6),
** indicates that the difference between the means is 
significant, * approximate value due to error of 
determination of small glucose changes.
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of these functions by adrenaline was not affected by the 
presence of nicotinic acid.
(c) Effects of nicotinic acid on the responses to 
adrenaline - second phase, mechanical.
Hearts from fat-fed rats treated with either adrenaline 
alone or with adrenaline in the presence of nicotinic 
acid did not differ significantly in their second phase 
responses to adrenaline with regard to developed tension.
Resting tension rose more in the presence of nicotinic 
acid (136 - 61%) than with adrenaline alone (27 - 8%),
Both these results contradict the expected saving effect 
of nicotinic acid. The other data do suggest beneficial 
effects of the antilipolytic agent. Thus heart rate 
declined more slowly (22.2 - 5.3 min to return to pre­
adrenaline control rate, compared with 8.9 - 2.4 min 
to return to control with adrenaline alone) and less 
extensively (214 - 8 b/min or 104 - 10% of control ^
compared with 112 - 11 b/min or 75 - 6% of control by
30min after adrenaline)than the group treated with 
adrenaline alone. In addition, the group of hearts which 
received nicotinic acid developed significantly fewer 
arrhythmias (19 - 9% of time compared with 43 - 9% of 
time for adrenaline alone) and more importantly developed
no ventricular fibrillations at all. By contrast, the 
group of hearts which received adrenaline alone developed
ventricular fibrillation frequently (23 - 9% of the 30 min 
period after adrenaline.
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The data concerning MVO and MVO /beat should be assessed
with caution since both control levels were significantly 
higher in the nicotinic acid - treated group. There was 
no obvious explanation for this difference. The difference 
in control values may explain the significantly smaller 
rise in MVO^/beat observed with the nicotinic acid -
treated group.
(d) Effects of nicotinic acid on the responses to 
adrenaline - second phase, metabolic.
Of the metabolic parameters studied, only FFA release
after adrenaline was significantly affected by the
presence of nicotinic acid. FFA release rate rose from
3.9 - 0.6 pmole/g/hr to 6.5 - 1,3 pmole/g/hr with adrenaline 
alone but did not Change significantly from the control 
in the presence of nicotinic acid (2.4 - 1.8 pmole/g/hr).
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Table 17
-6Effects of nicotinic acid (5,10 M) on the first phase
-6responses to adrenaline (10 M) of isolated perfused 
hearts from fat-fed rats.
Function Adrenaline Adrenaline +
nicotinic acid
Heart rate (beats/min) 229 - 22 236 - 13
r:on::)
+ + **Developed tension (g) 3,6 - 0,9 7,8 - 1,7
Developed tension + 33 195 ± 23
(% control)
Values are mean - S,E, representing peak responses to 
adrenaline during the first 2-8 min after challenge, 
** indicates significant difference between the means.
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Table 18
Effects of nicotinic acid (5.10 ^M) on the second phase 
mechanical responses to adrenaline (10 M) of isolated 






















112 -  n 
175 - 6
8.9 - 2.4
4.5 - 0.4 





214 ± 8 **
215 - 10 **
+ ** 22.2 - 5.3
= 6)
6.3 - 1,5
+ **239 - 61
+ ** 18,7 - 8,5
**none
observed
68,6 + 7,8 106,3 + 12,3
132 + 10 123 + 7
0,56 + 0.07 0,48 + 0,04
177 + 20 101 + **6
**
Values are mean - S,E, representing parameters determined
30min after adrenaline infusion (arrhythmias and fibrillations




Effects of nicotinic acid (5*10 ^M) on the second phase 
metabolic responses to adrenaline (10 ^M) of isolated
perfused hearts from fat-fed rats.
Function Adrenaline Adrenaline +(n = 16) nicotinic acid
(n = 6)
Glucose uptake 2.9 - 0.2 * 45.0 - 22,7
(pmole/g/hr)
Glucose uptake 100 * 100 - 0
(% control)
Lactate release 47,3 - 4,4 66,3 - 11,55
(pmole/g/hr)
Lactate release 466 - 85 241 - 48 **
(% control)
+ . **FFA release 6,5 - 1,3 2^0 - 1^2
(pmole/g/hr)






lease 1,9 - 0,3 1,6 - 0,3
lease 197 - 37 230 - 48
Values are mean - S,E. representing rates of uptake or 
release during the 30 min period after adrenaline infusion, 
** indicates a significant difference between the means,
* indicates approximate value due to error in the 
determination of small glucose changes.
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Section E. Tissue Analysis
(l ) General The investigation of the metabolism of the 
perfused hearts has depended on the measurement of changés
in the perfusate. The procedure gives an indication of 
tissue substrate utilisation and product release, but the
validity of the procedure as a means of determining the
tissue concentration of metabolic products is less certain.
For example, accumulation of FFA during recirculating
perfusion is suggested by the relatively small FFA
release compared to that observed during non-recirculating
perfusion. Glycerol release was not similarly increased in 
the non-recirculating perfusion, showing that the extra 
FFA release was not due simply to a greater degree of
lipolysis. In addition, a large accumulation of lactate 
in ischaemic tissue was reported by Rovetto et al (1973).
Thus although the perfusate may reflect in proportional 
terms the status of the tissue, the absolute relationship 
between tissue and perfusate concentrations is likely to 
be less predictable. For this reason, the concentration 
of FFA in the tissue has been measured directly.
It was anticipated that several questions could be 
answered :
(i) does fat-feeding result in a higher level 
of stored lipid in the tissue?
(ii) is the concentration of FFA within the 
tissue similar to that in the perfusate ?
(iii) do the various conditions of challenge 
alter tissue FFA concentrations in a way consistent with 
the hypothesis that the adrenaline-induced effects could
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be explained, at least in part, by the accumulation of
endogenously-generated FFA.
(2) Effect of fat-feeding on ventricular muscle lipids 
Hearts were removed immediately after decapitation, rinsed
with perfusate and frozen in liquid nitrogen. The results
(table 20) show that hearts from fat^fed rats contained 
significantly more TGFA (4.14 - 0.50 pmole/g wet ventricle)
than did hearts from normally-fed rats (2.36 - 0.40
pmole/g wet ventricle). The two groups of hearts did not
differ significantly with regard to DGFA or FFA.
(3) Relationship between tissue and perfusate concentrations 
of FFA. The relationships for the hearts from both fat-
fed and normally-fed rats are shown in figure 29. Both
sets of data contain results from both adrenaline-treated
and adrenaline + nicotinic acid-treated hearts. The sets
of data appear to belong to single families, thus the
two challenges do not appear to impose different
relationships although they do impose different absolute
concentrations.
The relationships are described by the equations ;
perfusate FFA = 0.95 x tissue FFA) + (-0.5)
(nmole/ml) (nmole/g)
for the normally-fed group (correlation coefficient = 0.85,
n =15 , P <  0.001).
perfusate FFA = (O.lx tissue FFA) + 48.8
(nmole/ml)
for the fat-fed group (correlation coefficient = 0 .66,
n =16 , P <0.01).
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Table 20




(pmole TGFA/ 4.16 - 0.45 2,36 - 0,48
g wet weight) (n = 4) (n = 6)
Diglyceride ^
(pmole DGFA/ 0,20 - 0,05 0.22 - 0,03
g wet weight) (n = 6) (n = 6)
FFA (pmole/ ^
g wet weight) 0,43 - 0,11 0,28 - 0,08
(n = 4 )  (n = 2)
Values are mean - S.E, Hearts were removed immediately 
after decapitation, rinsed in saline and dropped into 
liquid nitrogen. Results are for ventricular muscle only, 




Relationship between tissue (ventricular muscle) and 
perfusate FFA concentrations with isolated perfused 








P <0.01 (•') adrenaline
+ nicotinic 
acid
0 nmole FFA/g wet weight ICXX)
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Both lines seemed to deviate from linearity at the 
highest FFA concentrations but this was not a significant 
trend (the correlation coefficients for logarithmic plots 
were smaller than those obtained for the direct linear 
analysis). The relationships should not be greatly 
influenced by lack of binding capacity for FFA in the
perfusate over the range of concentrations studied. The
highest perfusate concentrations of FFA studied were about 
300nmole/ml (O.SmM) but the albumin concentration of 2g% 
(O.SmM) should provide a binding capacity, for FFA of 
600nmole/ml (0.6mM).
(4) Effect of challenge on tissue FFA concentration.
The elevation of tissue FFA concentration by adrenaline 
was highly significant in hearts from fat-fed rats
(0.83 - 0.13 — > 1.33 - 0.23 pmole/g wet ventricle) but was
not significant in hearts from normally-fed rats (0.15 - 
0.02 — > 0.24 - 0.05 pmole/g wet ventricle) - P = 0.1-0.05. 
Similarly, nicotinic acid significantly reduced the effect 
of adrenaline in the fat-fed group (1.33 - 0.23 — > 0.59 -
0.12 pmole/g) but the change in the normally-fed group 
was not significant (0.24 - 0.05 — >  0.15 - 0.02 pmole/g,
P = 0.1-0.05). See table 21.
(5) Effect of coronary flow on tissue FFA concentration.
As for section (c)j data were drawn from hearts perfused 
both with adrenaline alone and with adrenaline + nicotinic 
acid. The different treatments do not appear to affect 
the relationship studied. With hearts from fat-fed rats 
there was no significant relationship between coronary flow
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Table 21
"6Effects of adrenaline (10 M) and adrenaline + nicotinic 
acid (5.10 M) on the FFA concentration in the isolated 
perfused hearts from fat-fed and normally-fed rats.
Challenge Fat-fed Normally-fed
Adrenaline 1.33 - 0.23 0.24 - 0.05
(n = 10) (n = 6)
Adrenaline + ^ +
nicotinic acid 0.59 - 0.12 0.15 - 0,02(n = 6) (n = 7)
+No addition 0.83 - 0.13 0,15 - 0,02
(n = 22) (n = 8)
Values are mean - S.E. Hearts were perfused for 30min 
control period followed by 30min in the presence of 
adrenaline. Nicotinic acid, when used, was added 20min 
prior to adrenaline. * indicates significant difference 
between the two challenges. / indicates significant 
difference between challenge and control. All values were 
obtained by direct analysis of the (ventricular) muscle 
except ++ which were calculated from perfusate concentration 
and the known relationship between tissue and perfusate 
concentrations. These latter values should therefore be 
regarded as tentative. All values are pmole/g wet ventricle, 
indicates significant difference between fat- and 
normally-fed.
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and tissue FFA concentration (correlation coefficient = 0.35,
P = NS). With hearts from normally-fed rats, tissue FFA
was significantly related to coronary flow :
Tissue FFA = (-87.0 x coronary flow) + 374.6
(nmole/g) (ml/mi n/g)
(correlation coefficient = -0.70, n = 15, P ^0.01). This is
consistent with an increased oxidation of the available
FFA brought about by the increase in oxygen delivery to
the tissue. See figure 30.
(6) Lactate concentration of ischaemically-perfused hearts.
As yet, data are only available from studies of the
hearts of fat-fed rats. Several observations have been 
made ;
(i) no statistically significant relationship was
observed between the tissue and perfusate concentrations 
of lactate. Unlike the situation with FFA, therefore, it
is not legitimate to attempt to predict the tissue
concentration of lactate from the knowledge of perfusate 
concentration.
(ii) the concentration of lactate in the tissue was
found to decline progressively as coronary flow was
increased (figure 31). The regression equation describing
the relationship is as follows :
Tissue lactate = (-0.71 x coronary flow) + 11.53
(pmole/g wet (ml/min/g)
ventricle)
(correlation coefficient = -0.71, n = 13, P^O.Ol , all 
hearts were treated with adrenaline alon^. This is
consistent with a shift to a more oxidative mode of 
metabolism with the increase in oxygen delivery to the
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Figure 30
Effect of coronary flow on the FFA concentration of
ventricular muscle of isolated perfused hearts from
normally-fed rats.
Hearts were perfused for 30min control and then
30rain with adrenaline (•) or adrenaline (10 % )  + 







Effect of coronary flow on the lactate concentration







Coronary flow (ml/min/g wet weight)
Hearts were from fat-fed rats only, being perfused for 30 
min control and -then 30min in the presence of adrenaline 
(10“®M).
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tissue. It should be noted that the absolute concentration 
of lactate in the tissue (even with the very low 
glucose uptake in the fat-fed series) is of the order 
3-10 pmole/g wet ventricle, which is considerably higher 
than that of FFA (0-0.3 pmole/g wet ventricle in the 
fat-fed series).
(iv) Lactate concentration after adrenaline was not 
significantly affected by the presence of nicotinic acid. 
Thus with adrenaline alone the concentration of lactate 
was 7.2 - 0.6 pmole/g (n = 13) but was 9.3 - 1.1 pmole/g 
(n = 6) in the presence of nicotinic acid. Thus the 
observed saving effects of nicotinic acid were accompanied 
by a reduction of FFA concentration in the tissue but 
not by a reduction in the level of lactate. This offers 
further evidence for the dominant role played by FFA 
in the adrenaline-induced decline in performance in the 
ischaemically-perfused hearts used in the study. It 
should be stressed that the fat-fed series differs from 
the normally-fed series in that glucose uptake and lactate 
release are slower. Thus the relative contribution of 
lactate to adrenaline-induced deterioration may be considerab 
ly greater in the hearts from normally-fed rats. This 
observation suggests that it will be necessary to 
measure tissue lactate concentration in hearts from 
normally-fed rats.
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(?) Intracellular concentration of lactate and FFA 
The values previously reported as pmole/g wet weight 
have been corrected for the intracellular volume.
Total tissue water = 8 5 2 — 10 pl/g wet weight (n = 5)
Of the total water, 621 - 32 pl/g is extracellular and 
thus 231 pl/g is intracellular.
In hearts from fat-fed rats treated with adrenaline 
(table 22) a very large excess of both lactate ( 50x) 
and FFA (46x) developed, compared to the perfusate 
concentration. The molar concentrations in the intracellular 
water were 31.00 - 2.45 mM (lactate) and 5.70 - 1.02 mM 
FFA. This represents values of the extreme of fat-fed 
rats with hearts stimulated with adrenaline. The other 
extreme of normally-fed rats with hearts in control 
perfusion and adrenaline + nicotinic acid (FFA values 
only) is described in table 23. Here the FFA concentration 
is much lower, being 0.29 - 0.07 mM (control) and 0.24 -
0.06 mM (adrenaline + nicotinic acid). The excess of 




Intracellular concentration of FFA and Lactate in the 
ventricular muscle of isolated perfused hearts of fat- 
fed rats.
Product Lactic acid FFA
(n = 16) (n = 10)
Perfusate concentration + o.05 0.13 ± 0.01
(pmole/ml)









Values are mean - S.E. Intracellular concentration was
calculated on the basis of measurements which showed
that intracellular volume was 221pl of a total 852pl
tissue water/g wet weight. Hearts were perfused for
30min control period, followed by 30min in the presence
-6of adrenaline (10 M) and the frozen in liquid nitrogen.
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Table 23
Intracellular FFA concentration of the ventricular muscle
of isolated perfused hearts from normally-fed rats.
Challenge Control Adrenaline +
(n = 8) nicotinic acid
(n = 7)
Perfusate concentration ± Q.oi 0.14 1 0.03
(umole/ml)









Values are mean - S.E.' Hearts were perfused for 60min,
or for 30min followed by 30min in the presence of
— 0adrenaline (10 M) and nicotinic acid (5.10 M). Nicotinic
acid was added 20min before adrenaline. At the end of 
perfusion, hearts were frozen in liquid nitrogen prior 
to FFA analysis.
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Section p. Nature and Location of Cardiac Lipid.
(l)Location of Lipid. It had been assumed that the
major lipid reserve of the heart was located in the
ventricular muscle, and that this reserve was mobilised
during the perfusion. This assumption has been validated.
The total heart tissue was divided by gross 
inspection, into 5 discrete types of tissue. The wet 
weights of these different types are shown in table 24.
The ventricular muscle represented about 80% of the
total heart weight.
Several freshly excised hearts were perfused in the
usual way, but with medium containing dye (bromocresol
green). The dye rapidly stained the entire ventricular
muscle (within l-2sec). The atria and aorta also became 
stained but the extraneous tissue did not, suggesting
that the latter was unperfused. The lack of perfusion
restricts the contribution of this tissue to the overall
observed metabolism during perfusion. The only contribution 
will be by diffusion across the surface into the
perfusate which bathes the heart.
The lipid content of the ventricular and "atrial"
(fractions 2-5 pooled to provide sufficient material for 
analysis) fractions of the heart were measured before
and after perfusion. The results in table 25 confirm 
that the triglyceride reserve of the ventricular muscle 
is significantly depleted (2.36 - 0.48 — ^ 1.45 - 0.28
pmole/g, n = 11, P <0.05) whilst that of the atrial
fraction is not (3.20 - 0.80 — > 4.80 - 1.70 pmole/g)
during perfusion lasting Ihr with adrenaline present for
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the final 30min. All hearts were from normally-fed rats.
The results thus confirm the major contribution made by 
the ventricular muscle reserve. The decline in the 
triglyceride is insufficient, however, to account for the 
observed FFA release. The control rate of lipolysis is
1.9 pmole/g/hr, stimulated to 3.6 pmole/g/hr by adrenaline. 
The total FFA release in Ihr with 30min adrenaline is 
thus expected to be 2.75 pmole. This casts doubt on
the lipid extraction procedure and the values reported 
here are indeed smaller than those of Crass et al (1969), 
Taking these latter values, which are about 100% greater
than the ones reported, the decline in ventricular TG 
would be about 4.7 — ^ 1.9 pmole/g or 2.6 pmole. This 
is close to the observed FFA release.
(&) Nature of lipid. The fatty acid compositions of 
perfusate and tissue FFA pools have been studied by 
gas-liquid chromatography of the methyl esters of FFA.
Quantitation of FFA was obtained by calculating the area 
under the chromatogram trace, having deducted the control 
(albumin solution, for the perfusate samples). Individual 
FFA were characterised by comparison of retention times 
to those of known fatty acid methyl esters.
FFA compositions of the tissue and perfusate have 
been expressed as percent composition of the total 
content. The tissue contained significantly more of FFA 
of chain length above C-18 but significantly less of
0-16:1. The other detected FFA were similar in both pools,
i.e. 12:0, 14:0, 14:1, 16;0 and 18:0,:1,:2.
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Table 24
Relative weights of different component tissues of the 
rat heart,
Tissue type mg/g wet weight
total heart.
1. Ventricular muscle 778 - 20
2. Atrial muscle 6 1 - 5
3. Aorta 2 6 - 4
♦ +4. Connective tissue 84 - 10
/ +5. Extraneous tissue 50 - 12
Values are mean - S.E. (n =6). Freshly excised hearts 
from normally-fed rats were rinsed with saline and 
divided by dissection into anatomically discrete tissues.
* was essentially the atrio-ventricular septum and valves, 




Fatty acid compositions of the FFA pools of perfusate
and ventricular muscle of isolated perfused hearts from
normally-fed rats*
Individual FFA Tissue FFA Perfusate FFA
(retention time (n = 4) (n = 8)
—  min)
12:0 (1,5) 1.8 - 0.9 4.3 - 1.7
14:1 (2.5) 0^0 - 0.0 1.6 - 0.6
14:0 (3.4) 10.3- 5.0 11,8 - 6.0
16:1 (5.5) 0.8 - 0.8 17.5 - 4.3 **
16:0 (8.6) 27.0 - 13.8 34.5 - 10.0





+ + ** 45.3 - 18.0 0.5 - 0.5
Values are mean - S.E. representing the percent contribution
of the individual FFA to the total composition. ** shows
significant difference between tissue and perfusate. Hearts
were perfused for 30min control period followed by 30min
—6in the presence of adrenaline (10 M) and then frozen in 




SECTION A Myocardial Lipases
1. Activation
The main aim of the investigation was achieved in that 
an activatable lipase system (sensitive to cyclic AMP) was 
demonstrated in both the pig hearc and rat heart extracts. 
It should be emphasised that this tissue lipase was 
assayed under conditions which virtually exclude interference 
from lipoprotein lipase. In particular, the low pH and 
absence of serum activating factor would prevent lipoprotein 
lipase activity.
2. Location
No positive conclusion can be drawn concerning the 
intracellular location of the lipases in general but it
does appear that the 100,000g pellet is the only fraction
studied which contains the complete system for activation.
By analogy with adipose tissue this implies that both 
hormone-sensitive lipase and cA^P-dependent protein kinase 
are present in the 100,.000g pellet but are not both 
present in such useful concentration in the other fractions 
studied.
3. Complexity of the "lipase"
The results indicate that there are at least two 
discrete lipases present in the 100,000g pellet. One
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activity hydrolyses tripalmitin (and the TG component of 
ediol) and can be stimulated by cyclic AMP. Another
activity must be capable of monoglyceride (and possibly 
Tween) hydrolysis but is insensitive to cyclic AMP. It 
is not possible to say to what extent the monoglyceride
lipase might contribute to the non-cyclic AMP hydrolysis of 
triglyceride. It is safe to assume, however, that the 
triglyceride lipase is unable to hydrolyse monoglyceride, 
unless one imagines some change in substrate specificity 
coincident with cyclic AMP - induced activation. The latter 
possibility may be more feasible in the light of evidence 
from Okuda and Fujii (1975). Studying the adrenaline- 
stimulation of lipolysis in adipose tissue lipid micelles, 
they have presented evidence that the activation involves 
stimulation of the interaction between substrate and 
enzyme rather than stimulation of the enzyme per se. This 
may offer another explanation for the evidence of Huttenen 
and Steinberg (1968) and others who have shown activation 
to be coincident with phosphrylation of the lipase itself.
Previously, this had been assumed to stimulate lipase 
activity in a way analagous to the activation of glycogen
phosphorylase.
4. Further Work
(a) Purification. Further progress would seem to
require some degree of purification of the lipase 
preparation. This should lead to information concerning 
the nature of activation and its possible similarity to
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that of adipose tissue lipase. The requirement for protein
kinase as suggested by the experiments with rat heart 
lipases - and the phosphorylation of the lipase may be 
confirmed. Purification should also open the way to
investigation of the multiplicity oT otherwise of the 
"lipase system". In particular the number of discrete
lipases and their specificity with respect to both lipid
class (mono-di-triglycerides) and the nature of the fatty 
acid residues mcy be elacldoied.
(b) Endogenous Substrates The presentation of
substrates has been and remains a problem in the
investigation of lipases. Even with apparently good
activity, it is not possible to determine if the
substrate presentation is entirely satisfactory. An
interesting approach has been used by Okuda and Fujii
(1973) using endogenous substrate in the form of lipid
micelles prepared from adipose tissue. The micelles 
respond both lipolytically and lipogenically to hormones.
Endogenous lipJysis has also been studied in rat heart
extracts by Sonnenblick et al (1974) so it seems likely
that there is sufficient substrate to make this measureable. 
The adequate supply of substrate is confirmed by the
results to be shown later in this thesis. The
endogenous substrate is largely excluded in the present
method of lipase preparation by the removal of any
floating material. The specificity of activity would be
more difficult to test using endogenous substrate, requiring
quantitation of triglyceride, diglyceride and monoglyceride
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and also characterisation of FFA released.
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SECTION B. The Isolated Perfused Rat Heart as a Model 
of Ischaemia
1. Ischaemia / Hypoxia
It is important to emphasise that normoxic perfusate 
has been used throughout and that the effects of ischaemia 
(induced by low coronary flow) rather than the effects of 
hypoxia have been studied. The terms "ischaemia" and
"hypoxia" are used in a functional sense to describe the
challenge imposed.
The extent to which even high coronary flow will still
induce some degree of hypoxia in the isolated perfused rat 
heart has been discussed by Henderson et al (1969). The 
capacity of perfusate to carry oxygen is restricted to 
the solubility of oxygen whilst blood has a greatly
increased capacity afforded by haemoglobin in addition to
this simple solubility. Despite this an argument can be 
made to show the potential ad^uacy of oxygen supply in
simple solution. Thus, on the basis of evidence which 
shows that the MVO^ of the intact working heart in vivo
(Selkurt, 1971) is about lOOpl oxygen/g wet weight/min, the 
perfusate is theoretically able to deliver sufficient oxygen
even at lOml/min/g. When perfusate is exposed to a
partial pressure of oxygen of about 550 mm mercury, the 
oxygen content is about 16 jil/ml. Thus at lOml/min/g
coronary flow the oxygen delivery is 160 pl/min which
allows a considerable excess above the predicted requirement
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of the tissue of 100 pl/min/g. However, the initial 
reservation must be considered when any attempt is made
to extrapolate from results obtained in vitro to predict 
possible effects in vivo.
2. Graded Ischaemia
Previous reports have described the reduction in
mechanical performance and changes in metabolism associated 
with the imposition of low coronary flow in the isolated 
perfused rat heart (Opie, 1965; Neely et al, 1973). Such 
changes have been confirmed in this investigation and in 
addition it has been possible to generate a system of
graded ischaemia. The indices of ischaemia intensify 
progressively as coronary flow is reduced. Such a model
system allows for comparative investigations without the 
necessity to consider the less secure definition of the 
absolute limits of ischaemic and non-ischaemic tissue.
3. Whole Heart Ischaemia
The use of whole-heart ischaemia as in this model, 
is restrictive if one is interested in investigating the 
effects of ischaemia on cardiac performance in the
clinical sense. With clinically overt ischaemic disease 
there exists, within the myocardium, both tissue which has
a severely restricted blood supply and tissue which is 
adequately perfused (i.e. "regional ischaemia"). With
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imposed whole heart ischaemia, the gross effects upon 
rate and tension can be observed and in those studies in 
which cardiac output can be determined (Rovettq et al, 1973) 
it is found that the primary measures of performance 
(rate, tension, dP/dt) reflect the nett effect of ischaemia 
upon cardiac output. With imposed regional ischaemia, 
however, the relationship between the primary indices of 
performance and cardiac output is not as clear. Severely 
ischaemic tissue exhibits depressed output as one would 
expect, but the remaining tissue can perform at a normal 
or supranormal level in order to compensate for the 
depressed region (Lekven et al, 1973). The overall effect 
of regional ischaemia upon cardiac output is thus very 
difficult to predict and will depend upon both the size 
and location of the area of depressed tissue.
Despite this disadvatage, the model which utilises 
whole-heart ischaemia offers a more straightforward 
interpretation of information about the metabolism of 
ischaemic tissue. Since the tissue is uniformly perfused, 
it can be expected to respond in a relatively uniform 
fashion. By contrast, with imposed regional ischaemia, 
the biochemical responses of ischaemic tissue are difficult 
to isolate from those of nearby non-ischaemic tissue.
The reason is that it is difficult to distinguish between 
the blood (or perfusate) emerging from ischaemic tissue 
and that emerging from non-ischaemic tissue. Gross sampling 
at the coronary sinus is unlikely to be sufficiently 
sensitive since observations will be made upon perfusate
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from ischaemic tissue which has been diluted by perfusate 
from normal tissue (unless the size of the ischaemic
tissue is large compared to that of normal tissue and 
in the clinical setting this is extremely unlikely).
Instead of sampling from the coronary sinus alone, the 
sinus site can be used as an index for normal tissue
and is compared to perfusate drawn from a local vein
emerging from the ischaemic tissue. Such local vein 
sampling requires a very delicate technique in a small
experimental heart such as that of the rat. Alternatively,
a more conveniently - sized preparation such as a dog
heart is used. This means that the great advantage of
the inexpensive rat heart preparation is lost.
In addition to the differences between the whole-heart
and regional ischaemia models j results from both models 
S'hould be assessed in the light of evidence which shows 
that differences in metabolic response may occur depending 
on the depth of tissue. Subepidardial muscle is likely to
be more adequately perfused than subendocardial muscle (as 
described in the introduction). The differences in 
metabolism between the two levels of tissue are slight 
under normal conditions but become marked as the blood or 
perfusate supply is reduced. As total tissue coronary flow
is reduced, the decline in flow to subendocardial tissue 
is greater than the decline experienced in the subepidardial





The changes in oxygen utilisation with change in 
coronary flow suggest two interesting points. Firstly, 
although a straight line gives the best statistical fit 
of data to the line relating MVO^ to coronary flow, there 
is a tendency for the MVO^ to rise less per unit of 
coronary flow at the highest coronary flows studied. This
indicated that approaching 7.8 ml/min/g the coronary flow 
may be almost sufficient to meet fully the oxygen 
requirements of the heart. This would agree with literature 
data concerning MVO^ in vivo.
The second point arises from the relationship between 
coronary flow and the percent extraction of oxygen. At
the lowest coronary flow used (2ml/min/g) the heart extracts 
almost all the oxygen delivered. It is difficult to be 
certain of extraction at this extreme since a finite
error is involved in measurements due to the possibility 
of reoxygenation of the perfusate between the heart and 
the "venous" oxygen electrode (even with the closed system 
used). Despite the ability to eventually extract almost 
all the delivered oxygen at sufficiently low coronary flow, 
the extraction is still sub-mâ)cimal at flow rates where
performance is depressed. Thus at 5 ml/min/g even though 
both heart rate and developed tension are depressed the 
oxygen extraction is not maximal. One might expect 
maximal oxygen extraction at such flow rates in order to 
maximalise performance but this does not appear to happen.
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There are several possible explanations for this 
observation. One possibility is that as coronary flow is 
increased, the residence time of oxygen is sufficiently 
reduced to prevent maximal extraction. To test this 
possibility one would need to know the "mean residence 
time" of oxygen (i.e. perfusate) in the tissue (about 4 sec 
at 4 ml/min/g, 2 sec at 8 ml/min/g) and compare this to
the time required for gaseous diffusion between perfusate 
and tissue — if the latter is of the order of seconds it 
could significantly affect extraction.
Another possible explanation for sub-maximal oxygen 
extraction is some restriction upon oxygen utilisation 
other than simply oxygen supply. For example if oxidative 
metabolism were inhibited then oxygen utilisation would be 
depressed, (see 5, substrate utilisation)
One final point suggested by the data concerning 
oxygen consumption illustrates a similarity of the model 
to the situation existing in vivo. In both cases, the
major factor contributing to oxygen supply is the coronary 
flow and the maintenance of flow is crucial to the 
maintenance of function. There is some capacity to 
increase percent extraction of oxygen but this represents 
a comparatively small reserve.
5. Substrate Utilisation
The utilisation of glucose offers a sensitive index of 
the status of the tissue, particularly showing the difference
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between the challenges of hypoxia and ischaemia. In hypoxic
tissue one observes a faster response with a large increase 
in glucose uptake and lactate release. Thus the relatively 
inefficient glycolytic mode of energy production can proceed 
sufficiently rapidly to provide energy for contraction. In 
ischaemic tissue this response can occur for a short time
(Rovetto et al, 1973) but soon declines. The coronary flow 
(unlike that 'in hypoxia) is insufficient to supply glucose 
and more particularly to remove lactate. Thus even the 
relatively inefficient glycolytic mode of energy production
is inhibited in ischaemic tissue. This inhibition of 
glucose utilisation provides a possible explanation for the 
restriction of oxygen utilisation in the tissue.
The evidence of submaximal oxygen extraction suggests 
that there is still some unused capacity for oxygen 
utilisation in the perfused heart preparation. Interventions 
which are designed to release this unused oxygen capacity 
(thus encouraging greater substrate oxidation) might be 
expected to improve the performance of the heart during 
ischaemia (see Section C).
6, Electroc ardio gram
The electrocardiographic evidence, though somewhat limited^ 
indicates that the changes in T wave and ST segment 
commonly associated with ischaemia in the clinical sense 
can be observed in the isolated perfused rat heart. It 
is hoped that a direct epicardial electrode may provide a
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larger and more- consistent signal. A technique to achieve 
this has recently been suggested (Burges, 1975) whereby a 
light) coiled spring of stainless steel wire (offering very 
little mechanical resistance) would be attached to the 
apex of the ventricular muse le and coiled around the
strain-guage thread.
The EGG is potentially a very useful immediate
measure of the degree of ischaemia within the tissue, 
particularly when used in such an experimental situation 
which eliminates many of the anomolies observed with its 
clinical use (e.g. T wave changes are associated with 
conditions other than ischaemia - Armstrong, 1968). The 
application of the EGG in the perfused rat heart has 
suffered from a lack of knowledge as to the metabolic 
basis of the electrical changes. Recent evidence has 
begun to overcome this problem with the finding that the 
severity of the ST changes are quantitatively related to the
depression of tissue pO^ (Angell et al, 1975).
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SECTION C The Role of Myocardial Lipolysis in the 
Ischaemically - Perfused Rat Heart
1, Adrenaline-induced Deterioration in mechanical performance
Adrenaline induced significant deteriorations in performance 
in the ischaemically-perfused hearts after initial (first 
phase) chronotropic and inotropic responses. The second 
phase deteriorations were principally: a rise in resting
tension (taken to be an indication of a rise in end - 
diastolic pressure which is a sign of failure in the intaét 
heart in vivo - Braunwald and Ross 1963), a decline in 
developed tension and a rise in the incidence of 
arrhythmias. Over the time-course of the changes in
performance, marked changes in metabolism of the hearts
wQfg observed. In particular* endogenous lipolysis was 
stimulated as assessed by the release of FFA into the 
perfusate and the release of lactic acid was also increased. 
Moreover the lactic acid release occurred in the absence of
a significant rise in glucose uptake, thus suggesting a 
decrease in the extent of glucose oxidation. This 
inference from the data may be questioned, however, since 
adrenaline challenge is likely to stimulate glycogolysis 
(by the stimulation of the conversion of phosphorylase 
into the more active form) and so the extra lactate
output may be explained at least in part by glycogen 
degradation.
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The adrenaline-induced rise in resting tension was 
significantly correlated to both the rate of release of 
endogenously-generated FFA and that of lactic acid. In 
addition, the decline in developed tension was significantly 
correlated to the release of FFA (though not to that of 
lactic acid). These relationships are consistent with the 
involvement of FFA (endogenous lipolysis) and lactate in 
the adrenaline-induced (second phase) deteriorations in 
performance.
2. Amelioration of adrenaline-induced deterioration with
antilipolysis
To test the involvement of myocardial lipolysis in the 
adrenaline-induced deteriorations of the second phase repense 
an antilipolytic agent (nicotinic acid) was applied during 
the adrenaline challenge. The results show that the 
lipolytic component (but not the mechanical component) of 
the adrenaline challenge was inhibited. At the same time
the deteriorations in performance were greatly reduced.
Thus the rise in resting tension was abolished and the 
incidence of arrhythmias was reduced. In addition, the 
decline in developed tension caused in the second phase 
of the adrenaline challenge was also significantly reduced. 
Two experiments using insulin as an alternative antilipolytic 
agent gave similar results. This evidence indicates that 
the stimulation of endogenous lipolysis by adrenaline 
contributes significantly to the deteriorations in 
performance observed.
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A possible mode of action of the lipolytic factor 
(in addition to one of the several direct actions of 
FFA pointed out in the introduction) is suggested by the 
fact that the fractional conversion of glucose to lactate 
rises less with adrenaline in the presence of an 
antilipolytic agent. This would indicate either a smaller 
glycogenolytic response to adrenaline with nicotines acid or 
a greater degree of glucose oxidation - made possible by 
the reduction in the availability of FFA for oxidation,
which would be expected to release more oxidative capacity 
to glucose oxidation. This argument is based on the 
glucose - FFA cycle of Randle et al (1963).
3. Influence of Recirculating Perfusate
The imposition of a non-recirculating rather than the
usual recirculating perfusion greatly reduces the . deterioration
in performance induced by adrenaline. This suggests that
the recirculating perfusate contributes significantly to the
adrenaline effects. It has been assumed that the likelihood
of a direct action of adrenaline and/or its metabolites is
—6not great considering the maximum concentration is 10 M. 
Ignoring this possible contribution* the major components of 
the recirculating perfusate likely to be disadvantageous are
FFA and lactic acid. A contribution to deterioration by 
glycerol seems unlikely and the glucose concentration never 
fell sufficiently to limit the supply of that substrate.
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4, Presentation of Exogenous Palmitate and Lactate
Experiments in which either lactic acid or palmitic 
acid (bound to defatted serum albumin) were presented to 
the heart showed that these acids had no apparent effect
on performance or metabolism at concentrations well above 
those demonstrated in the recirculating perfusate.
The lack of effect of lactic acid and FFA as applied
exogenously argues against a direct effect of the 
recirculating metabolic products upon heart performance but
poses the problem concerning how the recirculating perfusate 
exerts its apparent effect. One possibility is that the 
rather low perfusate concentrations may reduce the
clearance of metabolic products from the tissue rather
than exerting a direct effect. This possibility is 
supported by the greater release of FFA into the non­
recirculating perfusate than into the recirculating perfusate. 
This is understandable in that fresh albumin (unloaded with
FFA) is continuously being presented in the non­
recirculating perfusion whereas the binding capacity of 
the recirculating perfusate is progressively reduced and 
can be expected to exert some restriction upon FFA
withdrawal from the tissue. In addition, the fractional 
conversion of glucose to lactate was significantly lower in 
the non-recirculating perfusion, indicating more extensive
oxidation of glucose. This is consistent with a release
of inhibition of glucose oxidation when FFA are more
extensively removed from the oxidation sites (Randle et al, 
1963).
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5, Possible central role of FFA
The evidence taken in total indicates the
involvement of both FFA and lactic acid in the
deteriorations in performance induced by adrenaline in 
the ischaemically-perfused rat heart. The evidence
available supports the contention that of these two
factors the generation of FFA within the tissue may be
the more primary factor. The rise in FFA production 
could exaggerate the tendency for lactic acid production 
by reducing the capacity of the tissue to oxidise glucose, 
according to the glucose - FFA cycle.
The effects have been developed in the absence of 
external FFA or lactate (except for relatively low
recirculating levels which alone could not induce obvious 
deteriorations in performance) and were thus caused by 
endogenously generated metabolic products. This is not to
deny an important role for recirculating products which may 
depress clearance of the endogenously-generated products as 
argued earlier. By comparison to externally-applied
metabolites, endogenously-generated metabolites may be 
generated in a more damaging mode. For example, from the
evidence of Stein and Stein (1968) FFA applied exogenously 
proceed across the cell wall and then through the
sarcoplasmic reticulum to lipid droplets and mitochondria. 
This uptake was dependent upon plasma concentration. By 
contrast, endogenously-generated FFA released from lipid 
droplets (located very close to mitochondria) would be
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immediately released into the vicinity of the mitochondria 
where localised effects on oxidative metabolism could become 
apparent. Such effects would be particularly exaggerated in 
ischaemic conditions where the capacity to remove FFA - by 
oxidation and by losses into perfusate - is reduced. By
contrast, in hypoxia only the oxidative removal of FFA 
would be depressed.
The decline in performance following the adrenaline
challenge during ischaemia could then be rationalised in 
two ways. Firstly, by the known metabolic and physio- 
chemical effects of FFA as described in the introduction;
and secondly by generalised acidosis. Acidosis would be 
primarily a function of the accumulation of lactic acid
rather than FFA. This is explained by the generation of 
a higher molar concentration of lactic acid than FFA (as
will be seen later). In addition, lactic acid can be 
expected to be more available to the general aqueous
phase than FFA (being more hydrophilic) and also as a 
stronger acid, would contribute more extensively to
cellular hydrogen ion concentration.
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SECTION D Perfusion of hearts from fat-fed rats 
I, Control Perfusion
The results obtained are consistent with the
hypothesis that myocardial lipolysis and the endogenously 
generated FFA can exert significant effects upon the 
performance of the ischaemically-perfused heart. Hearts from
fat-fed rats showed significantly elevated rates of
lipolysis compared to hearts from normally-fed animals. 
Evidence concerning tissue lipid and FFA concentrations also
supports the evidence from analysis of the perfusate (see 
later). The glucose utilisation of the hearts from fat-fed
rats was greatly depressed and lactate release was also 
reduced compared to hearts from normally-fed rats. The
almost complete dependence upon endogenous lipid as an
energy source was accompanied by a marked depression of 
performance and also an increase in the oxygen-cost of 
mechanical performance. The fat-fed series thus presents a 
situation in which the release of lactic acid is
relatively low, yet performance is markedly depressed.
This suggests that endogenously-generated FFA exert a more
significant effect than lactic acid and may indicate that 
FFA also exert a more important role than lactic acid in 
the hearts from normally fed rats.
The elevation of oxygen-cost of performance was 
considerably more than would be expected if the only
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reason were the relatively greater oxygen requirement for 
oxidation of lipid as opposed to carbohydrate. The 
expression of this function is the P : 0 ratio (see 
introduction) which is 3.0 for carbohydrate and 2.8 for 
lipid. The difference is about 6% only, much less than 
the difference between oxygen cost of performance in fat- 
fed and normally-fed series, which was about 50%. This 
suggests additional oxygen-wasting associated with lipid 
oxidation. The uncoupling of oxidative phosphorylation by 
FFA observed by Borst et al (1962) would offer an 
explanation for these results.
2. Effects of adrenaline
As in the normally-fed series, adrenaline induced 
marked deteriorations in performance during the second 
phase response (8 - 30 min after adrenaline infusion). One 
would predict a worsening of adrenaline response in view 
of the greater mobilisation of endogenous lipid and in 
some significant respects this was true. Thus the 
incidence of ventricular fibrillation and decline in heart 
rate were significantly increased in the fat-fed series 
compared to the normally-fed series. The adrenaline- 
induced incidence of arrhythmias, decline in developed 
tension and rise in resting tension were not further 
stimulated by the challenge of fat-feeding.
It should be remembered, particularly with respect to 
resting tension, that the fat-feeding induced a marked
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response during control perfusion so that a further 
worsening with adrenaline may not have been possible.
Although the evidence is not entirely consistent it 
largely supports the hypothesis that the stimulation of 
endogenous lipolysis contributes significantly to the decline
in performance observed in the second phase response to 
adrenaline. Of the individual parameters, the incidence of
ventricular fibrillation may be the most significant single 
element considering the critical effect of such a response 
upon the potential survival of the heart.
3. Effects of Nicotinic acid
(a) Control Perfusion In the normally-fed series
nicotinic acid had no effect upon the control rate of 
lipolysis, suggesting that a lipase was present which was 
insensitive to nicotinic acid (unlike the nicotinic acid- 
sensitive adrenaline-stimulated lipase). The effect of
nicotinic acid in reducing control lipolysis in the fat-fed 
series indicates that at least part of control lipolysis
is contributed by the adrenaline-stimulated lipase. The 
system of lipolysis may therefore be partly activated in 
the absence of exogenous catecholamines. This could be
explained by a greater concentration and activity of 
endogenous catecholamines in the hearts from fat-fed rats 
(which could be tested by direct measurement) or perhaps 
by a more sustained modification of the enzymic machinery 
of the hearts accustomed to a more extensive metabolism of
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lipid. Another consequence of the inhibition of control 
lipolysis might be the stimulation of the use of 
carbohydrate as an energy-yielding fuel. Evidence for this
from this work is not convincing as yet but it is worth
examining with further experiments. It would be particularly
interesting to see if the performance of the hearts
improved as the metabolism switched from lipid utilisation 
to carbohydrate utilisation. The lack of a significant 
effect in the experiments reported here may be due to the
fact that insufficient perfusion time was ’ used to allow 
full adaptation of the tissue to glucose utilisation.
(b) Adrenaline Challenge Nicotinic acid abolished the
lipolytic response to adrenaline and at the same time
exerted some saving effect upon the adrenaline-induced 
(second phase) deterioration in performance. Thus the 
incidence of both arrhythmias and ventricular fibrillations 
was significantly reduced. In addition* the decline in 
heart rate was slower and less extensive in the presence
of nicotinic acid. The evidence is not entirely consistent 
however, since no improvement in developed tension and no
reduction in the rise in resting tension were observed in 
the presence of nicotinic acid.
The oxygen cost of work (and to a lesser extent MVO^
vov̂lrv a&rcf'fLl'AG
itself) do not r i s e i n  the presence of nicotinic acid, 
whilst a marked rise is found in the challenge with
adrenaline alone. This is consistent with the depression
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of FFA availability and a consequent increase in glucose 
oxidation in the nicotinic acid-treated group compared to 
the adrenaline group.
As with the perfusion of hearts from normally-fed 
rats, the results in this section largely indicate the
important consequences of stimulation of endogenous lipolysis 
during ischaemia. The significance of the various parameters
involved must be carefully assessed in order to draw 
conclusions as to the nett effect of the antilipolytic
agent. In this respect the abolition of ventricular
fibrillations in the presence of nicotinic acid may be 
crucial since it represents the most severe challenge to 
the survival of the tissue.
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Section Ê. Tissue lipid and tissue lactate.
The metabolic studies had involved measurement of
changes in the perfusate and these vere assumed to 
reflect changes imposed by and within the tissue. The 
underlying assumption, in particular, had been that the 
effects of endogenous lipolysis were mediated by the 
intracellular concentration of FFA and also that of lactic 
acid. It was necessary, therefore, to test this assumption.
Evidence has been presented concerning the concentration 
of FFA within the tissue, but further work is required 
to complete the investigation of tissue lactate levels.
(l) Tissue TG elevated by fat-feeding. The finding of 
increased lipolytic rates in hearts of fat-fed rats 
compared to those of normally-fed rats was supported by 
the significant increase in the total triglyceride stores
of the hearts from fat-fed rats. The levels of FFA and 
di glycerides were not significantly different in the two 
groups.
(B) Tissue FFA changes and perfusate changes. The evidence 
provided by changes in tissue FFA concentration with 
different challenges supports the hypothesis concerning the 
involvement of FFA in the effects of adrenaline. Thus 
adrenaline significantly increased the tissue concentration 
of FFA in hearts from fat-fed rats ( the rise of FFA 
in the hearts of normally-fed rats after adrenaline was 
of marginal significance - P = 0.1-0.05). The presence of 
nicotinic acid depressed this rise of tissue FFA -
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significantly in the hearts from fat-fed rats but not 
significantly in hearts from normally-fed rats (P = 0.1-
0.05).
The relationship between perfusate and tissue concentrati 
on of FFA was linear and highly significant in the
hearts from both fat-fed and normally-fed rats, over the 
range of concentrations studied. Changes in perfusate
concentration of FFA thus accurately reflect the changes
taking place in the tissue. Such a relationship did not
exist between perfusate and tissue concentrations of lactate, 
indicating that lactate changes measured in the perfusate
need not reflect change in the tissue.
(3) Intracellular accumulation of FFA and lactate.
Although the perfusate concentration of FFA is an index
of the tissue concentration, the two values differ in
absolute terms. The difference is especially marked when
the tissue content is converted into intracellular 
concentration. The evidence indicates, moreover that the
pre-adrenaline control level (an excess in the tissue 
of 24x the perfusate concentration) is markedly shifted 
by adrenaline to a 46x excess. The challenge thus
greatly accentuates the accumulation of FFA in the
tissue. The shift in excess is abolished by nicotinic 
acid.
The concentration of FFA within the tissue changes as 
would be predicted if the effects of adrenaline (and the 
amelioration of those effects with antilipolysis) were to
be explained, at least in part, by the tissue concentration
of FFA. With the hearts from fat-fed rats, the
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concentration of lactate does not change in the direction 
expected for its involvement in the adrenaline-induced
effects. The lactate concentration after adrenaline is
not reduced in the presence of nicotinic acid. This 
indicates a more significant contribution by FFA than
lactate to the adrenaline-induced effects, in the hearts 
from fat-fed rats. It must be stressed that the
glycolytic flux is lower in these hearts than those from 
normally-fed rats and therefore the relative importance 
of lactate as a contributing factor in the adrenaline 
effects may be greater in the latter group.
The intracellular concentration of lactate is very 
high in the ischaemically-perfused hearts of the fat-fed 
rats (up to 30mM). Such concentrations would be 
expected to significantly affect tissue pH and the 
consequences of such*change have been described by Rovetto
et al (1973).
The poor relationship between the lactate concentration 
of the tissue and that of the perfusate indicates that 
the lactate concentration of perfusate cannot be
legitimately used as an index of the tissue concentration
during ischaemia. Further, the constant lactate release 
over a range of ischaemic flow rates indicates that the 
degree of lactate release is a poor index of the degree 
of ischaemia.
(4) Tissue binding capacity for FFA. The concentration 
of FFA and the accumulation of FFA in the intracellular 
space are both greater in the hearts from fat-fed rats
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than those from normally-fed rats. It is not known why
the accumulation in excess of the perfusate concentration 
should be so marked in such tissue. As was discussed 
earlier, the albumin content of the perfusate should
be sufficient to allow a much greater FFA release 
than is actually observed. The evidence indicates, rather, 
that the binding capacity of the tissue for FFA is 
increased in the hearts from fat-fed rats. A cytoplasmic 
protein, which binds FFA with high affinity has been 
described (Ochner, Manning, Poppenhausen and Ho, 1972).
It is possible that this protein is present in large 
amounts in the tissue of fat-fed animals, in order to
accommodate the greater dependence on lipid utilisation.
Another possibility for tissue binding of FFA is 
provided by the increase in the triglyceride content
of the myocardium with fat-feeding. This possibility
illustrates a reservation one must have when considering 
concentration terms for FFA. It is reasonable to assume 
a uniform dispersal of FFA in perfusate because of the 
binding capacity of the dispersed albumin. Adequate 
dispersal of FFA within the tissue is less certain,
so the localised concentration of FFA is a possibility.
A further factor which indicates the presence of 
extensive tissue binding of FFA is the non-energetic
nature of FFA uptake by the myocardium (Evans,1963). This 
requires equilibration of FFA concentration across the 
plasma membrane, which is far from the observed situation.
Thus a large proportion of the total tissue FFA must 
be unavailable to this equilibrium pool.
211
Section 6 .
(1) Location of lipid in heart. It was confirmed that 
the ventricular muscle provided the major part of the 
available cardiac TG reserve. The "atrial" fraction 
contained a significant amount of TG but this appeared
to be inert during perfusion.
(2) Possible role for phospholipid. The depletion of the 
ventricular TG reserve was insufficient to account for
the observed FFA release during perfusion. This observation 
casts doubt on the effectiveness of the lipid extraction 
procedure (tested by the recovery of isotopically- 
labelled FFA and TG). It is difficult to assess the 
adequacy of the control, since the labelled lipids 
(injected into the tissue just before extraction) are 
likely to be more available to the extraction medium
than lipids buried within the depth of the tissue. The 
values reported above are about 50% of those reported
by Crass et al (1969) and using these latter values,
the amount of TG appears to be sufficient to account
for the observed FFA release.
A factor not yet considered, is the contribution of 
FFA oxidation. The FFA which are oxidised should be 
added to the FFA released in order to assess the
the total FFA liberation from the endogenous reserve.
The FFA oxidation can be roughly estimated as below.
With MVO^ of 50pl/g/min (3^moles oxygen/g/min) the heart 
could oxidise 30pmole glucose/g/hr. Glucose uptake is 
actually about 40pmo1e/g/hr of which about 50% appears
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as lactate (assuming no glycogen degradation). Thus 
oxygen sufficient to oxidise 10 pmole glucose/g/hr may
be available for FFA oxidation - sufficient to oxidise 
3 pmole FFA/g/hr. This means that the total TGFA 
decline during Ihr (including 30min adrenaline) should 
be approximately 5-6 pmole/g in order that all FFA arise
from TG.
The possible discrepency between FFA mobilisation 
and the TGFA reserve would suggest an alternative source
for FFA. Since the contribution of DGFA and MGFA is
small (Garland and Randle, 1963), this leaves phospho­
lipid as the remaining large lipid reserve. This pool
of lipid has previously been regarded as relatively
inert, Opie (1968).
These points suggest further investigation to test
(i) the true extent of recovery of tissue lipid by the
method used,
(ii) the possible role of phospholipid-fatty acid as a
source of FFA within the tissue.
(3) Selectivity of FFA mobilisation. The investigation of
the nature of the FFA released into the tissue and the
perfusate has raised two main points. The first point
arises from the observation that the composition of the
perfusate and tissue FFA pools differs significantly with
respect to 16:1 (higher in perfusate) and FFA of chain
length above C-18 (higher in tissue). This suggests
selectivity of transport from the tissue, assuming that
all the FFA are equally available for transport. Such
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selectivity has been suggested by Evans (1963) but 
contradicted by Stein and Stein (1963).
The second point concerns the difference in FFA 
composition of the FFA pools determined in this study 
compared to reported TGFA compositions (Gloster and 
Harris, 1973; Szuhaj and McCarl, 1973). This indicates 
the need to determine TGFA content of the hearts used
in this study in order to account for any differences 
in the composition of the diets. Such an investigation 
of tissue FFA and TGFA compositions would also be 
revealing with regard to selectivity of FFA utilisation, 
and mobilisation. Such selectivity of mobilisation is 
suggested by recent (unpublished) work in these laborator 
ies, which have\ shown that the hormone-sensitive lipase 
of the rat heart exhibits a smaller degree of
activatability (with cyclic AMP) towards triolein than 
to tripalmitin.
In experiments to test the effects of exogenous FFA,
palmitic acid was used. These results suggest that the 
application of different exogenous FFA could be tested 
(in particular, 14:0 and 18:0, :1,: 2, which are present in
large amounts in the tissue). In addition, the delivery 
of different FFA from the endogenous reserve might be 
possible with the imposition of different lipid diets.
The different composition of the TG reserve may modify 
the lipolytic response to adrenaline (on the basis that 
HSL attacks different TG to different degrees) and thus
may modify the mechanical responses also.
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Section g . Summary
The results presented demonstrate the damaging effects 
of FFA mobilised from endogenous reserves during ischaemic 
perfusion. The TG mobilised is located within the 
ventricular muscle itself. Exogenous FFA had much less
effect, suggesting different availability and potency 
of endogenously-generated FFA.
With hearts from fat-fed rats and normally-fed rats 
adrenaline induced inotropic and chronotropic (first phase) 
responses which were followed (second phase) by marked 
deteriorations in performance. Thus heart rate and 
developed tension declined to/below the pre-adrenaline 
values. In addition resting tension and the incidence of
arrhythmias both increased after adrenaline. In the 
normally-fed series, the rise in resting tension was 
directly proportional to the rates of release of lactate
and FFA. The decline in developed tension was directly 
proportional only to the rate of FFA release. The 
second phase deteriorations were greatly reduced by the
abolition of the lipolytic component of the adrenaline
challenge with nicotinic acid. Preliminary results show
the deteriorations were similarly reduced in the presence
of an alternative antilipolytic - insulin. The concentrations 
of the antilipolytics was not sufficient to reduce the 
first phase responses of the hearts to adrenaline. The
reduction of FFA release was accompanied by greater 
glucose oxidation, consistent with the glucose-FFA cycle
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(Randle et al, 1963).
With hearts from fat-fed rats control lipolysis was 
significantly stimulated and control performance was 
depressed compared to the hearts from normally-fed rats.
Thus heart rate and dT/dt were smaller, resting tension 
rose more and a greater incidence of arrhythmias was 
observed. These hearts were almost completely dependent 
upon endogenous lipid as an energy source. The performance
of hearts from fat-fed rats also declined more markedly
after adrenaline challenge (although the first phase 
responses were not significantly different) - in 
particular the development of ventricular fibrillation was 
a sharp contrast to the hearts from normally-fed rats. 
Nicotinic acid again offered protection from the second 
phase deteriorations, abolishing the ventricular fibrillations
In both groups of hearts, adrenaline increased the 
tissue concentration of FFA and this was offset by the 
presence of nicotinic acid. The changes in tissue FFA 
were accompanied by much smaller changes in the perfusate. 
The excess tissue concentration of FFA over that in the
perfusate thus increased markedly after adrenaline and the 
shift was abolished by nicotinic acid. The importance 
of the tissue FFA concentration is further, indirectly,
indicated by the response to coronary flow. In the
normally-fed series performance improves with a rise in
coronary flow and the FFA concentration declines. In the 
fat-fed series, however performance does not improve
greatly over the range of coronary flow studied and in
216
addition, the FFA concentration does not decline with 
increasing coronary flow. The validation of this argument 
is dependent on the confirmation that the control FFA 
concentration in the tissue responds to flow as does 
the concentration during adrenaline (and adrenaline + 
nicotinic acid) challenge.
The parallel involvement of lactate in the deteriorative
effects of adrenaline is concluded from most of the 
evidence. The primary role of FFA in contributing to 
the accumulation and release of lactate (according to 
the glucose-FFA cycle) is suggested by the increase in 
glucose oxidation in the presence of antilipolytics. In
addition, the relatively minor role of lactate in the 
fat-fed series is suggested by the fact that the saving 
effects of nicotinic acid are accompanied by a reduction 
of tissue FFA concentration but by no reduction of
lactate concentration. This argument could, however, be 
used to opposite effect. Thus the maintainance of tissue 
lactate might explain the fact that not all the effects 
of adrenaline were abolished by nicotinic acid.
The effects of increasing the myocardial TG reserve, 
demonstrated by the differences between the hearts from 
fat-fed and normally-fed rats, raises the question of 
the significance of the lipid in those species in which 
it is present in greater amounts. Human myocardium 
contains significantly more lipid than rat myocardium 
(Gloster and Harris, 1973, 1974). In addition, the hearts
of pigs and rabbits possess discrete fatty deposits bn
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the epicardial surface, particularly in the region of 
the atrio-ventricular septum. It is reasonable to predict 
that in species with relatively more stored lipid, the 
stimulation of mobilisation is likely to be accompanied 
by more severe effects on performance during ischaemic 
perfusion.
The potential significance of endogenous lipid in vivo
is questioned by the recent evidence of Crass et al 
(1975). In studies with perfused rat hearts, adrenaline 
stimulation of myocardial lipolysis was inhibited by 
about 75% by 0.6mM exogenous palmitic acid. The contribut 
ion of endogenous lipid to the intracellular pool of
FFA was thus restricted by the presence of external FFA. 
It will be of great importance to investigate the extent 
of this effect during ischaemic perfusion. In addition 
and of crucial importance is to determine the overall 
effect upon tissue FFA concentration. Thus, does the 
presence of external FFA lead to an equal intracellular 
accumulation of FFA?
Another factor of importance in determining the 
importance of the myocardial lipid pool in vivo is the
relative speed of delivery of exogenous and endogenous
FFA to the tissue. The delivery of the endogenous FFA 
is likely to be considerably more rapid, particularly 
in ischaemic tissue - in which endogenous catecholamine 
activity is high and to which the delivery of external 
factors is, by definition, depressed.
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Figure 32
Early Metabolic changes in ischaemic myocardium -
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Further work
The points raised in the individual discussion 
sections are summarised below.
Lipase (i) Further purification to investigate mode of 
activation and substrate specificity (lipid class and 
fatty acyl residue)
(ii) activity towards endogenous substrates
(iii) activity in hearts from fat-fed rats as
compared to normally-fed rats - is this consistent with 
the higher pre-adrenaline lipolytic rates and susceptibility 
to nicotinic acid of the control lipolysis in the
fat-fed series?
Perfusion (i) Investi gat ion of the FFA composition of TGFA 
and FFA pools and the changes caused by perfusion with
adrenaline - antilipolytic treatment.
(ii) effects of imposition of different FFA 
composition in the endogenous lipid by modified diet - 
complimented by the application of different exogenous FFA.
(iii) investigation of the sensitivity of 
adrenaline-stimulated lipolysis to inhibition by external 
FFA and the overall effect of the modification of the
lipolytic response on the tissue FFA concentration.
Similarly, do external FFA generate high intracellular FFA 
concentrations as found with adrenaline?
(iv) investigation of the tissue lactate 
concentration of ischaemically-perfused tissue during 
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1. Instruments Automatic recording spectrophotometers were 
from Unicam Instruments Ltd., England. (SP600, 8P1800). 
Automatic sampling and recording spectrophotometer (8300) 
was from LKB instruments Ltd., Stockholm, Sweden.
Physiological recorders (MX2, M19) were from Devices
Instruments Ltd., Welwyn Garden City, Herts., England.
Peristaltic pump and silicone tubing were from Watson
Marlow Ltd., Falmouth, England.
Tri-carb liquid scintillation counter was from Packard
Instruments Ltd., Caversham, Berks., England.
Potter-Elvejelm motor was from Electric Motors Ltd.,
Bournemouthj Hants., England.
Gas chromatograph was from Pye-Unicam Instruments Ltd., 
England.
Ultrasonicator was composed of a low heat-conducting 
probe (titanium-steel) powered by a 400watt amplifier and 
a model 512 oscillator (Waveforms Inc., New York).
2. Chemicals Laboratory chemicals were AnalAr grade from
BDH Ltd., Poole, Dorset, England.
All biochemicals were from The Boehringer Corporation, 
Lewes, East Sussex, England, except those described below.
Sigma Chemical Co. (Kingston-upon-Thames, Surrey,
England) supplied nicotinic acid, lactic acid, streptomycin
sulphate, penicillin-G, lauric and myristic acids and their 
triglycerides.
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Other pure glycerides and FFA were from Associated 
Scientific Ltd., Richmond, Surry, England.
Glucose oxidase test kit was from Roche products Ltd., 
Welwyn, Herts., England. Bovine serum albumin (fraction 5 
powder) was from Armour pharmaceuticals Ltd., Eastbourne, 
Sussex, England. Ediol was from Calbiochem Ltd., Wyndham
pl., London. Tween-60 was from Koc>-Light Ltd., Colnbrook, 
Bucks., England. Radiochemicals were from the Radiochemical
Centre, Amersham, Bucks., England.
3. Animals and Supplies Rats were obtained from Animal 
Supplies Ltd., Welwyn, Herts., England. Pig hearts were
obtained from the factory of Spears and Son Ltd., Bristol, 
England. Laboratory chow (diet modified-41B) was from Oxo
Ltd., London. Out-dated bank blood was obtained from the 
regional transfusion unit, Southmead Hospital, Bristol.
4. Miscellaneous Vinyl tubing was from Portex Ltd., Hythe, 
Kent, England. Specialised perfusion glassware was from 
Jencons Scientific Ltd., Hemel Hempstead, Herts., England.
Vinyl sampling taps were from Travenol Labs. Ltd., Thetford,
Norfolk, England. Medical supplies were from Gallenkamp,
London.
